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Brucellosis is an ancient and one of the world’s most widespread zoonotic diseases affecting both, public 
health and animal production. It is endemic in many developing countries of Asia, Africa and Latin 
America including Bangladesh. Since the first report in 1970, a lot of brucellosis seroprevalence reports 
are available in cattle, goats, sheep and humans in Bangladesh. Most of the previously reported 
prevalence studies were based on non-random samples, which may not give a true representation of the 
status of the disease in respective populations. Some authors also investigated the risk factors in cattle. 
The tests used for the diagnosis of brucellosis in domestic ruminants and humans are imperfect and their 
performance was not evaluated in Bangladesh. The true prevalence of brucellosis in domestic ruminants 
is not known and is essential for analyzing the impact of this disease in domestic ruminants in 
Bangladesh. Indeed, when diagnostic tests are used without evaluating their performance in a context 
usually generate unreliable results, which in turn may lead to wrong epidemiological inferences.  In 
addition, information on risk factors of brucellosis in humans and animals is also scarce. Moreover, the 
different species of Brucella prevalent in animals is scarce and not known in humans in Bangladesh. The 
overall objective of this thesis was to investigate the epidemiology of brucellosis in humans and domestic 
ruminants in Bangladesh in terms of the evaluation of commonly used diagnostic tests, estimation of true 
prevalence, identification of risk factors and detection of Brucella species in order to provide information 
that will guide the selection of appropriate control strategies. 
 
Study design and data analysis 
Sampling 
To collect random samples of animals a system of map digitization and selection of one geographical 
point from selected unions (Sub-Upazilla) using a hand held GPS machine was used. Blood (milk 
also where applicable) samples were then collected from livestock farmers and their animals within 
0.5 km of the selected points. A convenient blood sample of butchers, dairy hands and veterinary 
practitioners were collected from Dhaka and Mymensingh districts. The sera of pyretic humans were 
collected from Mymensingh Medical College hospital randomly once in a week. Random milk 
samples were collected from Sirajgonj and Chittagong districts.  
Systematic random milk and blood samples of cattle including breeding bulls (semen also) of central 
cattle breeding and dairy farm (CCBDF) were also collected. Milk and blood samples of gayals of a 
herd in regional Bangladesh Livestock Research Institute at Naikhonchari, Bandarban were also 
collected. Convenient samples of placenta and vaginal swabs were also collected from Mymensingh 
district. 




Data collection and Analysis 
Data on serology was generated by using Rose Bengal test (RBT), Slow Agglutination test (SAT) 
/Standard tube agglutination test (STAT) (animals/humans) and indirect enzyme linked immunosorbent 
assay (iELISA). Animal, their herd level data and human data on potential risk factors were collected 
using a pretested questionnaire. The data was stored in Microsoft Excels worksheets and transferred to 
respective software for analysis. To estimate true prevalence and evaluate three conditionally 
dependent serological tests, Bayesian latent class models were used. Random effect and Firth’s 
logistic regression analyses were used to determine the risk factors of human brucellosis. The 
STATA, R and OpenBUGS softwares were used for data analyses. Staining, culture, genus and 
species-specific real time PCR assays were applied to isolate and to detect Brucella Spp./DNA in 
seropositive human sera and animal samples. 
 
Main results 
Only 0.29% (95% CI: 0.06-0.86) cattle were acutely infected whereas 0.49% (95% CI: 0.16- 8 1.1) were 
chronically infected with brucellosis in Mymensingh. On the other hand, in CCBDF 15.58% (95% CI: 
11.89-19.89) cattle were acutely infected with brucellosis and only 3.2%(95%CI: 1.63-5.72) were 
chronically infected. The true prevalence of brucellosis among cattle in Mymensingh and CCBDF were 
0.3% (95%CI: 0.03-0.7) and 20.5% (95% CI: 16.4-26.3) respectively. The performance of iELISA was 
best in both Mymensingh and CCBDF with the sensitivity of 90.5% and 91.3% and specificity of 99.3% 
and 99.2% respectively. The performance of RBT was better in Mymensingh than CCBDF with 81.0% 
and 76.1% sensitivity and 99.0% and 95.6% specificity respectively. Similar to RBT, the performance of 
SAT was also better in Mymensingh than CCBDF with 63.5% and 79.7% sensitivity and 98.6% and 
95.3% specificity respectively.  
Through this test validation study, a new cut-off of 5 IU/ml for iELISA was recommended both in low (as 
at Mymensingh) and high prevalence scenarios in cattle populations (as at CCBDF) for routine screening. 
It was recommended to do nothing for the control of bovine brucellosis under small-scale dairy and 
subsistence management systems in Bangladesh. However, vaccination should be applied in herds where 
the prevalence is very high as like CCBDF. 
The true prevalence of brucellosis in goats and sheep were estimated as 1% (95% CI): 0.7–1.8) and 
1.2% (95% CI: 0.6–2.2) respectively. The sensitivity of iELISA was 92.9% in goats and 92.0% in 
sheep with corresponding specificities of 96.5% and 99.5% respectively. The sensitivity and 
specificity estimates of RBT were 80.2% and 99.6% in goats and 82.8% and 98.3% in sheep. The 
sensitivity and specificity of SAT were 57.1% and 99.3% in goats and 72.0% and 98.6% in sheep. 
The prevalence of brucellosis in occupationally exposed people (HROG) using three tests was 
observed to be 4.4% based on a parallel interpretation. The results of the multiple random effects 
logistic regression analysis with random intercept for district revealed that the odds of brucellosis 




seropositivity among individuals who had been in contact with livestock for more than 26 years was 
about 14 times higher as compared to those who had less than 5 years of contact with livestock. In 
addition, when the contact was with goats, the odds of brucellosis seropositivity were about 60 times 
higher as compared to when contact was with cattle only. The seroprevalence of brucellosis among 
patients with pyrexia of unknown origin (PUO) was estimated to be 2.7% (95% CI: 1.2-5.2). The age, 
residence, type of patient, contact with animals, type of animal handled, arthralgia and backache were 
found to be significantly associated with a positive serological result in bivariable Firth’s logistic 
regression. Brucella abortus was detected from seropositive pyretic patients. 
Only B. abortus DNA was amplified from 19 seropositive human samples (both HROG and PUO) and 
six animal samples (3 cows milk, one goat milk, one gayal milk and one bull semen). No Brucella like 
organism was observed under microscope in stained smears. Similarly, no Brucella organism was 
isolated from any of the clinical samples.  
 
Conclusion 
The true exposure prevalence of brucellosis in cattle under small-scale dairy and subsistence/backyard 
management systems is very low (0.3%; 95% CI: 0.03-0.7). The active/acute infection is also very low 
(0.29%: 95% CI: 0.06-0.86) and similar to true exposure prevalence. The brucellosis in cattle under 
such management system is naturally controlled and further control program is not recommended 
considering the poor socioeconomic conditions. 
The true exposure prevalence of brucellosis in CCBDF is very high (20.5%; 95% CI: 16.4-26.3). The acute 
infection in this farm is also very high (15.58%; 95% CI: 11.89-19.89). Immediate control measures by 
initiating calf hood (female calf) vaccination are recommended to protect a valuable herd which also 
provides frozen semen for artificial insemination all over the country. 
The SAT and iELISA may simultaneously be applied to know the stage of brucellosis infection in domestic 
ruminants in high prevalence scenarios. 
The true exposure prevalence of brucellosis in goats and sheep are also low and around 1%. Due to lower 
positive predictive value, these test results should be interpreted with caution to avoid misleading 
information. 
Breeding bulls used for artificial insemination all over the country were found to be infected with 
brucellosis. 
Brucellosis is not a serious problem for the general population in Bangladesh as drinking raw milk and milk 
products is unusual and not a risk factor. The apparent prevalence of brucellosis in high risk occupationally 
exposed people (4.4%; 95% CI: 2.8-6.6) and in pyretic patients (2.7%; 95% CI: 1.2-5.2) are also low. 
The RBT may be applied as a screening test in humans having signs and symptoms of brucellosis along with 
the history of animal contact. In case of suspicion, genus or species specific rt PCR may be applied for 
confirmation. 




Only Brucella abortus is dominant in humans and animals in Bangladesh. Regular screening of 
occupationally exposed people and pyretic patients with animal contact by serology and species specific rt 
PCR will indirectly help to know the species of Brucella prevalent in animals in Bangladesh. 






This thesis is a compilation of two papers published in peer reviewed scientific journals like 
Foodborne Pathogens and Disease and Preventive Veterinary Medicine, three submitted or prepared 
for submission in the scientific journals (PLoS One, Transboundary and Emerging Diseases). The 
document consists of 13 chapters: Chapter 1 and chapter 2 consist of summary and preamble of the 
thesis. 
Chapter 3 provides information on epidemiology of brucellosis in domestic ruminants and humans 
with especial emphasis on prevalence, risk factors, evaluation of serological tests in the absence of 
gold standard. It also briefly describes the context of this study. 
Chapter 4 describes the objectives of this thesis. 
Chapter 5 to chapter 9 isnclude 5 manuscripts published, submitted or prepared for submission. 
Chapter 5 describes the efficacy of three conditionally dependent serological tests like Rose Bengal 
test (RBT), Slow Agglutination test (SAT) and indirect enzyme linked immunosorbent assay (iLEISA) 
for the diagnosis of bovine brucellosis in naturally infected cattle in Bangladesh; the true prevalence of 
bovine brucellosis and stage of infection are also reported. The performance of these three tests was 
also compared in low and high prevalence scenarios. Random blood samples of cattle from 
Mymensingh district and central cattle breeding and dairy farm were collected and used for this study. 
In chapter 6, the Bayesian latent class model based evaluation of three conditionally dependent 
serological tests like RBT, SAT and iELISA for the simultaneous diagnosis and estimation of true 
revalence of brucellosis in small ruminants are described. Representative blood samples of goats and 
sheep populations in Bangladesh were collected and used in this study. 
The dominant species of Brucella prevalent in humans and domestic ruminants Bangladesh is 
described in chapter 7. The chapter describes the prevalence of only Brucella abortus in humans and 
animals. 
In chapter 8, the prevalence and risk factors of brucellosis in a high-risk group of people in Bangladesh 
is reported. The high risk group of people included in this study was livestock farmers, milkers, 
butchers and veterinary practitioners. The RBT, STAT and iELISA were used in every individual. 
The chapter 9 describes the prevalence of brucellosis in pyretic people in Bangladesh and detection 
Brucella species from seropositive pyretic patients. Randomly collected blood samples from pyrexia 
of unknown origin patients were used for this study. The same tests were also used in pyrexic people. 
The chapter 10 describes the general discussion. This chapter critically analyzes the results obtained 
from a series of studies and compared with relevant studies. The probable reasons of low prevalence of 
brucellosis in domestic ruminants were explained. The practical relevance of the generated knowledge 
form this study to design and implement future brucellosis control program was also discussed. 




Chronologically, chapter 11, chapter 12 and chapter 13 consist of conclusions, recommendations and 
bibliography. 






3.1 Epidemiology of brucellosis in humans and animals 
3.1.1 Brief history of brucellosis 
Brucellosis is an ancient and one of the world’s most widespread zoonotic diseases affecting both, public 
health and animal production (Ariza et al., 2007) which is caused by a Gram-negative, facultative 
intracellular bacteria of the genus Brucella (B.). The paleo-pathological evidence form the partial skeleton 
of the late Pliocene Australopithecus africanus suggests that brucellosis occasionally affected our direct 
ancestors 2.3–2.5 million years ago (D’anastasio et al., 2011). The pathological, molecular (DNA 
analysis) and electron microscopy findings from the human skeletal remains (Rashidi et al., 2001; 
Capasso, 2002; Mutolo et al., 2012; D’Anastasio et al., 2011), remains of buried cheese (Capasso, 2002) 
also suggested the presence of brucellosis long time ago for example: 3000-1200 B.C. in Bahrain, Persian 
Gulf, 2100-1550 B.C. in Palestine and Jordan, 79 A.D. in Roman town Pompeii and Herculaneum. 1260-
1020 A.D. in Butrint, Albania. However, the causative agent of brucellosis, “Micrococcus melitensis” (i.e. 
Brucella melitensis), was discovered in 1887 by British surgeon captain David Bruce, his wife Mary 
Elizabeth Steele and the Maltese microbiologist doctor Giuseppe Caruana-Scicluna from the liver of 
diseased soldiers in the Mediterranean island of Malta (Spink, 1956; Ruiz- Castañeda, 1986;Wyatt, 2009). 
After this discovery, the Maltese medical doctor Fioravanti Temistocle Archimede Laurenzo Giuseppe 
Sammut, (known as Temi Zammit) had revealed that the causative agent of Malta fever was transmitted 
from infected goats to humans through contaminated milk (Wyatt, 2005, 2011). After ten years of 
“Micrococcus melitensis” discovery, the Danish scientist Bernhard Bang identified “Bacillus abortus” 
(i.e. Brucella abortus) in bovine aborted fetuses (Bang, 1897). Another organism similar to “Micrococcus 
melitensis” was isolated from aborted pigs in United States, which was finally designated as Brucella suis 
(Traum, 1914). At that time, this disease was further studied by Alice Catherine Evans (an American 
microbiologist) and based on her findings pasteurization of milk was proposed as a preventive measure 
(Evans, 1918). Finally in 1920, Louis Meyer and Wilbur Shaw honored David Bruce by proposing a 
single new genus named Brucella to group these pathogenic bacteria (Meyer and Shaw, 1920).  
 
3.1.2 Species, biovars and zoonotic potentials 
Species identification and sub-typing of Brucella isolates are very important for epidemiologic 
surveillance (to know the species and/or biovar diversity) and investigation of outbreaks (to know the 
source of infection) in Brucella-endemic regions (Al Dahouk et al., 2007; Marianelli et al., 2007). There 
are several concepts (species concept) for the nomenclature for bacteria like “Taxospecies”, 
“Nomenspecies”, “Genomospecies”. The “genomospecies” (based on DNA-DNA hybridization) is 
defined as a group of strains sharing approximately 70% or greater DNA-DNA relatedness with 5°C or 
less change in melting temperature (Wayne et al., 1987). Based on this concept, the genus Brucella should 




be mono-specific as DNA similarity is above 90% between the six classical species (Verger et al., 1985). 
Hence, it was proposed and this proposal was supported by the Subcommittee on the Taxonomy of 
Brucella at that time with B. melitensis becoming the sole representative species and the other species 
being considered biovars of B. melitensis (Corbel, 1988). However, a monospecific genus concept (i.e. 
“genomospecies”) did not get widespread support among the scientific community both from practical 
and scientific background (Moreno et al., 2002; Cohan, 2002; Gevers et al., 2005). So, the classical 
Brucella species are “nomenspecies” with no true taxonomical standing. “Nomenspecies” is defined by 
the cluster of strains to which it is convenient to give a species name on basis other (e.g. host specificity) 
than taxonomical (Ravin, 1963). 
Since 1920, in addition to B. melitensis, B. abortus and B. suis, at least 7 new species have been identified 
as belonging to the Brucella genus with several additional new species under consideration for inclusion 
(Oslen and Palmer, 2014) as shown in Table 3.1. Now, this genus consists of at least ten nomospecies 
having characteristic host preferences and zoonotic potential (Table 3.1). Of 10 recognized species of 
Brucella, infections with B. abortus, B. melitensis, and B. suis are the most pathogenic to humans, 
considered as bioweapons, and are listed as category B priority pathogens by the US Center for Disease 
Control (CDC). Because, the organism is highly infectious, can be readily aerosolized and outbreaks 
might be difficult to detect due to non-specific symptoms associated with infection (Doganay and 
Doganay, 2013). Out of seven biovars of B. abortus, biovar 1 is most frequently isolated from cattle in 
countries where biovar prevalence has been studied, such as the USA (Bricker et al., 2003), Latin 
America (Lucero et al., 2008), Brazil (Poester et al., 2002), India (Renukaradhya et al., 2002) and 
Pakistan (Ali et al., 2014). Brucella melitensis biovar 1 has been predominantly isolated from India (Sen 
and Sharma, 1977; Hemashettar et al., 1987), Libya (Refai, 2002), Iran (Zowghi et al., 2009) and Latin 
America (Lucero et al., 2008). But Brucella melitensis biovar 3 is the most commonly isolated from China 
(Man et al., 2010), Egypt, Tunisia, Israel, Turkey and Jordan (Refai, 2002). 
However, B. melitensis has never been reported from Brazil and Uruguay (Lilenbaum et al. , 2007; 
Garin, 2011) and surveys of 80% of the ovine and caprine populations in El Salvador and Costa Rica 
did not reveal antibodies against Brucella, suggesting the absence of B. melitensis in these countries 
(Moreno, 2002).  
B. suis biovar 1 is most often found in South America and Asia. Both biovars 1 and 3 have been 
reported in the United States, Australia, and China (Cvetni´c et al., 2009). Biovar 2 is the most 
common strain in Europe (Fretin et al., 2013; Szulowski et al., 2013). Biovars 1, 2, and 4 can be 
transmitted from swine to cattle, inducing transient seroconversion, which can confound B. abortus 
diagnostic assays (Musser et al., 2013). Previously it was known that B. suis biovar 2 does not infect 
humans but it was isolated from wild boar hunters and are pathogenetically implicated (Garin-Bastuji 
et al., 2006). 
 
  




3.1.3 Ecology of Brucella spp. 
Bacteria of the genus Brucella spp. are coccobacilli, Gram-negative, aerobic, non-spore-forming, non-motile 
and non-capsulated (Bargen et al., 2012). Although able to multiply in life-less media, Brucella organisms 
are better described as facultative extracellular intracellular parasites (Moreno and Moriyon, 2002). The 
brucellae are members of the α–proteobacteria (Moreno et al., 1990) and interestingly (being animal 
pathogens) have close relationships with soil organisms (e.g. Ochrobactrum spp.), with plant symbionts (e.g. 
Rhizobium spp.) and with phytopathogens (e.g. Agrobacterium spp.). The species Ochrobactrum 
intermedium is considered to be phylogenetically and taxonomically most closely related to Brucella (Scholz 
et al., 2008). All of these bacteria inhabit eukaryotic cells, and comparative genomic studies indicate that 
they have evolved from a common ancestor (Boussau et al., 2004). 
The target organs and tissues of Brucella spp. are placenta, mammary glands, and epididymis in animal 
reservoir host (Adams, 2002; Xavier et al., 2009; Neta et al., 2010). 
 
  




Table 3.1: The species, biovars/biotypes, host preferences and zoonotic potentials of Brucella 
species 
Species Biovars Colony 
type 
Host tropism First reported, country Zoonotic 
 Potential 
B. melitensis 1-3 Smooth Goat, sheep, camels, cows Bruce, 1887, Malta High 
B. abortus 1-6, 9 Smooth Cattle, buffalo, camels, bison, 
elk, yaks 
Bang, 1897, Denmark High 
B. suis 1-5 Smooth Pigs (biotypes 1-3), wild boar and 
European hares (biotype 2), reindeer 
and caribou (biotype 4), wild rodents 
(biotype 5) 
Traum, 1914, USA High 
B. neotomae - Smooth Desert woodrat Stoenner and 
Lackman, 1957, USA 
Unknown 
B. pinnipedialis - Smooth Seal Foster et al., 2007, 
Scotland 
Mild 
B. ceti - Smooth Dolphin, porpoise, whale Foster et al., 2007, 
Scotland 
Mild 
B. microti - Smooth Vole, fox, (soil) Scholz et al., 2009, 
Czech Republic 
Unknown 
B. inopianata - Smooth Unknown Tiller et al., 2010, 
Australia 
Mild 
B. ovis - Rough Sheep McFarlane et al. 1952, 
New Zealand 
No 
B. canis - Rough Dog Carmichael and 
Kenney, 1968, USA 
Mild 
Future species      
Brucella papionis 
sp. nov. 
- Smooth Baboon Schlabritz-Loutsevitch 
et al., 2009, USA 
Unknown 











Transmission within these hosts may occur via ingestion of Brucella contaminated feed or water or 
licking an infected placenta, calf or fetus, or the genitalia of an infected animal soon after it has 
aborted or gave birth (Alexander et al., 1981; Godfroid et al., 2004). As the bacterial concentrations in 




 colony-forming units (CFUs)/g and 




 CFU range, abortion events can laterally 
transmit brucellosis to many cattle that have contact with birthing materials (Olsen and Tatum, 2010). 




Moreover, transmission within the natural hosts can occur through milk or via semen or genital 
secretions during mating. Zoonotic transmission occurs most frequently via unpasteurized milk 
products in urban settings, while occupational exposure of farmers, veterinarians, or laboratory 
workers can result from direct contact with infected animals or tissues or fluids associated with 
abortion (Olsen and Palmer, 2014). Only rare cases of vertical and horizontal (Wyatt, 2010) 
transmission between humans have been reported (Ruben et al., 1991; Mantur et al., 1996; Çelebi et 
al., 2007; Meltzer et al., 2010) and humans are generally considered to be incidental, or dead-end 
hosts for Brucella species (Meltzer et al., 2010). The spillover of brucellae from wildlife to domestic 
ruminants is also possible (Mick et al., 2014). 
 
3.1.3.2 Entry into the host and evading immune system 
The most common portals of entry for Brucella in animals and humans are mucous membranes of the 
respiratory (aerosol) (Franz et al., 2001) and digestive tracts, and in the natural host, also the 
conjunctiva and membranes covering the sexual organs. Bacteria are eventually taken up by 
phagocytic cells (macrophages, dendritic cells, etc.) and reach the regional lymph nodes, leading to 
subsequent systemic dissemination (Ackermann et al., 1988; Salcedo et al., 2008). As Brucella cannot 
multiply outside their mammalian hosts, the most important aspect of Brucella ecology is their ability 
to establish an intracellular replicative niche and remain protected from the host immune responses 
(Bargen et al., 2012). Brucellae lack classic virulence factors like toxins, fimbriae and capsules which 
raises the possibility that they might have unique and subtle mechanisms to penetrate host cells, elude 
host defenses, alter intracellular trafficking to avoid degradation and killing in lysosomes and 
modulate the intracellular environment to allow long-term intracellular survival and replication 
(Delrue et al., 2004). The Brucella LPS O-polysaccharide appears to be a key molecule for cellular 
entry, to prevent complement-mediated bacterial lysis and to prevent apoptosis (i.e. programmed cell 
death) of the macrophages within which they reside allowing them to extend their longevity (de 
Bagüés et al., 2004; Lapaque et al., 2005). 
Brucella has developed mechanisms to avoid innate immunity by minimizing stimulation of pattern 
recognition receptors (PRRs) of the host. The Brucella cell envelope has high hydrophobicity and its 
LPS has a non-canonical structure that elicits a reduced and delayed inflammatory response compared 
with other Gram-negative bacteria (Rittig et al., 2001) and has lower stimulatory activity on TLR4 
receptors (Rittig et al., 2003). The O side chain on the LPS can form complexes with the major 
histocompatibility complex class II molecules that interfere with the ability of macrophages to present 
exogenous proteins. Brucella ornithine-containing lipids and lipoproteins in the outer membrane are 
poor activators of innate immunity. 
The rough (vaccine) strains (i.e., strains with lipopolysaccharide lacking the O-side chain) are less 
virulent because of their inability to overcome the host defense system (Rittig et al., 2003). However, 




under in vitro conditions, up to 90% of virulent Brucella and 99% of nonvirulent Brucella may be 
killed following intracellular entry (Porte et al., 1999).  
3.1.3.3 Survival inside host cell 
After entering into the host cell, smooth Brucella quickly traffic through the early endosomal 
compartment and depart the phagosome to form the modified phagosome (termed brucellosome). 
Brucella initially localize within acidified phagosomes (Rittig et al., 2001), where they are exposed to 
free oxygen radicals generated by the respiratory burst of phagocytes. Brucellae have multiple 
mechanisms to detoxify free radicals. Brucella expresses 2 superoxide dismutases (SodA and SodC), 
which detoxify superoxide anions generated by the respiratory burst of phagocytes. Brucellae require 
acidification of the phagosomal compartment to a pH <4.5 before they display wild-type intracellular 
replication in initial stages of intracellular infection. Localization in an acidified environment induces 
expression of the VirB operon (virB 1–10), which controls expression of genes associated with a type 
IV secretion system. The VirB operon interacts with the endoplasmic reticulum to neutralize the pH of 
the phagosome (Anderson et al., 2008). The Brucella-induced modifications of the phagosome prevent 
fusion with the lysosome. 
Virulent Brucella strains express a cyclic glucan synthase (cgs) that produces and secretes low 
molecular weight cyclic glucans. These molecules disrupt the lipid raft microdomain structures within 
intracellular membranes surrounding the bacteria. This modification of lipid raft distribution in 
phagosomal membranes inhibits phagosome maturation, prevents fusion with lysosomes (Arellano-
Reynoso et al., 2005). 
 
3.1.3.4 Survival outside host cell 
Brucella may remain viable within the environment for a period of time. In general, the viability of 
Brucella spp. outside the mammalian host is enhanced by cool temperatures and moisture and 
decreased by high temperatures, dryness and direct exposure to sunlight. For example, B. abortus 
survives a couple of hours under direct sunlight but up to 185 days in the cold and shade. Brucella 
abortus also survives in aborted fetuses, manure and water for periods of up to 150 to 240 days 
(Saegerman et al., 2010).  
 
3.1.3.5 Brucella is everywhere 
Brucella can infect domestic and wild animals, rodents, sea mammals and even fresh water fish. If 
Brucella infected meat waste is thrown into river directly without proper treatment fresh water fish 
may also become infected with Brucella. As happened in case of a Nile river fish (Clarias gariepinus) 
in Egypt from which B. melitensis has been isolated (El-Tras et al., 2010). So, it is evident that 
Brucella knows no boundary as infecting humans, domestic and wild animals, fresh water fish and 
even marine mammals. 
 




3.1.4 Prevalence, risk factors and impact in domestic ruminants 
3.1.4.1 Bovine brucellosis 
Brucellosis in cattle is caused almost exclusively by B. abortus. There are some areas where the co-
existence of cattle and small ruminants facilitate cattle infection with B. melitensis (Samaha et al., 2008). 
Cattle can also become transiently infected by B. suis biovar 1 which prefer mammary gland as their 
preferred site (Olsen and Hennager, 2010). Brucellosis has been eradicated in many developed countries 
in Europe, Australia, Canada, and New Zealand (Minas, 2006). The European Union (EU) has granted 
brucellosis-free status to Sweden, Denmark, Finland, Germany, Cyprus, the UK (excluding Northern 
Ireland), Austria, Netherlands, Belgium, and Luxembourg (Pappas et al., 2006). Norway and Switzerland 
are also considered brucellosis-free countries. The areas at high risk of brucellosis infection are the 
countries of the Mediterranean Sea Basin (Portugal, Spain, South France, Italy, Greece, Turkey, North 
Africa), also countries of South and Central America, Asia, Africa, the Caribbean and Near East (Galínska 
and Zagórski, 2013). The prevalence of bovine brucellosis in some of the endemic countries is presented 
in Table 3.2.   




Table 3.2: Reported prevalence of bovine brucellosis in some endemic countries 
Country Sample size 
(Herd/animal) 










12.4% (10.89–14.0) 2.10% (1.90–
2.40) 
de la Sota et al., 2005 
Brazil 921/10170 Sub-
national 
RBT and  
2-ME 
15.9% (13.6-18.5) 2.32% (2.04-2.63) Borba et al., 2013; 
 Chiebao et al., 2013 
Georgia 5673 Sub-
national 
RBT  8.5% (7.8-9.3) Mamisashvili et al., 2013 
Algeria 95/1032 Sub-
national 
RBT 26.3% (17.8-35.4) 8.2% (6.6-10.1) Aggad and Boukraa, 2006 
Cameroon 146/1377 Sub-
national 
cELISA 20.3% (4.2-77.6) 3.1% (1.8-4.4) Scolamacchia et al., 2010 
Egypt 1966 National RBT  4.98% (4.1-6.0) Samaha et al., 2008 
Ethiopia 903/7196 National RBT, CFT 20.4% (17.8-23.2) 4.3% (3.6-4.5) Ibrahim et al., 2010; Mekonnen 
et al., 2010; Megersa et 
al.,2011b; Megersa et al., 
2011a; Megersa et al., 2012;  
Adugna et al., 2013 
Libya 42 Sub-
national 
  42.1% (20.3-66.5) Ahmed et al., 2010 
Niger  Sub-
national 
iELISA 14.9% (12.4-17.8) 3.2% (2.7-3.9) Boukary et al., 2013 
Nigeria 271/4745 Sub-
national 





56.4% (48.8-63.8) 16.3% (14.9-17.8) Muma et al., 2006; Chimana et 
al., 2010; Muma et al., 2013 
Iran 600 Sub-
national 
RBT  3.7% (2.3-5.5) Akbarmehr and Ghiyamirad, 
2011 
Jordan 62/671 National RBT, 
iELISA 
25.8% (15.5-38.5) 10.1% (7.9-12.7) Al-Majali et al., 2009 
Kyrgyzstan 1818 National RBT, 
iELISA, 
FPA 
 12.0% (7.0-23.0) Dürr et al., 2013 
Tajikistan 443/904 Sub-
national 
iELISA 4.1% (2.1-6.3) 2.0% (1.2-3.1) Lindahl et al., 2014 
Turkey 626 Sub-
national 
RBT  35.3% (31.6-39.2) Sahin et al. , 2008 
India 6813 Sub-
national 
iELISA  13.6% (12.8-14.4) Kumar et al., 2005; Aulakh et 
al., 2008; Trangadia et al., 
2010; Trangadia et al., 2012; 








 14.1% (12.9-15.2) Nasir et al., 2004; Hamidullah 
et al., 2009; Abubakar et al., 
2012; Shafee et al., 2011; Iqbal 
et al., 2013; Gul et al., 2014; 
Saleha et al., 2014 
Legend: CI: Confidence Interval; Herd Prev.: Herd level Prevalence; Cattle Prev.: Cattle level prevalence; RBT: Rose Bengal test; CFT: 
Complement Fixation Test; BPAT: Buffered Plate Agglutination Test; SAT: Slow Agglutination Test; 2-ME: 2-Mercaptoethanol Test; 
cELISA: Competitive ELISA; FPA: Fluorescence Polarization Assay; PAT: Plate Agglutination Test; NA: not available. 




The range of reported prevalence varied from 2.0% to 42.1%. However, in countries where control 
measures have been undertaken, the prevalence was decreased gradually as in Brazil and Chile (Lopes et 
al., 2010). 
Bovine brucellosis is associated with abortion during the last trimester of gestation, and production of 
weak newborn calves, and infertility in cows and bulls (Xavier et al., 2009). Bovine brucellosis may also 
be responsible for retention of placenta and metritis and results in 25% reduction in milk production in 
infected cows (Acha and Szyfres, 2003; FAO, 2006).  
In some parts of Africa, hygromas and abscess in carpal joints are the major clinical signs in nomadic or 
semi-nomadic cattle herds infected with B. abortus biovar 3 (FAO, 2006; Bankole et al., 2010; Boukary et 
al., 2013). The brucellae localize in the supra-mammary lymph nodes and mammary glands of 80% of the 
infected animals and thus continue to secrete the pathogen in milk throughout their lives (Hamdy and 
Amin, 2002; FAO, 2006). Venereal transmission is not a major route of infection under natural 
conditions, but artificial insemination with contaminated semen is a potential source of infection 
(Radostits et al., 2010; Chiebao et al., 2013). 
The reported animal level risk factors of bovine brucellosis include age, breed, history of abortion, etc. 
(Al-Majali et al., 2009; Ibrahim et al., 2010; Boukary et al., 2013; Chand and Chhabra, 2013; Patel et al., 
2014). The herd level risk factors of bovine brucellosis identified are large herd size, mixed farming, agro-
ecological zones, contact with wildlife, new entry in the herd, artificial insemination, etc. (Muma et al., 
2007; Al-Majali et al., 2009; Ibrahim et al., 2010; Chiebao et al., 2013; Chand and Chhabra, 2013; Patel 
et al., 2014). 
 
3.1.4.2 Brucellosis in small ruminants 
Brucellosis in goats is caused mainly by B. melitensis but in countries where there is no B. melitensis, 
goats can get infected with B. abortus (Lilenbaum et al., 2007). As in cattle, brucellosis in goats is 
characterized by late abortion, stillbirths, decreased fertility and low milk production (Lilenbaum et al., 
2007). Mammary gland is also commonly infected in sheep and goats. Mastitis is commonly observed 
feature of caprine brucellosis compared with bovine brucellosis. The affected mammary gland maybe 
characterized by multinodular firmness with watery, clotted milk (Cutler et al., 2005). Prolonged 
excretion of organisms in milk may occur in goats but less so in sheep (Poester et al., 2013).  
  














Mexico: Goat 83/1713 Sub-
national 
RBT, CFT 71.1% 
(60.1-80.5) 
19.0% (17.2-20.9) Montiel et al, 2013 
Georgia: Sheep 3823 Sub-
national 
RBT  5.5% (4.8-6.3) Mamisashvili et al., 2013 
Georgia:Goat 1323 Sub-
national 
RBT  3.2% (2.3-4.3) Mamisashvili et al., 2013 
Kosovo: 
Sheep 
3548 National RBT  6.5% (5.7-7.4) Jackson et al., 2004 
Kosovo:Goat 511 National RBT  7.8% (5.7-10.5) Jackson et al., 2004 
Egypt:Sheep 1604 National RBT, 
iELISA 
 7.8% (6.6-9.3) Samaha et al., 2008; Hegazy et al., 2011 
Egypt: Goat 749 National RBT, 
iELISA 
 6.7% (4.9-8.7) Samaha et al., 2008; Hegazy et al., 2011 
Libya: Goat 340 Sub-
national 
RBT  30.6% (25.7-35.8) Ahmed et al., 2010 
Libya: Sheep 188 Sub-
national 
RBT  23.9% (18.0-30.7) Ahmed et al., 2010 
Ethiopia: Goat 2005 Sub-
national 
RBT, CFT  1.6% (1.1-2.3) Megersa et al., 2011b; Megersa et al., 
2012 
Niger: Sheep 1186 Sub-
national 





  0.5% (0.1-1.2) Boukary et al., 2013 
Iran: Sheep 740 Sub-
national 
RBT  4.2% (2.9-5.9) Akbarmehr and Ghiyamirad, 2011 
Iran: Goat 160 Sub-
national 














37.6% (35.0-40.2) Al-Majali et al., 2007 
Tajikistan: Sheep 6238 National RBT  5.7% (5.2-6.3) Jackson et al., 2007 
Tajikistan:Goat 6767 National RBT  5.5% (4.9-6.0) Jackson et al., 2007 
Kyrgyzstan: Sheep 2101 National RBT, 
iELISA, 
FPA 
 12% (7%–23%) Dürr et al., 2013 
Kyrgyzstan:Goat 1310 National RBT, 
iELISA, 
FPA 
 15% (7%–30%) Dürr et al., 2013 
Pakistan:Sheep 384 Sub-
national 
mRBT  7.0% (4.7-10.1) Iqbal et al., 2013 
Legend: CI: Confidence interval; Flock Prev.: Flock level prevalence; Animal Prev.: Animal level prevalence; 
RBT: Rose Bengal test; CFT: Complement Fixation Test; iELISA: Indirect ELISA; FPA: Fluorescence 
Polarization Assay; mRBT: modified RBT. 
  




In sheep, brucellosis can be divided into classical brucellosis and ram epididymitis. Ram epididymitis is 
caused by non-zoonotic agent B. ovis, while classical brucellosis is caused by B. melitensis and remains a 
major public health threat equal to goat brucellosis (Acha and Szyfres, 2003). The reported prevalence of 
brucellosis in some of the endemic countries is summarized in Table 3.3. The highest prevalence of 
caprine and ovine brucellosis were reported from Libya and Jordan respectively.  
 
Table 3.4: Reported prevalence/incidence of human brucellosis in some endemic countries 
Country Sample size Type of sample Test used Prevalence/ 
Incidence 
Reference 
Brazil 180 General people cELISA 13.3% (8.7-19.2) Angel et al., 2012 
Bosnia and 
Herzegovina 
286 Unknown RBT, STAT 20.6% (16.1-25.8) Hamzi´c et al., 2005 
Chad 860 Nomadic 
pastoralist 
iELISA 3.3% (2.2-4.7) Schelling et al., 2003 
Egypt 4490   64-70 cases per 
100 000 
individuals 
Jennings et al., 2007 




9.9% (7.6-12.8) Kassahun et al., 2006; Regassa et al., 2009 
Tanzania 199 OEP RBT 5.5% (2.8-9.7) Swai and Schoonman, 2009 
Togo 683 OEP and 
general 
people 
RBT, iELISA 1.0% (0.4-2.1) Dean et al., 2013 
Iran 39359   0-37.3 cases 
per 100 000 
individuals 
Mollalo et al., 2014 
 1681 Referred patients, 
OEP 
iELISA 4.1% (2.8-5.8) Esmaeili et al., 2014; Nikokar et al., 2011 
Kyrgyzstan 1777 Random sample RB, iELISA, 
FPA 
7.0% (4.-9.0) Dürr et al., 2013 
Turkey 2038 Farmers, 
veterinarian and 
general people 
RBT, STAT 8.8% (7.6-10.1) Cetinkaya et al., 2005; Otlu et al., 2008; 
Kutlu et al., 2014 
Saudi Arabia 26613 Healthy and 
individuals with 
symptoms 
STAT 4.2% (3.9-4.4) Al-Sekait, 1999 




8.4% (7.1-9.9) Agasthya et al., 2007; Agasthya et al., 
2012; Pathak et al. , 2014 
Pakistan 852 OEP RBT, SAT, 
iELISA 
15.0% (12.7-17.6) Hussain et al., 2008; Mukhtar and Kokab, 
2008; Ali et al., 2013 
Legend: OEP: Occupationally exposed people; RBT: Rose Bengal test; LFA: Lateral Flow Assay; 
STAT: Standard Tube Agglutination Test; SAT: Slow Agglutination Test; 2-ME: 2-Mercaptoethanol 
Test; cELISA: Competitive ELISA; FPA: Fluorescence Polarization Assay. 
 




The herd level important risk factors for small ruminants brucellosis identified are large flock size, 
addition of new animals from unscreened sources, intensive system of management, history of abortion, 
grazing communal pasture, keeping sheep and goat together (Kabagambe et al., 2001; Lithg-Pereira et al., 
2004; Solorio-Rivera et al., 2007; Al-Majali et al., 2007; Islam et al., 2010; Montiel et al., 2013; Teklue et 
al., 2013). 
 
3.1.5 Prevalence, clinical symptoms and signs and risk factors in human 
Brucellosis in humans almost always originates from an animal reservoir (Godfroid et al., 2013). The 
highest prevalence of human disease is currently found in areas of Africa, Asia, Latin America, and the 
Middle East. Despite being endemic in many developing countries, brucellosis remains under diagnosed 
and underreported (Godfroid et al., 2005). The range of reported incidence of human brucellosis cases per 
100,000 people per year are 0.28-268.81 in North Africa and Middle East, 34.86 in Sub-Saharan Africa, 
0.03-32.49 in Western Europe, 88.0 in Central Asia, 12.84-25.69 in Central and Southern Latin America 
and 0.02-0.09 in North America (Dean et al., 2012b). The highest incidence of human brucellosis is 
reported from Saudi Arabia, Iran, Palestinian Authority, Syria, Jordan and Oman (Pappas et al., 2006). 
The prevalence of human brucellosis in some endemic countries is given in Table 3.4. Human cases are 
useful indicator of the presence of disease in animal populations. It is also important to determine if the 
infection was acquired locally or elsewhere and if food products are implicated, to establish whether these 
were locally produced or imported (FAO, 2006). 
 
3.1.5.1 Clinical symptoms and signs 
The most common clinical symptoms are fever (78%), arthralgia (65%), myalgia (47%) and back pain 
(45%) (Dean et al., 2012a). As 78% patients with brucellosis suffers from fever, it is a diagnostic 
challenge in malaria-endemic areas. Hepatomegally and splenomegally are reported in 23% and 26% 
patients respectively (Dean et al., 2012a). Life-threatening focal complications are endocarditis and 
neurobrucellosis but the overall case fatality is less than1% (Godfroid et al., 2011; Olsen and Palmer, 
2014). Severe complications of brucellosis infection are not rare, with 1 case of endocarditis and 4 
neurological cases per 100 patients as reported by Dean et al. (2012a). It is also reported by Dean et al. 
(2012a) that one in 10 men suffers from epididymo-orchitis. 
 
Poor diagnosis and treatment may result in complications like osteoarticular (sacroilitis, spondylitis, 
peripheral arthritis and osteomyelitis), dermal (erythematous papular lesions, purpura, dermal cysts), 
genitourinary (orchiepididymitis, glomerulonephritis and renal abscess), respiratory (pleural effusions 
and pneumonia), cardiovascular (endocarditis), and neurologic disorders (peripheral neuropahties, 
meningoencephalitis, transient ischemic attacks, psychiatric manifestations and cranial nerve 
compromise) resembling many other infectious and non-infectious diseases (Franco et al., 2007; 
Godfroid et al., 2011). 




3.1.5.2 Risk factors 
The most important species of Brucella responsible for human disease in order of their significance 
are B. melitensis, B. abortus, and B. suis (Acha and Szyfres, 2003). Transmission of brucellosis occurs 
from ingesting (foodborne), directly contacting (penetration through breaks in the epidermis), and 
inhaling the organism (occupationally exposed). The most common means of exposure is eating 
contaminated animal products in endemic areas (Olsen and Palmer, 2014). The less common means of 
infection include person to person (Meltzer et al., 2010; Wyatt, 2010), accidental infection with live 
vaccines (Ashford et al., 2004; Strausbaugh and Berkelman, 2003) and through blood donation and 
tissue transplantation (FAO, 2006). 
Brucellosis is also one of the most common laboratory-acquired infections. Laboratory workers while 
handling specimens containing Brucella species may generate aerosol and may results in infection 
(Noviello et al., 2004). In countries where milk and dairy products are always pasteurized before 
consumption, brucellosis principally affect persons who are in close contact with animals and animal 
products (occupationally exposed) (Seleem et al., 2010). 
The occupationally exposed vulnerable groups include veterinary doctors, butchers, veterinary 
technicians, insemination service employees, zoo technicians, farmers working on multi-herd farms, 
employees of meat and milk processing enterprises (Gali ´nska and Zagórski, 2013). 
Brucellosis may also occur through international travel to endemic countries. Tourists or business 
travelers to endemic areas may acquire brucellosis by consumption of unpasteurized milk or dairy 
products. They may also import contaminated cheese or other dairy products into their countries and 
infect their families (Godfroid et al., 2005; FAO, 2006). 
 
3.1.6. Control of human brucellosis 
Every case of human brucellosis is directly or indirectly linked with infected animals or their products. 
So, the control of human brucellosis depends on minimizing/controlling disease burden in animals and 
reducing animal to human transmission (Zinsstag et al., 2007; Rubach et al., 2013). The control of 
animal brucellosis will be discussed in section 3.4. 
The consumption of nonpasteurized dairy products from Brucella-infected animals is the most frequent 
route of human infection in general. So, pasteurization of milk will reduce Brucella transmission to 
humans (Rubach et al., 2013). 
If pasteurization is not available, boiling or heating of milk at 80–85°C (176–185°F) for several minutes 
will also kill the Brucella (Corbel, 2006). The risk of infection among occupationally exposed group of 
people can be reduced through personal hygiene measures and adoption of safe working practices, 
including use of protective clothing, disinfection of protective clothing, and disinfection of potentially 
infected utensils and premises. To avoid aerosol transmission, eating and smoking must be forbidden in 
the abattoirs/heavily contaminated environments while handling animals and inhalation of dust or aerosols 
derived from dried excreta or tissues released at abortion, parturition or slaughter should be prevented by 




the use of suitable respirators (Corbel, 2006; Islam et al., 2013b). However, these measures may be 
unfeasible in low and middle-income countries due resource limitations and nomadic animal husbandry 
practices (Corbel, 2006). In this situation, steps should be taken to reduce the impact of the disease by 
educating the population regarding the disease and its risk factors (Corbel, 2006; Islam et al., 2013b). 
Ideally, occupationally exposed group of people should be kept under medical surveillance with 
periodic serological examinations. It is strongly recommended that new staffs provide a baseline blood 
sample before starting work. Those who develop clinical disease should be treated promptly. Young 
people less than 18 years of age and pregnant women should be excluded from high-risk occupations 
(Corbel, 2006). 
 
3.2 Diagnosis in animals 
In the history of microbiology, very few diseases have more diagnostic tests than brucellosis and the 
list of some indirect tests is given in Table 3.5. Diagnostic tests are applied for the following purposes: 
confirmatory diagnosis, screening or prevalence studies, certification, and, surveillance in order to 
avoid the reintroduction of brucellosis (in countries where brucellosis is eradicated) through 
importation of infected animals or animal products (Godfroid et al., 2010). The diagnostic methods 
include direct tests, involving isolation of organism or DNA detection by polymerase chain reaction 
(PCR)-based methods and indirect tests, which are applied either in vitro (mainly to milk or blood) or 
in vivo (allergic test). Isolation of Brucella spp. or detection of Brucella spp. DNA by PCR is the only 
method that allows certainty of diagnosis. 
 
3.2.1 Direct diagnosis 
3.2.1.1 Stained smears 
Smears of placental cotyledon, vaginal discharge or fetal stomach contents may be stained using 
modified Ziehl-Neelsen (Stamp) method. The presence of large aggregates of intracellular, 
coccobacillus red organisms is presumptive evidence of brucellosis. It is still often used, even though 
this technique is not specific as other abortive agents such as Chlamydophila abortus or Coxiella burnetii 
are also stained red (Alton et al., 1988; FAO, 2006). 
 
3.2.1.2 Culture 
Bacterial culture plays an important role in confirming the presence of disease and it is essential for 
antimicrobial susceptibility, biotyping and molecular characterization which provides valuable 
epidemiological information to know the sources of infection in outbreak scenarios and the strain diversity 
in endemic regions (Kattar et al., 2008; Álvarez et al., 2011). However, two studies reported direct 
molecular typing of Brucella organisms without culture from clinical materials of both human and animal 
origin (Zhang et al., 2013; Gopaul et al., 2014). The likelihood of obtaining a positive culture from 
material (other than samples collected from an abortion event) from a live infected animal is too low (15-




70%) for reliable diagnosis. Isolation of Brucella bacteria is time and resource-intensive; it requires level 
3 biocontainment facilities and highly skilled technical personnel to handle samples and live bacteria 
for eventual identification and biotyping (Yu and Nielsen, 2010). Handling all live Brucella involves 
risk of laboratory infection and very strict biosafety rules must be observed. In order to avoid these 
disadvantages, methods based on PCR are becoming very useful and considerable progress has been 
made recently to improve their sensitivity, specificity, and technical ease and to lower costs. So, 
culture is not an appropriate technique for routine screening of brucellosis in animals and humans 
(Seleem et al., 2010; McGiven, 2013). 
Important clinical samples include aborted fetuses (stomach, spleen, and lung), fetal membranes, vaginal 
secretions, colostrum, milk, sperm, and hygroma fluid. Brucella may also be isolated post-mortem from 
supra-mammary, internal iliac and retropharyngeal nodes, spleen, udder tissue, testes and gravid uterus. 
Care should be taken to minimize the fecal and environmental contamination of the material to give the 
greatest chance of successfully isolating Brucella. For the isolation of Brucella spp., the most commonly 
used medium is the Farrell medium (FM), which contains antibiotics able to inhibit the growth of other 
bacteria present in clinical samples.  
However, due mainly to the nalidixic acid and bacitracin contained in its formulation, FM is inhibitory for 
B. ovis and also for some B. melitensis and B. abortus strains (Marin et al., 1996). A new selective 
medium (CITA) containing vancomycin, colistin, nystatin, nitrofurantoin, and amphotericin B was found 
to be more sensitive than FM (De Miguel et al., 2011). The cream and the sediment part of the milk 
obtained after centrifuge are spread on to the surface of at least three plates of solid selective medium. 
Placenta and other solid tissues need to ground manually or homogenize in a blender or stomacher with a 
small proportion of sterile water. Fetal stomach contents are collected, after opening the abdomen, by 
searing the surface of the stomach with a hot spatula and aspirating the liquid contents with a Pasteur 
pipette or syringe. As some Brucella species, like B. abortus biovars 1-4, need CO2 for growth the culture 
plates should be incubated at 35°C to 37°C in 5% to 10% CO2. Brucella colony may be visible after 2-3 
days, but cultures are usually considered negative after 2-3 weeks of incubation (Alton et al., 1988). 
 
3.2.1.3 Biotyping 
Biotyping of Brucella spp. is performed using different tests, like agglutination tests with antibodies 
against rough (R antigen) or smooth LPS (against the A or M antigens); lysis by phages, dependence on 
CO2 for growth; production of H2S; growth in the presence of basal fuchsine or thionine; and the crystal 
violet or acriflavine tests (Alton et al., 1988).  
These techniques must be carried out using standardized procedures by experienced personnel and usually 








3.2.2 Molecular methods 
3.2.2.1 Identification 
Several PCR based methods have been developed. The best-validated methods are based on the 
detection of specific sequences of Brucella spp., such as the 16S-23S genes, the IS711 insertion 
sequence or the BCSP31 gene encoding a 31-kDa protein (Ouahrani-Bettache et al., 1996; Baddour 
and Alkhalifa, 2008). These techniques were originally developed on bacterial isolates and are now 
also used to detect Brucella spp. DNA in clinical samples. 
PCR-based assays are rapid and highly sensitive and specific, with some assays detecting down to 10 
cells in less than two hours (Bounaadja et al., 2009). 
 
3.2.3 Indirect diagnosis 
There are two types Brucella colony known as ‘smooth’ and ‘rough’ based on the 
lipopolysaccharide (LPS) in their outer cell wall (Baldwin and Goenka, 2006). The ‘smooth’ 
phenotype has complete LPS consisting of lipid A, a core oligosaccharide and an O-side chain 
polysaccharide (S-LPS/OPS) while LPS of ‘rough’ strains lack the O-side chain (R-LPS). B. 
ovis and B. canis are both naturally ‘rough’ species and all the others are ‘smooth’ species 
(Cardoso et al., 2006). The S-LPS or B. abortus whole cells and R-LPS are usually used as 
antigen for the diagnosis of brucellosis caused by smooth and rough species respectively 
(Nielsen and Duncan, 1990; OIE, 2008). For example, the RBT uses B. abortus biotype 1 (Weybridge 
99) whole cells as antigen, which will be able to detect antibody against B. melitensis also as both 
share common epitopes in OPS. 
 
3.2.3.1 Tests used 
Nielsen and Yu (2010) had reviewed serological diagnosis of brucellosis. The authors described the 
kinetics of immune response and discussed the principles, merits and demerits of the available diagnostic 
tests. As stated there, the serological tests detect different types of antibody produced in response to 
Brucella infection. For example, the IgM isotype antibody response usually appears 5 to 15 days post 
exposure.  
The IgM antibody response is followed very shortly by production of IgG1 isotype of antibody and 
subsequently by IgG2 and IgA (Sutherland, 1984; Godfroid et al., 2002; Saegerman et al., 2004). As the 
IgM response commences early, theoretically it would be most suitable to measure this isotype as an 
indicator of exposure. There is, however, a number of other microorganisms containing antigens with 
epitopes similar to those of OPS and measurement of IgM antibody may result in a false positive reaction 
in serological tests. False positive reactivity would lead to specificity problems which would be of 
considerable consequence in an early control programme resulting in unnecessary slaughter; in the last 
stages of an eradication program and in free areas, resulting in expensive follow-ups. Production of IgG2 
and IgA isotypes occurs later in infection and, as a result, measurement of these antibodies would 




generally lower assay sensitivity. Based on these observations, the most useful antibody for serological 
testing for brucellosis is IgG1 (Nielsen and Yu, 2010). 
Godfroid et al. (2010) had reviewed the diagnosis of brucellosis in livestock and wild life. It is stated 
there that the kinetics of production and disappearance of the principal immunoglobulin isotypes 
during infection, and the activity of these immunoglobulins in the different serological tests, will 
usually permit the distinction between acute and chronic infections.  
 
Table 3.5: List of some available tests for the diagnosis of brucellosis 
Tests Agglutination tests Primary Binding Assays 
Slow Slow Agglutination (SAT) Radioimmunoassay 
 SAT with added reducing agents such as 2-
mercaptoethanol or dithiothreitol 
Fluorescence immunoassay 
 SAT with addition of rivanol to precipitate 
glycoproteins 
Particle counting fluorescence 
immunoassay 
 SAT with addition of ethylene diamine tetraacetic 
acid to reduce IgM binding (EDTA) 
Indirect enzyme immunoassay 
 SAT with antiglobulin added to enhance 
agglutination 
Competitive enzyme immunoassay 
 Milk ring test Fluorescence polarization assay 
Rapid Rose Bengal  
 Modified Rose Bengal 
 Buffered Plate agglutination 
 Card 
 Heat Treatment of serum 
 Addition of 10% sodium chloride  
Tests Precipitation Tests Compliment Fixation Test 
 Agar gel immunodiffusion Warm 
 Radial immunodiffusion Cold 
  Hemolysis in gel 
 Indirect hemolysis 
Tests Allergic tests  
 Skin test  
 
The authors explained the following principles about the status of brucellosis based on serological test 
results: 
• The concomitant presence of IgM and IgG suggests acute brucellosis, while chronic brucellosis is 
characterized by the presence of IgG alone. 




• A positive response in an agglutination test, which detects mainly IgM, is not indicative of 
brucellosis if it is not confirmed by a positive IgG response by iELISA within one week. 
Accordingly, in this research multiple testing strategy was used so that the stage of infection in 
domestic ruminants can be determined using three agglutinating (one rapid: RBT and two slow: MRT 
and SAT) and one primary binding assay (iELISA).  
 
These four tests are further discussed in this section.  
 Slow Agglutination Test with EDTA: In 1897, Smith and Wright (Weight, 1897) published the first 
description of this test for the serological diagnosis of brucellosis in man. The antigen used is B. 
abortus biotype 1 (Weybridge 99). The SAT detects IgM isotype of antibody efficiently. The SAT 
detects IgG less efficiently, especially IgG1, resulting in low assay specificity. Addition of EDTA has 
improved it specificity significantly (Alton et al., 1988). Reading is done on the basis of degree of 
agglutination and expressed in international units (IU). Any serum with an antibody titer greater than 
or equal to 30 IU/ml, as prescribed by the EU (Shey-Njila et al., 2005), is considered positive. Due to 
specificity problem, the OIE has recommended the discontinuation of this test as a diagnostic tool for 
bovine brucellosis (OIE, 2009). However, it is a standardized and extremely robust test that has 
shown good results and has proven efficacious in several countries now declared officially free of 
brucellosis (Emmerzaal et al., 2002). This test is simple, cheap and if used simultaneously with other 
test IgG detecting test like iELISA will help to determine the stage of infection in animals based on 
the above-mentioned principle (Godfroid et al., 2010). 
 Milk Ring test: The test consists of mixing colored Brucella whole-cell antigen with fresh bulk/tank 
milk. In the presence of anti-Brucella antibodies, antigen-antibody complexes form and migrate to 
the cream layer, forming a purple ring on the top of the column of milk. In the absence of antigen-
antibody complexes, the cream remains colorless. This test is not considered sensitive and may 
fail to detect a small number of infected animals within a large herd. 
However, this lack of sensitivity is compensated by the fact that the test can be repeated, usually 
monthly, due to its very low cost and gives a good reflection of serum antibody.  
False positive reactions may also occur due to abnormal milk such as mastitic milk, colostrum and 
late lactation cycle milk. This test is prescribed by the OIE for use only with cow milk. 
Bulk milk can be screened to detect the presence of infected animals within the herd, which can 
then be identified by blood testing. This method of screening is extremely effective and is usually 
the method of choice in dairy herds (OIE, 2009). 
 Rose Bengal Test: B. abortus biotype 1 (Weybridge 99) whole cells stained with Rose Bengal and 
suspended in a buffer which when mixed with the appropriate volume of serum results in a final 
pH of 3.65±0.05. After thorough mixing of the serum and antigen, agglutination must be visible be 
within 4 minutes for positive result. The low PH used reduces non-specific reactions because it 
prevents some agglutination by IgM and encourages agglutination by IgG1. The RBT is a rapid 




agglutination tests lasting 4 minutes done on a glass plate with the help of an acidic-buffered 
antigen (pH 3.65 ±0.05). These tests have been introduced in many countries as the standard 
screening test followed by confirmatory testing because it is very simple, the consumables are 
cheap, there is a low equipment requirement and the assay is standardized (Nielsen and Ewalt, 
2010). False negative reactions may occur, due to pro-zoning with sera containing very high levels 
of antibody. In addition, false positive serological reactions (FPSR) may occur due to some cross-
reacting antibodies and antibodies resulting from B. abortus S19 vaccination (OIE, 2009). 
 Indirect ELISA: Most iELISAs use purified B. abortus biotype 1 (Weybridge 99) S-LPS as antigen. 
The iELISA is highly sensitive but lacks the capability to fully resolve the FPSR problem and the 
problem of differentiating between antibodies resulting from cross-infection and S19 vaccination 
(OIE, 2009). Competitive ELISA and fluorescence polarization assay have been reported to 
circumvent the FPSR problems due to cross-reacting antibodies and S19 vaccination (Nielsen and 
Ewalt, 2010). However these tests are not in use in Bangladesh for the diagnosis of brucellosis. 
 
3.3 Evaluation of diagnostic test and estimation of true prevalence in the absence of gold 
standard 
Using diagnostic tests without evaluating their performance in a context may generate unreliable results, 
which may also lead to wrong epidemiological inferences (Godfroid et al., 2013). The performance of a 
diagnostic test is typically described by two quantities, the sensitivity (Se) and the specificity (Sp), each 
describing the capacity of the test to reflect the unknown “true” disease status (Speybroeck et al., 2013). 
The Se is the probability of a positive test given the disease is present and Sp is the probability of a 
negative test result given the disease is absent. An important fact, which is often overlooked, is that the Se 
and SP are population specific parameter, as opposed to some intrinsic constant, as it depends upon the 
specific biological characteristics of the study population (Greiner and Gardner, 2000). The evaluation of 
the performance of a diagnostic test is straightforward when a gold standard test (Se=1 and Sp=1) is 
available for verifying disease status or from an experiment where a proportion of the subjects are 
artificially infected (diseased) and a proportion of the subjects are known to be disease-free as shown in 
equations 3.3.1, 3.3.2 and 3.3.3 from Table 3.6. 
  




Table 3.6: Evaluation of a diagnostic test by a gold standard test 
 Gold Standard Test Total 
Test under 
evaluation 
Positive Negative  
Positive TP FP TP + FP 
Negative FN TN FN + TN 
 TP + FN FP + TN n = TP + FP + FN + TN 
 
Legend: n indicates the number of subjects; TP, FP, FN, and TN indicate true positive, false 
positive, false negative and true negative respectively; TP + FN indicates diseased and FP + TN 
indicate disease-free; TP =True positive: truly infected individual with a positive test result; TN =True 
negative: truly non-infected individual with a negative test result; FP =False positive: truly non-
infected individual with a positive test result; FN =False negative: truly infected individual with a 
negative test result 
 
The sensitivity, specificity of the test under evaluation and the true prevalence of the disease can be 




                                                        3.3.1 
𝑆𝑝 =
𝑇𝑁
 𝐹𝑃 + 𝑇𝑁 
                                                         3.3.2 
𝑇𝑟𝑢𝑒 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 =
𝑇𝑃 + 𝐹𝑁
𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁 + 𝑇𝑁
         3.3.3 
 
However, gold standard tests are rarely available and most diagnostic tests are imperfect (Se <1 and/ or 
Sp <1). For example, although culture is considered as gold standard for the diagnosis of brucellosis, 
its sensitivity varies from (30 -70% in chronic cases and 80-90% in acute cases) in humans (Franco et 
al., 2007; Espinosa et al., 2009). 
Apparent prevalence (test positive / sample size) can be converted to true prevalence based on the 
results of a screening test using the Rogan-Gladen estimator as shown in the equation 3.3.4 (Rogan 
and Gladen, 1978) when the Se and Sp of that test are known. 
 
 𝑇𝑟𝑢𝑒 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 =
𝐴𝑝𝑝𝑎𝑟𝑒𝑛𝑡 𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 + 𝑆𝑝 − 1
𝑆𝑒 + 𝑆𝑝 − 1
                 (3.3.4) 




In this equation, the only variable is apparent prevalence, the Se and Sp are fixed parameters which is 
not realistic as many factors like the presence of cross-reacting pathogens (Saegerman et al., 2004) and 
low infection pressure, may influence the test parameter values (Speybroeck et al., 2012). Even if, the 
Se and Sp are considered as variables, as it should be, it is not possible to estimate three unknown 
quantities (true prevalence, Se and Sp) from a single equation like 3.3.4. Under certain conditions, 
using several diagnostic tests may partially solve this problem, but most often external information on 
the diagnostic test characteristics will be needed (Berkvens et al., 2006). 
It is also fully explained that the Rogan-Gladen estimator can produce estimates of prevalence, which 
exceed one or are negative (Hilden, 1979; Speybroeck et al., 2013).  
Several other approaches have been developed for evaluation of tests in the absence of gold standard 
including both frequentist (maximum likelihood estimation based) and Bayesian latent class models 
(Lewis and Torgerson, 2012). The class of models where the disease status of the individual is 
unknown are known as latent class models as the disease status is latent: existing but not presently 
evident or realized (Toft et al., 2005). Among the frequentist approach, the most widely used latent 
class model of test accuracy based on maximum likelihood estimation was proposed by Hui and 
Walter (1980). Hui and Walter model depends on three assumptions: 
• the tested individuals are divided into two or more populations with different disease prevalences; 
• the tests have the same properties in all populations; 
• the tests are conditionally independent given the true (but latent) disease state. 
In fact, these assumptions are not always true ((Dendukuri and Joseph, 2001; Branscum et al., 2005; 
Toft et al., 2005; Berkvens et al., 2006). 
Bayesian latent class model for the simultaneous estimation of true prevalence and evaluation of 
diagnostic test characteristics are preferred over the frequentist approach as it assumes Se and Sp as 
random population parameters (not fixed) and can combine observed field data (likelihood) with any 
external (a prior) information on Se, Sp and apparent prevalence within a single model (Dunson, 2001; 
Speybroeck et al., 2013). The external information may be obtained from similar previous studies or 
even the beliefs of investigators (i.e. expert opinions). The choice of prior information thus plays a 
central role when interpreting diagnostic test results and every effort should be made to verify that the 
prior probability distributions assigned to the different variables are not in conflict with the data 
(Berkvens et al., 2006). The deviance information criterion (DIC) (Spiegelhalter et al., 2002) and 
Bayesian p value (Bayes-p) (Gelman et al., 2013) are two measures of discordance which can be used 
to verify whether the prior information is in conflict with the data/test results. A systematic review 
summarizing data using appropriate meta-analysis is preferred to obtain informative priors on 
diagnostic test performance (EFSA, 2009). A beta or uniform distribution of the priors is usually used 
in Bayesian latent class models. The sensitivity analysis of prior information should always be 
performed to assess its potential influence on estimates (Rahman et al., 2013). 




In Bayesian latent class model, rather than using a single imperfect test, multiple imperfect tests 
(either in series or parallel) are combined to estimate the true prevalence of the disease and diagnostic 
test accuracy parameters (Joseph et al., 1995; Black and Craig, 2002). The overall misclassification 
errors are reduced in multiple testing strategy (Sanogo et al., 2014). 
An important consideration in the evaluation of multiple diagnostic tests is whether or not the tests can 
be assumed conditionally independent of each other given the true disease status. It has been 
demonstrated that the assumption of conditional independence may lead to biased estimates for test 
characteristics if in fact the tests are conditionally dependent (Vacek, 1985; Gardner et al., 2000). For 
example, in the context of brucellosis serology, the IgG iELISA detects only IgG, whereas RBT 
detects IgG mainly (IgM and IgA also) and SAT detects IgM mainly (IgG and IgA also) antibodies. 
So, they can be considered to be partially conditionally dependent on each other given the true disease 
status (Gardner et al., 2000; Nielsen and Yu, 2010). Therefore, the estimation procedures should be 
adjusted for the dependencies among the tests (Georgiadis et al., 2003; Branscum et al., 2005). In this 
scenario, Bayesian latent class model should incorporate the covariance factor expressing the extent of 
the dependence among positive and negative results, to estimate the Se and Sp of the tests under 
evaluation and by taking into account the testing strategy also (Gardner et al., 2000). 
 
3.4 Control and eradication of brucellosis in domestic ruminants 
Before developing a national control strategy, the impact of brucellosis on the livestock economy and 
human health, adequacy of national veterinary service organization to carry out the strategy, collaboration 
between public health and veterinary services and the costs of the different control or eradication 
strategies must be evaluated as part of this strategy (Blasco and Molina-Flores, 2011). Some of the 
developed countries have successfully eradicated animal brucellosis by combined vaccination and test-
and-slaughter programs (Pappas et al., 2006), along with effective disease surveillance and animal 
movement control (Godfroid et al., 2013). 
 
3.4.1 Eradication 
In order to eradicate brucellosis, the combined test and slaughter program is usually implemented 
initially by compulsory vaccination, then vaccination is gradually restricted and eventually prohibited 
during removal of seropositive animals or herd depopulation (when the herd or flock prevalence is 
low: for example <2%). More than a decade is usually needed to complete the brucellosis eradication 
program by a “test-and-slaughter” policy and key for success is a sufficient financial compensation 
scheme for farmers for their culled livestock (Corbel, 2006; Godfroid et al., 2013). Other than expense, 
a good record keeping, infrastructure, cooperation between all related stakeholders and epidemiologic 
surveillance are also essential for successful eradication program. 
The vaccination primarily prevents clinical effects of the disease (i.e., abortions or infected calves) that 
lead to transmission (Olsen and Stoffregen, 2005). The most widely used live attenuated vaccines are B. 




melitensis Rev1 (Rev1) for sheep and goats and B. abortus S19 (S19) for cattle. Both induce good 
protection but can induce abortion if administered during pregnancy. In the United States, routine 
brucellosis vaccination is administered via intramuscular or subcutaneous injection and limited to 
prepubescent heifers (4–12 months) (Olsen and Tatum, 2010). Both S19 and Rev1 interfere serological 
diagnostic testing. However, conjunctival vaccination with reduced doses before the age of 4 months 
avoids the serological interference as well as the abortions and udder infections (Godfroid et al., 2011). 
For example, the original dose of S19 vaccine is (2.5–12x1010 CFUs) for calfhood vaccination, but the 
United States and some other countries switched to a reduced dosage (3–10x109 CFUs) in the 1980s in an 
effort to reduce the number of calfhood vaccinates having retained antibody titers (Olsen and Tatum, 
2010). Since 1996, the United States and some Latin American countries are using B. abortus strain RB51 
vaccine instead of S19. The RB51 is a rough strain and hence does not induce antibody responses that are 
detected by conventional brucellosis serologic tests. Moreover, cattle that were calfhood vaccinated with 
S19 did not seroconvert as adults when boostered with calfhood dosages of RB51. Under experimental 
conditions, cattle vaccinated with 1 to 3.4x10
10
 CFUs of RB51 have reduced incidence of abortion or 
Brucella infection at necropsy when compared with non-vaccinated cattle (Poester et al., 2006). As with 
S19, adult vaccination with RB51 has been used to protect cattle against brucellosis. Under experimental 
conditions, parenteral vaccination of pregnant cattle with 1 to 3 x 109 CFUs of RB51 is safe and 
efficacious for the subsequent pregnancy (Olsen, 2000). Similar to S19, RB51 can induce abortions under 
field conditions (Van Metre et al., 1999). The data suggests that calfhood vaccinated cattle can be safely 
booster vaccinated with RB51 (1–3 x109 CFUs) as pregnant adults (Leal-Hernandez et al., 2005). 
However, some authors have questioned the efficacy and safety of RB51 with regard to bovine brucellosis 
(Moriyón et al., 2004; Mainar-Jaime et al., 2008; Bagnat and Manett, 2011) and it is not effective against 
B. melitensis or B. ovis infections in sheep (Moriyón et al., 2004). In addition, human infections due to 
RB51 have also been described (Villarroel et al., 2000); this strain is resistant to rifampin, a widely used 
antibiotic in the treatment of human brucellosis (Ariza et al., 2007).  
S19 strain of B. abortus has also been found to be associated with human infection (Strausbaugh and 
Berkelman, 2003; Wallach et al., 2008). In countries having a high prevalence of brucellosis and/or 
limited regulatory programs, S19 may be the vaccine of choice because it may be slightly more 
protective and many countries can produce commercial S19 vaccines. However, in countries, where 
prevalence of brucellosis is low and serologic surveillance is high, the RB51 vaccine is preferred 
because of its lack of interference with serologic surveillance and comparable efficacy in protecting 
against brucellosis (Olsen and Tatum, 2010). 
The only available vaccine against B. melitensis infection is Rev1 has been proved to be effective for 
prevention of brucellosis in sheep and goats (Blasco, 1997). The individual doses of 1–2x109CFUs 
subcutaneously induces long-lasting serologic response, which makes an eradication program based on 
combined test and slaughter impractical. But, that problem may be solved by vaccinating via conjunctival 
instillation (using same dose) where the immune response is similar to that induced by the classic 




subcutaneous method, but the serologic responses evoked by the vaccine are significantly reduced, 
making this program fully compatible with the application of an eradication program based on vaccination 
combined with test and slaughter (Blasco and Molina-Flores, 2011). Rev1 in both routes may induce 
abortion in pregnant animals (Blasco, 1997). Another alternative may be vaccinating only sexually 
immature female animals to minimize stimulation of postvaccinal antibodies, which may confuse the 
interpretation of diagnostic tests, and also to prevent possible abortions induced by the vaccines (Corbel, 
2006). 
A potential public health risk with the Rev1 vaccine is that this strain also can infect humans (Ollé-Goig 
and Canela-Soler, 1987; Blasco and Diaz, 1993) and is resistant to streptomycin, an antibiotic that in 




Eradication of brucellosis by test-and-slaughter is unfeasible in developing countries because of 
limited resources to compensate farmers whose animals are slaughtered during such screening 
programs (Godfroid et al., 2011). However, a mass vaccination strategy (avoiding pregnant animals in 
mid-gestation) may be applied to control brucellosis in developing countries. 
The herd/flock level control of animal brucellosis may be achieved using some general principles: 
reducing the exposure to Brucella spp. and increasing the resistance to infection of animals in the 
populations 
1. The reduction of exposure to Brucella spp. 
Farm sanitation and biosecurity: Aborted fetuses, placentae and contaminated litter should be disposed 
by incineration or deep burial mixing with lime at sites away from water courses. Any area in which 
an abortion or infected parturition has occurred should be washed down with an approved disinfectant. 
Dung should be cleaned daily and stored in a secluded area until rendered safe by natural decay (this 
will probably require about one year) or else burnt or soaked in disinfectant before disposal. Premises 
that have held Brucella-infected animals should not be re-stocked until at least four weeks have elapsed 
between cleaning and disinfection. Rodent control measures should be enforced and insect infestation 
kept to a minimum by the use of fly screens, light traps and insecticides. The use of maternity pens to 
isolate animals during and post-parturition is essential as these animals shed the most Brucella. 
Isolation of post-parturient animals reduces the spread of infection to the rest of the herd or flock 
(Corbel, 2006). 
Control of animal movement: The control of animal movements between herds, and especially from farms 
or regions with a high prevalence of disease is a basic principle of animal disease control and is a 
necessary and highly effective measure. The control of animal movement within a country is sometimes 
impossible without regulatory/legislative support. The permanent, individual identification of animals is 
also very important to identify the inter state/division/district and cross-border movements and market 




chain interactions of livestock within the country and the region is also necessary. Unauthorized sale or 
movement of animals from an infected area to other areas should be forbidden. Replacement stock should 
be procured from brucellosis free herds/flocks. The application of pre-movement testing will reduce the 
risk of spread of brucellosis between herds/holdings and provides additional assurance for the purchaser in 
this regard. Isolation of purchased replacements for at least 30 days and a serological test prior to entering 
the herd/flock is necessary. In case of porous borders with neighboring countries, a regional control 
strategy should be developed to prevent illegal trafficking of livestock. All imported livestock should be 
monitored in quarantine stations before entered into the country (Corbel, 2006; Loth et al., 2011; Islam et 
al., 2013b; Mondal and Yamage, 2014). 
2. Increasing the resistance to infection of animals in populations: 
Vaccination: The most successful method for prevention and control of brucellosis in animals is 
through vaccination. While the ideal vaccine does not exist, the attenuated strains of B. melitensis strain 
Rev.1 for sheep and goats and B. abortus strain 19 have been used widely as described earlier. 
 
3.5 Diagnosis in human 
The diagnosis of human brucellosis is usually based on the isolation of Brucella spp. from blood, tissue 
specimens, body fluids and bone marrow, the serological tests for the detection of anti-Brucella spp. 
antibodies and the molecular methods for the detection of Brucella spp. DNA (Sakran et al., 2006). In 
countries where brucellosis is enzootic (i.e. present in animal reservoirs), human confirmed cases are 
based on clinical symptoms associated with positive serology without attempts to isolate Brucella spp. 
(CDC, 1997). 
 
3.5.1 Isolation of brucellae from blood and tissue 
The confirmatory diagnosis of brucellosis necessitates the isolation of the pathogen from blood, bone 
marrow or other tissues and body fluids. The isolation of Brucella depends on the stage of disease (acute 
versus chronic), antibiotic pre-treatment, the existence of an appropriate clinical specimen and the 
culturing methods used. Isolation is much higher during the first two weeks of symptomatic disease and in 
blood cultures taken during the pyrexial phase (Memish et al., 2000). However, isolation of Brucella spp. 
has the risk of laboratory-acquired infections and is time consuming, and the sensitivity of culture method 
is often low (30 -70% in chronic cases and 80-90% in acute cases), depending on the culture medium, 
Brucella species, disease stage and quantity of circulating bacteria (Franco et al., 2007; Espinosa et al., 
2009). 
Brucella selective media like such as Farrell’s medium (FM) is most commonly used for the isolation 
(Farrell, 1974). Due to the presence of nalidixic acid and bacitracin in FM, growth of B. suis and several B. 
melitensis and B. abortus strains can be significantly inhibited. 
So, a new selective medium containing vancomycin, col-istin, nystatin, nitrofurantoin and amphotericin B 
has been developed for veterinary samples (De Miguel et al., 2011). However, the new selective media 




has not been evaluated for the diagnosis of human brucellosis. Automated continuously monitored blood 
culture systems such as Bactec (BD Diagnostics, Sparks, MD, USA) and BacTAlert (bioMerieux, 
Durham, NC, USA) give higher yields than the conventional culture method and reduces the time to 
detection significantly (Mantur and Mangalgi, 2004; Raj et al., 2014). 
Bone marrow cultures have proven to be more sensitive (15-20% more than peripheral blood culture) than 
blood cultures for the detection of Brucella spp. at any stage of disease, and the mean time to detection is 
significantly reduced (Gotuzzo et al., 1986; Mantur et al., 2008). This method has also proven its 
usefulness in patients treated with antibiotics. As bone marrow aspiration and biopsy is painful, the 
procedure should be restricted to seronegative patients in whom there is a strong clinical suspicion of 
brucellosis (Gotuzzo et al., 1986). 
 
3.5.2 Identification and Typing 
The colonies of Brucella spp. are usually recovered from clinical specimens on FM or other media, 
within 24–48 h of aerobic incubation or under 5–10% CO2 incubation at 37°C. The colonies of smooth 
Brucella strains are raised, convex, circular, translucent, and 0.5 mm to 1 mm in diameter. Colony 
morphology, as well as virulence, antigenic properties and phage sensitivity of the bacteria, is subject 
to changes after subcultivation or prolonged culture (more than four days) (Cardoso et al., 2006). 
Thus, smooth brucellae dissociate to rough forms, which grow in less convex and more opaque 
colonies with a dull, dry, yellowish-white granular appearance. The identification of Brucella species 
and biovars is based on CO2 requirement, H2S production, urease activity, agglutination with 
monospecific sera (A and M), selective inhibition of growth on media containing dyes such as thionin 
or basic fuchsin, and phage typing (Alton et al., 1988). But, these procedures are cumbersome, time 
consuming, hazardous and have a high risk of laboratory-acquired infection. A good alternative to the 
standard microbiology methods is the semi-automated metabolic biotyping system (MicronautTM), 
based on a selection of 93 different substrates (Al Dahouk et al., 2010). 
This new method reduces time and also minimizes the risk of laboratory-acquired infections. Using 
this technology, Brucella can be identified and differentiated up to the species and biovar level within 
48 hours. Ferreira et al. (2010) developed a powerful tool for bacterial identification termed as matrix-
assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS). In 
comparison with conventional phenotypic techniques or molecular methods, it is rapid, precise and 
cost effective. MALDI-TOF MS is able to identify Brucella spp. directly, from both culture plates and 
blood culture bottles. 
 
  




3.5.3 Serological diagnosis 
Serological testing is fast, non-hazardous and more sensitive than culture and therefore preferred in 
routine clinical practice. However, serological tests can only indirectly prove Brucella infections by 
high or rising titers of specific antibodies. Agglutination titers ≥1: 160 or a fourfold rise of titers in 
follow-up sera are considered to be indicative of active infection. Diagnostic titers, however, can be 
detected months or even years after acute infection despite therapeutic success and negative blood 
cultures (Ariza et al., 1992). In addition, a high proportion of the population in endemic regions may 
have persistent antibody titers due to ongoing exposure to Brucella. Validation of serological tests and 
setting cut-off in the context of its use are crucial for the diagnosis of human brucellosis (Kiel and 
Khan, 1987; Memish et al., 2002). 
Just detection of antibody without clinical signs and symptoms or a history of potential exposure does 
not indicate brucellosis (Ariza et al., 1992; Al Dahouk and Nöckler, 2011). Serological tests may be 
negative, especially early in the course of the disease, and laboratory testing should be repeated after 
one to two weeks in clinically suspicious cases. Sequential serological testing also allows the 
monitoring of treatment response. In the first week of infection, immunoglobulin (Ig) M isotype 
antibodies predominate, followed by a shift to IgG in the second week (Al Dahouk et al., 2002). Titers of 
both subtypes rise continuously and reach a peak within four weeks. Successful antibiotic therapy is 
usually indicated by a rapid decline in antibody titers, whereas persisting high IgG titers reflects treatment 
failure (Casanova et al., 2009; Bosilkovski et al., 2010). Relapse is often characterized by a second peak of 
anti-Brucella IgG and IgA, but not IgM, immunoglobulins. 
The diagnostic antigen of classic serological tests is usually made from whole-cell extracts containing 
large amounts of smooth lipopolysaccharides (S-LPS). As the humoral immune response during natural 
infection is mainly mediated by antibodies directed against S-LPS, these assays reliably detect 
agglutinating and/or non-agglutinating antibodies. However, because of cross-reactivity with various other 
clinically relevant bacteria, the specificity of LPS based assays can be low. The immune-dominant epitope 
of the Brucella O-polysaccharide (OPS) resembles the corresponding epitopes of Yersinia enterocolitica 
O:9, Salmonella urbana group N, Vibrio cholerae, Francisella tularensis, Escherichia coli O157 and 
Stenotrophomonas maltophilia (Al Dahouk et al., 2002). In contrast, the S-LPS antigen is not shared by B. 
canis and B. ovis, thus explaining why canine brucellosis cannot be diagnosed by standard serological 
methods based on smooth Brucella antigens (Lucero et al., 2005). These strains exist in a rough colony 
form and do not share cross-reacting antigens with the other Brucella spp. (Araj and Kaufmann, 1989). 
The list of some diagnostic tests available for the diagnosis of brucellosis is presented in Table 3.5 
(Nielsen and Yu, 2010). 
In this study, the RBT, STAT and iELISA were used simultaneously for the diagnosis of human 
brucellosis. The principle and procedures are similar as described in previous section. Although STAT 
was introduced over a century ago, in 1897, it is widely used in human brucellosis diagnosis (Alton et 




al., 1988). The test is performed in tubes by reacting a known standardized volume and concentration 
of whole Brucella cell suspension with a standardized volume of doubling serum dilutions, usually 
ranging from 1:20 to 1:1280. The suspension mixture is incubated in a water bath at 37
°
C for 24 h, and 
agglutination at the bottom of the tubes is examined visually. Most authors considered a STAT titer of 
1:160 as diagnostic in conjunction with a compatible clinical presentation (Konstantinidis et al., 2007; 
Gómez et al., 2008). But, in regions where brucellosis is endemic, a large proportion of the population 
may have persistent Brucella-specific antibody titers. In this scenario some authors recommend to use a 
STAT titers of 1:320 or higher to make the test more specific (Kiel and Khan, 1987; Memish et al., 
2002; Mantur et al., 2007). 
WHO and OIE provide guidelines for STAT and RBT standardization, but not for the iELISAs. In 
general a ‘new’ cut-off should be determined under local conditions to avoid false positives. 
 
3.5.4 Molecular method 
Polymerase chain reaction (PCR) assays can be applied to detect Brucella DNA in pure cultures and in 
clinical specimens, i.e. serum, whole blood and urine samples, various tissues, cerebrospinal, synovial 
or pleural fluid, and pus (Colmenero et al., 2010; Debeaumont et al., 2005; Queipo-Ortuño et al., 2006, 
2008a). The PCR is more sensitive than blood cultures and more specific than serological tests (Al 
Dahouk et al., 2013). The analytical sensitivity can be further increased by using real-time PCR assays, 
which can detect as few as five bacteria per reaction (Navarro et al., 2006; Al Dahouk et al., 2007). 
Moreover, real-time PCR enables high-throughput screening of clinical samples and delivers results 
within a few hours. 
 
3.5.4.1 Standard PCR 
For the diagnosis of human brucellosis, a PCR assay with one pair of primers was developed, which 
amplifies the target genomic sequence of Brucella species. Primer pairs include the primers for sequences 
encoding 16S rRNA (Romero et al., 1995; Nimri, 2003), outer membrane protein (omp2a, omp2b) (Leal-
Klevezas et al., 1995; Sifuentes-Rincan et al., 1997; Bardenstein et al., 2002), 31-kDa immunogenic 
Brucella abortus protein (BCSP 31) (Matar et al., 1996; Queipo-Ortuño et al., 1997), 16S-23S ribosomal 
DNA interspace region (Fox et al., 1998) and insertion sequence (IS711) (Cloeckaert et al., 2000; Elfaki et 
al., 2005). In fact, blood samples are often used for the diagnosis of human brucellosis by the standard 
PCR (Navarro et al., 1999). Several factors were reported to affect PCR results in a blood specimen such 
as the high concentrations of leukocytes DNA and heme compounds (Morata et al., 1998). Additionally, 
human genomic DNA affects the sensitivity of peripheral-blood PCR assay for the detection of Brucella 
DNA (Navarro et al., 2002). Zerva et al. (2001) reported that serum samples should be used preferentially 
over whole blood for diagnosis of human brucellosis by PCR, but Mitka et al. (2007) revealed that buffy 
coat and whole blood were the optimal specimens. 




Genus specific PCR assays are generally adequate for the molecular diagnosis of human brucellosis (Al 
Dahouk and Nöckler, 2011). The BCSP31 gene, coding for a 31-kDa immunogenic outer membrane 
protein conserved among all Brucella spp., is the most common molecular target in clinical applications 
(Baily et al., 1992). Such a genus-specific PCR can help to avoid false-negative results in patients infected 
with unusual species and biovars. 
 
3.5.4.2 Real Time PCR 
Real-time PCR for the rapid detection and differentiation of Brucella species in clinical samples has 
recently been developed, targeting 16S-23S internal transcribed spacer region (ITS) and the genes coding 
omp25 and omp31 (Kattar et al., 2007), BCSP 31 (Colmenero et al., 2005; Debeaumont et al., 2005; 
Queipo-Ortuño et al., 2008b), and IS711 (Queipo-Ortuño et al., 2005; Zhang et al., 2013). The major 
advantages of real-time PCR are that it can be performed in a very short time, does not require 
electrophoretic analysis, and avoids contamination. The samples that can be tested by real-time PCR 
include Brucella isolates (Redkar et al., 2001), serum (Queipo-Ortuño et al., 2005), blood, and paraffin-
embedded tissues (Kattar et al., 2007; Zhang et al., 2013). A study analyzed the sensitivity and specificity 
of the 3 established real-time PCR methods using primers and TaqMan probes targeting the IS711, 
BCSP31 and per genes, and it also compared their efficiencies for the detection of the Brucella genus. The 
results showed that the IS711-based real-time PCR was the most sensitive, specific and efficient to detect 
Brucella spp (Bounaadja et al., 2009).  
However, a primary molecular diagnosis must always be confirmed using a second gene target (Scholz et 
al., 2007). For confirmation and distinction from closely related microorganisms, 16S rRNA gene 
sequencing can be used (Gee et al., 2004). Using real time PCR, species and even biovars level 
differentiation of the isolates is possible (Huber et al., 2009). 
Subtyping at the strain level is useful for differentiating re-exposure from relapse (Al Dahouk et al., 
2005). A multiple locus VNTR (variable number of tandem repeats) analysis assay based on 16 
markers (MLVA-16) has proven its usefulness for diagnostic purposes in human brucellosis (Al 
Dahouk et al., 2007). 
A relapse or primary treatment failure can be confirmed by assessing identical MLVA-16 genotypes of 
Brucella strains isolated from the same patient before and after first-line therapy, and, as a 
consequence, antibiotic therapy should be prolonged. Re-infection is usually characterized by 
divergent genotypes of Brucella isolates, and standard therapy can be repeated without substantial loss 
of efficacy (Al Dahouk et al., 2013). Quantitative real-time PCR using human sera maybe applied not 
only for initial diagnosis but also for differentiating active from past Brucella infections (Queipo-
Ortuño et al., 2008b). 
Detection of Brucella at species level using real time PCR assays is also possible from clinical samples 
of both human and animal origin (Gwida et al., 2011; Ali et al., 2014). Recently direct molecular 




typing of Brucella organisms from clinical material (ct value <26) was also reported using MLVA-16 
(Gopaul et al., 2014). 
 
3.6 Treatment 
The prerequisite for an effective therapy of brucellosis are that treatment should start on time, should 
consists of combination of drugs along with at least one drug having good penetration into 
macrophages and can act in the acidic intracellular environment cells and should be prolonged 
(Mantur et al., 2007). In 1986, the World Health Organization issued guidelines for the treatment of 
human brucellosis. The guidelines discuss two regimens, both using doxycycline (100 mg twice daily) 
for a period of six weeks, in combination with either streptomycin (15 mg/Kg body weight 
intramuscularly) for two to three weeks or rifampin (600-1200mg/day) for six weeks. A recent meta-
analysis of the efficacy of various combinations of drugs against brucellosis proved superiority of 
doxycycline and streptomycin over doxycycline and rifampicin with less relapses (4.2%) and less side 
effects (18.6%) (del Pozo and Solera, 2012). 
Childhood brucellosis can be successfully treated with a combination of two drugs: doxycycline 4 
mg/Kg/day and rifampicin 10 mg/Kg/day orally for six weeks (Mantur et al., 2004). Rifampicin with or 
without Trimethoprim–sulfamethoxazole (960 mg twice daily for 6 weeks) has proved safe to treat 
brucellosis during pregnancy (Ozbay and Inanmis, 2005; Pappas et al., 2006). 
Relapses occur about 10% cases and are often milder in severity than initial disease and can be treated 
with a repeated course of the usual antibiotic regimens (Roushan et al., 2006). 
 
3.7 Scenario of brucellosis in human and animals in Bangladesh 
3.7.1 Human population 
According to the Population and Housing Census 2011, there are about 150 million people and 32 
million households in Bangladesh. The male and female ration is 100.3. The population density and 
growth rate are 1015/km
2
and 1.37% respectively (BBS, 2011). About 71% of the total population is 
rural and 85% of the rural households own animals. The exact number of skilled veterinary 
practitioners, milkers, butchers, artificial inseminators and unskilled veterinary practitioners are not 
known in Bangladesh. About 5000 staffs (including officers and supporting staffs) are working in the 
DLS to deliver veterinary services. 
 
3.7.2 Livestock population, its impact on national economy and an overview of the context of 
the study 
3.7.2.1 Livestock population 
Livestock in Bangladesh include cattle, buffalo, goats, sheep, chickens and ducks. In the fiscal year of 
20122013, there were about 23.4, 1.5, 25.2, 3.1 and 296.3 (Total 349 million) million heads of cattle, 




buffalo, goats, sheep and poultry respectively (DLS, 2014). Bangladesh has one of the highest cattle 
densities: 145 large ruminants/km
2
 compared with 90 for India, 30 for Ethiopia, and 20 for Brazil. The 
average weight of local cattle ranges from 125 to 150 kg for cows and from 200 to 250 kg for bulls that 
falls 25-35% short of the average weight of all-purpose cattle in India. Milk yields are extremely low: 
200-250 liter during a 10-month lactation period in contrast to 800 liter for Pakistan, 500 liter for India, 
and 700 liter for all Asia. Despite highest cattle densities in Bangladesh, the current production of milk, 
meat and eggs are inadequate to meet the current requirement and the deficits are 85.9%, 77.4% and 
73.1% respectively (Anon., 2007; Teufel et al., 2010). 
 
3.7.2.2 Breeds of livestock 
The common cattle breed are indigenous and their crosses with Holstein Friesian and Sahiwal (Teufel 
et al., 2010). The exact proportion of crossbred cattle population in Bangladesh is not known but it is 
assumed that around 15% of the cattle population in the country are crossbred (Jabbar et al., 2010). 
However, this figure differs in certain areas, for example, in milk sheds the proportion of crossbred 
cows may be more than 80% where targeted milk marketing and input supply systems are operational 
(Jabbar et al., 2005; Uddin et al., 2010). There are two common breeds of goats: Black Bengal and 
Jamunapari (Anon., 2013). The Black Bengal is the outstanding breed for meat and skin production, 
and is characterized by high prolificacy and disease resistance. It is an important asset for the resource-
poor farmers, providing them with animal protein and improved economic security. The sheep of 
Bangladesh are also indigenous, are kept for mutton and coarse wool, although mutton is not preferred 
by people (Teufel et al., 2010). 
 
3.7.2.3 Contribution of livestock in national economy 
The cattle and buffalo in Bangladesh provide power for cropping (traction for ploughing), transport, 
threshing and oil seed crushing, manure as a source of fuel and fertilizer (increase crop production), a 
ready source of cash and meat and milk for human consumption. The 30% of the total tillage is still 
covered by draught animals (DLS, 2014). However, with mechanization and improved rural transport 
network, need for tillage and transportation has been declining and will decline further over time (Jabbar 
et al., 2010). In Bangladesh, around 8% of total protein (44% of animal protein) for human consumption 
comes from livestock. Hides and skin of cattle, buffaloes, goats and sheep are valuable export items, 
ranked third in earnings after ready-made garments and shrimp. About 4.31% of the total export earning 
comes from leather and leather goods (DLS, 2014). In the year of 2012-2013, the Govt. earned about US$ 
534.0 million by exporting livestock products and byproducts (4133.52 crore BD Taka). Another report 
indicates that livestock plays an important role in the national economy of Bangladesh with a direct 
contribution of around 3% percent to the agricultural GDP and providing 15% of total employment 
(Anon., 2007). 




Livestock are often one of the main assets of rural households. Although, livestock ownership is often 
a symbol of wealth, but for many cases, the poor households typically move up the ‘livestock 
ladder’from poultry to goats or sheep, to cattle/buffalo (Deshingkar et al., 2008). Livestock (mainly 
poultry and small ruminants) are an important asset for women because it is often easier for many 
women in developing countries to acquire livestock assets, whether through inheritance, markets or 
collective action processes, than it is for them to purchase land or other physical assets or to control 
other financial assets (Rubin et al., 2010; Kristjanson et al., 2014). For the poor people, livestock serve 
as ‘piggy banks’, to save and store money and manage risk (Herrero et al., 2013). As 70% (20% 
directly and 50% indirectly) of the population rely on livestock to some extent for their livelihood, the 
poverty reduction potential of the livestock sub-sector is very high (Anon., 2007, 2013; DLS, 2014). 
 
3.7.2.4 Veterinary services and disease surveillance 
Inadequate veterinary services are one of the major obstacles for livestock development in 
Bangladesh. The ratio of Veterinary Surgeons to farm animals and birds was estimated at 1: 1.7 
million (Anon., 2007). Department of Livestock Services (DLS) under the Ministry of Fisheries and 
Livestock, offers rudimentary public goods services and some private goods services. At present, the 
veterinary services of DLS are dominated by private goods services like treatment of sick animals and 
birds, production of vaccines and frozen semen for artificial insemination, fodder production, etc. The 
national livestock development policy recommended DLS to engage increasingly in delivery of public 
goods services like enforcement of laws and regulations, quality control of feeds, drugs, vaccines, 
semen and breeding materials, extension services, disease investigation and surveillance, veterinary 
public health, conservation and development of native breeds, policy formulation and strategy 
development (Anon., 2007). 
The veterinary services are provided through Upazilla (sub-district) Livestock Development Centers 
(ULDC). The ULDCs also serve as passive disease surveillance centers for livestock in Bangladesh as 
the limited manpower and fund restrict the ability of the veterinary authorities for active surveillance 
and the passive surveillance below Upazilla level (i.e., unions and villages). The Upazillas are the 
lowest administrative level up to which all extension and animal health services of DLS are available. 
In the meantime, the USAID funded cell phone-web based SMS-(Short Message Service) gateway 
system for active surveillance of HPAI H5N1 was successful and got popularity at national and 
international level (Yamage and Ahmed, 2011). It may also be of value for the surveillance of other 
important animal diseases provided the availability of fund for the sustenance. Recently, a web-based 
software, namely Livestock Disease Information System (LDIS), has been developed with the support 
from FAO ECTAD for reporting livestock diseases in Bangladesh, which will enable tracking field 
cases of all diseases on a daily basis at least at Upazilla level (Mondal and Yamage, 2014). The most 
common clinical diseases of cattle include parasitic diseases, mastitis and FMD and of small 
ruminants include PPR in addition to parasitic diseases. 




The Veterinary public health section exists in DLS but it is neither equipped nor does it have the funds 
to deal with disease surveillance and reporting, control of zoonotic diseases, food safety and other 
public health issues. It does not have a supporting legal framework to implement its mandate (Anon., 
2007). 
The private sector and NGOs are gradually participating in livestock development activities. 
 
3.7.2.5 Food habit of people and close contact with animals 
The possibility of foodborne zoonosis like brucellosis in Bangladesh is very high as the food safety 
laws are conventional, inadequate and ineffective (Rahman et al., 2014). However, due to the habit of 
proper boiling and cooking before consumption, the prevalence of infectious foodborne illness may be 
low. 
Being unable to make separate houses for livestock, some poor farmers pose themselves to zoonotic 
disease risk through sharing same premises with their livestock (mostly small ruminants) (Halder and 
Barua, 2003).  
 
3.7.2.6 Livestock slaughter for meat 
Round the year in Bangladesh, livestock are slaughtered for meat. It is estimated that around 3.5 
million cattle are slaughtered annually in the country of which 40% are imported through cross-border 
illegal trade (Anon., 2002, 2007; Rweyemamu et al., 2008; Ghosh, 2014; Mondal and Yamage, 2014; 
Khatun et al., 2014). Approximately 15 million goats are also slaughtered annually mostly of local 
origin. Of the total slaughter of cattle and goats, around 40 percent is performed during Eid-ul-Azha (a 
muslim festival) (Anon., 2007). 
 
3.7.2.7 Cross-border cattle movement 
India has an enormous cattle population (approximating 200 million) used for dairy production and 
draught purposes; the slaughter of cattle is forbidden (for religious cause) in most Indian provinces 
and their meat is not consumed (Anon., 2002; Ghosh, 2014). The Indian policy does not allow the 
export of live animals from India. Despite the restriction, cattle export continues from India to 
Bangladesh (Ahmed and Khan, 2011). Religious practice in India and Nepal and insufficient beef 
production in Bangladesh also facilitate market price driven movement of animals (Loth et al., 2011). 
Bangladesh is almost surrounded by India and shares a poorly patrolled 2,400-mile border through 
which cattle informally moves into Bangladesh from various parts of northern and northeastern 
borders of India. It is estimated that up to 25,000 Indian cattle illegally enter into Bangladesh from 
West Bengal every single day (Ghosh, 2014). Another report indicates that from West Bengal’s border 
district of Murshidabad more than 0.35 million animals are entering into Bangladesh every year 
(Anon., 2002). Survey results from 407 respondents including 11 Bangladesh land port areas, also 
support above statements regarding cattle smuggling from India. Clinical diseases like FMD and black 




quarter and clinical signs like diarrhea were also reported by the respondents in imported animals. 
About 98% of the imported cattle come from India and the remaining 2% from Nepal. Almost 89% of 
the imported bovines are cattle and the rest are buffaloes. Out of 11 land port areas only in Meherpur, 
young cattle are found to be reared for fattening and in the remaining areas animals are distributed to 
larger cities for slaughter (Khatun et al., 2014). Uncontrolled movement of animal is a potential risk 
factor for most of the transboundary animal diseases like FMD, PPR, brucellosis, etc. (Rweyemamu et 
al., 2008; Loth et al., 2011; Mondal and Yamage, 2014). 
The Scientific evidence also supports this fact. For example, analysis of sequence data showed very 
close relationship of FMD isolates from Bangladesh with FMD serotype O viruses from Nepal and 
from India (Loth et al., 2011). The possibility of introduction of other transboundary diseases like 
brucellosis in Bangladesh from border countries cannot be ruled out. However, Bangladesh 
government has approved a project to establish and run 24 quarantine stations at air, land and sea ports 
(DLS, 2014). If quarantine is applied properly in different ports of entry it will no doubt help to 
prevent introduction of trasnboundary diseases. However, it will fail to do so in case of 
informal/illegal import, as usually occurring between India and Bangladesh, where trader and 
suppliers will not cooperate, which is essential for effective quarantine (Bhuyan and Hasan, 2014). 
 
3.7.2.8 Livestock identification system 
The animals and even their herds/flocks are not identified in Bangladesh. It is also an important 
constraint for research, extension and thereby the livestock development. Animal identification system 
is also necessary for disease surveillance and control programs. As all people of Bangladesh are not 
yet identified (without national ID), probably it will take some more time for the Govt. to pay attention 
to this need. 
 
3.7.3 Animal husbandry practice 
3.7.3.1 Production system 
Mixed crop-livestock production system is predominant in Bangladesh. In this system, majority of rural 
population keep cattle, goats, native chickens and ducks together for multiple uses (Tiller et al., 2010; 
Saadullah, 2012). Poor and landless livestock farmers either rear their own or take care of others’ 
livestock as a paid service. Households having single species of livestock are common (Shamsuddin et al., 
2010). Domestic ruminants live on scavenging roadside and riverbank grasses either freely or under 
tethering system. Rice gruel and rice straw are provided usually at night. 
The small-scale dairy farms consisting of 1-4 cattle are also found all over the country (Uddin et al., 
2010). Medium (herd size 5-10) and large (herd size >10) scale dairy farms are also found in milk rich 
pockets like Chittagong, Satkhira, Sirajgoanj, Munshiganj, etc. (Jabbar et al., 2005; Shamsuddin et al., 
2010).  




The small-scale dairy system mainly practices zero grazing (cut-and-carry system) with occasional 
semi-zero and tethering systems (Saadullah, 2001). The medium and large-scale dairy system practices 
only zero grazing all over Bangladesh with the exception in Pabna-Sirajgonj districts. There the cattle 
graze freely and remain in the pasture (“Bathan: common grazing land”) for about six months 
(December to May). 
 
3.7.3.2 Feeds and feeding 
Crop residues (rice straw), tree leaves, native roadside grasses, household waste, tree fodder are the 
principal forms of roughage for livestock (Saadullah et al., 2012). The rice straw constitutes 80% of the 
total dry roughage for ruminants. The concentrate feed are cereal grain, rice bran, wheat bran, oil cake, 
pulse bran, salt, vitamin-mineral premix and molasses but their supply to animals are low, irregular and 
restricted mostly to milking cows. Poor farmers do not provide concentrates to their animals and depend 
on natural grass. 
 
3.7.3.3 Breeding practice 
With regard to breeding, sporadic and indiscriminate crossbreeding has been practiced with 
insignificant proportion in livestock species of Bangladesh like buffalo, goat and sheep. As a result, 
some quasi-indigenous animals have been generated as well but their impact on the total production 
system is negligible except in the case of cattle. Cattle crossbreeding through AI program has been 
initiated since 1969 where both tropical and temperate dairy breeds have mainly been used but without 
following any consistent breeding policy. No doubt, it gradually narrows the genetic diversity of our 
indigenous genetic resources. Artificial insemination is gradually getting more popularity for breeding 
cows. In commercial dairy farms more than 80% cows are bred by AI (combining regular and irregular 
use) (Hossain et al., 2005; Jabbar et al., 2010). The national coverage of AI is around 36%. The DLS is 
expanding its coverage by increasing semen production and also by establishing more AI sub-
centre/points all over Bangladesh. For example, in 2006, there were 23 district AI centers (including 
CCBDF), 423 subcenters and 554 AI points. The DLS is increasing the number of AI 
subcenters/points to 3212. The production of semen in 2007-2008 was 2.31 million doses and in 2012-
2013 it has been increased to 3.43 million doses (Anon, 2014; DLS, 2014).  
Studies reported that crossbreeding in Black Bengal goat is more intense in the urban and peri-urban 
areas of North Western region of Bangladesh utilizing several Indian goat breeds like Jamunapari, 
Sirohi and Beetal. The male mediated introgression is a great threat for Black Bengal goat germplasm 
and their conservation efforts. The situation is not much worse in case of species buffalo and sheep 
where crossbreeding practices is negligible. It is notable to mention that yet there is no national body 
to oversee and control any germ-plasm introduction in this country (Bhuiyan and Bhuiyan, 2014). 
  




Table 3.7a: Reported seroprevalence of brucellosis in cattle in Bangladesh 
Year Area (Serology) Sample size 
(positive) 






150 (23); 270 (23); 
190 (2): 610 (71) 
RBT; Rapid 
Brucella ab test 
kit, iELISA 
11.6% (9.2-14.5) Islam et al., 2013c; Belal and 
Ansari, 2013; Dey et al., 2013 
2012 Bagerhat, Bogra, 
Gaibandha, 
Mymensingh, Sirajgonj 
465 (4) iELISA, RBT, 
cELISA and FPA 
(performed in 
South Korea) 
0.9% (0.4-2.2) Rahman et al., 2012b 




188 (4) RBT, iELISA 2.1% (0.6-5.4) Rahman et al., 2011b 
2010 Dinajpur, Mymensingh 182 (6) RBT, iELISA, 
cELISA 
3.3% (1.2-7.0) Ahasan and Song, 2010 
2009 Mymensingh 200 (9); 200 (10): 
400 (19) 
RBT 4.8% (2.9-7.3) Nahar and Ahmed, 2009; 
Rahman et al., 2009 
2006 Mymensingh, Sherpur 300 (7) TAT 2.3% (0.9-4.7) Sikder et al., 2012 
2005 Mymensingh 120 (4) RBT, PAT, TAT 3.3% (0.9-8.3) Amin et al., 2005 
2004 Mymensingh 250 (5) RBT, PAT, TAT 2.0% (0.7-4.6) Amin et al., 2004 
1992 Chittagonj, Comilla, 
Jessore, 
Manikgonj 
350 (17) RBT, PAT, TAT 4.9% (2.9-7.7) Ahmed et al., 1992 
 Sub-total 2865 (137)  4.8% (4.1-5.7)  
1970 Mymensingh 412 (76) TAT 18.4% (14.8-22.5) Rahman and Mia, 1970 
 Overall 3127 (167)  5.3% (4.8-6.2)  
Legend: RBT: Rose Bengal Test; iELISA: indirect ELISA; cELISA: Competitive ELISA; FPA: 
Fluorescence Polarization Assay; PAT: Plate Agglutination Test; TAT: Tube Agglutination Test. 
 
3.7.3.4 Disease control strategy 
The only disease control effort of DLS is initiation of vaccination against 16 different types of diseases 
(like FMD, anthrax, hemorrhegic septicemia, black quarter for cattle, PPR for small ruminants and 
Newcastle disease, infectious bursal disease, chicken pox, duck cholera, duck plague for poultry) for 
domestic animals and poultry. The quantity of vaccines produced and delivered by the DLS are 
inadequate. The government subsidy in vaccine production in present form is a possible obstacle for 
the private investors. The regulatory authority to check the quality of domestically produced or 
imported vaccines does not exist (Anon., 2007). Vaccination is done in a haphazard manner without 
any strategic plan for controlling the targeted diseases. Approximately 112 million doses of vaccine 
were produced in 2013-2014 for the 349 million livestock and poultry (Anon, 2014). 
Vaccination against brucellosis in domestic ruminants has never been initiated in Bangladesh. 
 
  




Table 3.7b: Reported prevalence of brucellosis in cattle in Bangladesh based on milk ring test 
Year Area  
(Milk based) 
Tested (Positive) Tests used Prevalence  
(95% CI) 
References 
2012 Chittagong 500 (25) MRT (Individual 
milk) 
5.0% (3.3-7.3) Sikder et al., 2012 
1983 Dhaka, Tangail, 
Mymensingh 
1992 (80) MRT (Individual 
milk) 









8.3% (6.4-10.75) Pharo et al., 1981;  




490 (42) MRT (Bulk milk) 8.6% (6.2-11.4) Rahman et al., 1978 
 Overall 3743 (210)  5.6% (4.8-6.3)  
Legend: MRT: Milk Ring Test. 
 
3.7.4 Reported prevalence and risk factors of brucellosis in humans and animals 
The reported seroprevalence of brucellosis in cattle in Bangladesh is summarized in Tables 3.7a and 
3.7b. The seroprevalence seems to be static over the years except in 1970 and 2013. It is not clear what 
happened in these years with regard to brucellosis. The report of Islam et al. (2013c) used RBT reagent 
procured from South Korea and found 23 (15.3%) seropositive out of 150 cattle. In the same area and 
in the same year Dey et al. (2013) also tested 190 cattle sera but found only 2 (1.1%) positive cases, 
however, using different test. So, such a significant difference of seroprevalence in cattle of the same 
area is unusual. The quality of antigen may influence the test result. In addition, the RBT antigen 
could deteriorate when repeatedly cycled between refrigerator and room temperature during use 
(MacMillan, 1990). Similarly, the problem with the test may also be the reason for higher prevalence 
of bovine brucellosis in 1970. The overall seroprevalence of cattle brucellosis is 5.3% (4.8-6.2). The 
overall prevalence of brucellosis in cows based on MRT is 5.6% (4.8-6.3). 
Similarly, the reported seroprevalence of brucellosis in small ruminants is summarized in Table 3.8. 
The overall seroprevalence of brucellosis in goats and sheep respectively are 2.9% (95% CI: 2.1-4.1) 
and 5.4% (95% CI: 3.9-7.1). In small ruminants also, the temporal variation of seroprevalence was not 
noticed. Among the three species of domestic ruminants, the overall seroprevalence of brucellosis is 
higher in sheep than goats and cattle.  




Table 3.8: Reported seroprevalence of brucellosis in goats and sheep in Bangladesh 





113 (7) RBT 6.2% (2.5-12.3) Akhter et al., 2014 















127 (4); 120 (3): 
247 (7) 




208 (8) RBT, SAT 3.8% (1.7-7.4) Islam et al., 2010 
2007 Dhaka, 
Mymensingh 
300 (6) RBT, PAT, TAT, 
MET 




350 (51) PAT, TAT 14.5% (11.0-
18.7) 
Rahman et al., 1988 
 Overall 1252 (37)  2.9% (2.1-4.1)  
Year Area (sheep) Sample size 
(positive) 





102 (6); 101 (6): 
203 (12) 
RBT, iELISA 5.9% (3.1-10.1) Ahsan et al., 2014; 
Akhter et al., 2014 




206 (14); 170 (12); 
80 (1): 456 (27) 
RBT, iELISA, 
cELISA, FPA 







130 (4) RBT, iELISA 3.1% (0.8-7.7) Rahman et al., 2011b 
2007 Dhaka, 
Mymensingh 
60 (2) RBT, TAT, PAT 3.3% (0.4-11.2) Uddin et al., 2007a 
 Overall 839 (45)  5.4% (3.9-7.1)  
Legend: RBT: Rose Bengal test; SAT: Slow Agglutination Test; MET: 2-Mercaptoethanol Test; 
cELISA: Competitive ELISA; iELISA: Indirect ELISA; FPA: Fluorescence Polarization Assay; PAT: 
Plate Agglutination Test; TAT: Tube Agglutination Test. 
 
The reported prevalence of human brucellosis especially in HROG is summarized in Table 3.9. Only 
four studies so far reported brucellosis seroprevalence in humans. The sample size varied from 50-210. 
Temporal variation was noted in seroprevalence of human brucellosis over the years. The 




seroprevalence of brucellosis up to 1988 and after 2009 differed significantly in humans. The reason is 
not clear as the seroprevalence in animals are static over the years. The type human sample, tests used 
and their interpretation may the reasons for such difference. 
Commercial production system and abortion were reported to be significantly associated bovine 
brucellosis seroprevalence (Islam et al., 2013b). Pregnancy status in goats and age in sheep were also 
found to be significantly associated with brucellosis (Islam et al., 2013b).  
 
Table 3.9: Reported seroprevalence of human brucellosis in Bangladesh 
Year Area Sample size 
(Positive) 








190 (21) Milker, livestock 
and crop farmer 
RBT, 
STAT 
11.1% (6.9-16.4) Rahman et al., 1983 
1988 Tangail, 
Mymensingh 
116 (25) Goat farmer TAT 21.6% (14.5-
30.1) 
Rahman et al., 1988 
2009 Mymensingh 50 (3) Livestock farmer STAT 6.0% (1.3-16.5) Nahar and Ahmed, 2009 




3.3% (1.4-6.7) Muhammad et al., 2010 
 Overall 566 (56)   9.9% (7.6-12.7)  
Legend: RBT: Rose Bengal Test; STAT: Standard Tube Agglutination Test; TAT: Tube 
Agglutination Test. 
 
It is evident from the above review that brucellosis is also endemic in Bangladesh. Several studies on 
seroprevalence brucellosis in animals and humans and its risk factors in cattle, sheep and goats are 
available as shown above. Most of the previous studies used non-random sampling and the size of the 
samples were also very small in some cases like 50, 60 and 80 (Uddin et al., 2007b; Nahar and 
Ahmed, 2009; Rahman et al., 2011a). Prevalence of a disease is a population parameter, if it is not 
estimated from a random and representative sample, it will not reflect the disease status in that 
population due to selection bias. The tests used for the diagnosis of brucellosis in domestic ruminants 
and humans are imperfect and their performance was not evaluated in Bangladesh context. The true 
prevalence of brucellosis in domestic ruminants is not known and is essential for analyzing the impact 
of this disease in domestic ruminants in Bangladesh. Indeed, when diagnostic tests are used without 
evaluating their performance in a context usually generate unreliable results, which in turn may lead to 
wrong epidemiological inferences (Godfroid et al., 2013). The prevalence of brucellosis in pyrexic 
patients and risk factors of human brucellosis were not studied. Moreover, the information on different 
species of Brucella prevalent in animals is scarce and not known in humans in Bangladesh (Rahman et 
al., 2014). The epidemiological understanding of brucellosis in domestic ruminants and humans in 




Bangladesh is incomplete and sometimes misleading for the decision makers to initiate a control 
strategy. The figure 3.7.1 shows the study areas and type of samples collected for this study.  
  











































The overall objective of this thesis was to investigate the epidemiology of brucellosis in humans and 
domestic ruminants in Bangladesh in terms of the evaluation of commonly used diagnostic tests, 
estimation of true prevalence, identification of risk factors and identification of Brucella species in 
order to provide information for appropriate control strategies. 
The specific objectives and underlying research questions are: 
1. To evaluate the performance of Rose Bengal test (RBT), Slow agglutination test (SAT) and 
indirect enzyme linked immunosorbent assay (iELISA) for the diagnosis of bovine brucellosis and 
to estimate the true prevalence of bovine brucellosis (Chapter 5). The research questions addressed 
under objective 1 are: 
 How do the RBT, SAT and iELISA perform for the diagnosis of bovine brucellosis in 
Bangladesh? 
 Does the true prevalence of bovine brucellosis vary greatly from the reported apparent 
prevalences? 
 What is the proportion of cattle infected with acute and chronic brucellosis? 
2. To evaluate the performance of RBT, SAT and iELISA for the diagnosis of brucellosis in small 
ruminants and estimation of true prevalence of small ruminants brucellosis (Chapter 6). The 
research questions are the same as those in objective1 but for small ruminants. 
3. To identify the species of Brucella prevalent in human and animals in Bangladesh (Chapter 7). The 
underlying research question is: 
 Which species of Brucella is prevalent in humans and animals in Bangladesh? 
4. To study the prevalence and risk factors of brucellosis in high-risk group of people in Bangladesh 
(Chapter 8). The research questions are: 
 Are the livestock keepers, butchers, dairy hands and veterinarians at high risk to be infected 
with brucellosis? 
 What are the factors associated with brucellosis in occupationally exposed group of people? 
5. To estimate the prevalence of brucellosis in pyretic patients in Bangladesh (Chapter 9). The 
research question is: 
 Do the pyretic people also suffer from brucellosis? 
 









There are about 23.4 million heads of cattle in Bangladesh. The study on bovine brucellosis was 
started in 1970. Since then, several studies focused on the seroprevalence of bovine brucellosis in 
Bangladesh. However, most of them were based on non-representative and non-random samples. A 
prevalence study based on non-representative and non-random sample does not reflect true status of 
that disease in a population. The true prevalence of bovine brucellosis, the proportion of cattle infected 
with acute and chronic brucellosis and also the performance of commonly used tests are unknown in 
Bangladesh. This chapter addresses these issues based on Bayesian latent class analysis of three 
serological test applied on randomly collected cattle blood samples from one district and one 
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A Bayesian latent class analysis framework was used to estimate the true prevalence of bovine 
brucellosis and to evaluate the performance of three conditionally dependent serological diagnostic 
tests: indirect Enzyme Linked Immunosorbent Assay (iELISA), Rose Bengal Test (RBT) and Slow 
Agglutination Test (SAT) in Bangladesh. One thousand three hundred and sixty randomly selected 
cattle sera were tested in parallel from Mymensingh district and one Government (Govt.) owned dairy 
farm of Bangladesh. Only 0.29% (95% Credible Interval (CI): 0.06-0.86) cattle were acutely infected 
whereas 0.49% (95% CI: 0.16-1.1) were chronically infected with brucellosis in Mymensingh. On the 
other hand, in Govt. farm 15.58% (95% CI: 11.89-19.89) cattle were acutely infected with brucellosis 
and only 3.2% (95% CI: 1.63-5.72) were chronically infected. The estimated true prevalence of 
brucellosis among cattle of Mymensingh and Govt. dairy farm were 0.3% (95% CI: 0.03-0.7) and 
20.5% (95% CI: 16.4-26.3) respectively. The performance of iELISA was best in both Mymensingh 
and Govt. farm with the sensitivity of 90.5% and 91.3% and specificity of 99.3% and 99.2% 
respectively. The performance of RBT was better in Mymensingh than Govt. farm with 81.0% and 
76.1% sensitivity and 99.0% and 95.6% specificity respectively. Similar to RBT, the performance of 
SAT was also better in Mymensingh than Govt. farm with 63.5% and 79.7% sensitivity and 98.6% and 




95.3% specificity respectively. Through this test validation study, we recommend iELISA with a new 
cut-off of 5 IU/ml both in chronically (as at Mymensingh) and acutely infected cattle population (as at 
the Government Farm) for routine screening. We recommend to do nothing for the control of bovine 
brucellosis under the small-scale dairy and subsistence management system in Bangladesh. However, 
vaccination should be applied in herds where the prevalence is very high such as at Govt. farm. 
 
Introduction 
Bovine brucellosis, an economically important reproductive disease of livestock, is one of the most 
widespread zoonoses and remains a major public health problem in many developing countries [1]. It 
is predominantly caused by Brucella abortus and induces infertility and delayed heat, leads to loss of 
calves and interrupts lactation thereby leading to reduction in milk yield. 
Brucellosis is endemic in Sub-Saharan Africa, the Middle East, South America, and South East Asia 
[2]. In Bangladesh, it was reported by [3] that 37% of adult cows were infertile and that brucellosis 
could play an important role in causing infertility in cows. 
The total annual economic loss due to bovine brucellosis in indigenous cows in Bangladesh was 
estimated at €720,000 and the loss per 1,000 cross-bred cows at €12,000 [4]. The range of reported 
animal level seroprevalence in cattle of Bangladesh was 0.0%-18.4% [5–15]. Previous serological 
studies of brucellosis in Bangladesh used the Rose Bengal Test (RBT), Plate Agglutination Test or 
Standard Tube Agglutination Test (SAT) either alone or in series. As none of these tests is considered 
to be a gold standard, seroprevalence reported using these tests were apparent prevalence. Moreover, 
the performance of these tests has not been evaluated in naturally infected cattle of Bangladesh. Using 
diagnostic tests without evaluating their performance may generate unreliable results which may also 
lead to wrong epidemiological inferences. The IgG iELISA detects only IgG, whereas RBT detects 
mainly IgG (also IgM and IgA) and SAT detects mainly IgM (plus also IgG and IgA) antibodies. So, 
they can be considered to be partially conditionally dependent on each other given the true disease 
status. The Brucella spp. induced humoral IgG immune responses persist after the peak of the 
response (3-4 weeks post-infection) and remain detectable over long periods of time (up to several 
years); in contrast, the IgM response is rapidly induced 2-3 weeks after exposure and may disappear 
after a few months. Considering this fact it can be concluded that, the simultaneous presence of IgM 
and IgG indicates acute brucellosis, while the presence of IgG alone is an indication of chronic 
brucellosis. Moreover, a positive response in an agglutination test like SAT, which detects mainly 
IgM, is not indicative of brucellosis if it is not confirmed by a positive IgG response by iELISA within 
one week [16]. So, the selection of three tests in this study will also help us to know the stage of 
infection of brucellosis (acute vs chronic) in cattle. 
The performance of a diagnostic test is traditionally evaluated by comparison to a perfect or reference 
test, i.e. a gold standard test, a diagnostic test with 100% sensitivity and specificity [17]. Isolation and 
identification of Brucella spp. is considered as the “gold standard” for brucellosis diagnosis [18], 




which is difficult to perform in developing countries due to the lack of trained personnel and the 
requirement of sophisticated laboratory facilities with high level safety containment. Moreover, the 
sensitivity of the culture method is low [19, 20]. However, there are alternative ways of investigating 
accuracy of diagnostic tests even in the absence of a gold standard test. Among them, latent class 
analysis has been increasingly gaining acceptance in veterinary medicine [21, 22]. In this situation, 
rather than using a single imperfect test, multiple imperfect tests are combined to estimate the true 
prevalence of antibodies to bovine brucellosis and diagnostic test accuracy parameters [17, 23]. An 
important consideration in the evaluation of multiple diagnostic tests is whether or not the tests can be 
assumed conditionally independent of each other given the true disease status. It has been 
demonstrated that the assumption of conditional independence may lead to biased estimates for test 
characteristics if in fact the tests are conditionally dependent [24]. As iELISA, RBT and SAT are 
partially dependent on each other, any estimation procedure should therefore adjust for the 
dependencies among the tests. Different theoretical frameworks have been developed over the years 
[21, 25]. Specific publications where authors considered test dependence in a multiple testing strategy 
for the diagnosis of brucellosis are [26, 27]. At the other end of the spectrum a system allowing 
estimation without explicit external information exists as well: this approach assumes conditional test 
independence and constant values for sensitivity and specificity across different populations [28]. In 
this study, the true exposure prevalence to bovine brucellosis in a population of naturally infected 
cattle in Mymensingh district and the largest Government (Govt.) dairy farm of Bangladesh was 
estimated. In addition, the performance of three conditionally dependent serological tests namely 
indirect ELISA (iELISA), Rose Bengal Test (RBT) and Slow Agglutination Test (SAT) was evaluated 
using a Bayesian analysis. 
 
Materials and Methods 
Study area and animal husbandry practice 
The study area included Mymensingh district (MD) and the Government owned Central Cattle 
Breeding and Dairy Farm (CCBDF) in Savar, located in the Dhaka district of Bangladesh (Figure 5.1). 
These areas are located between latitudes 23°31’ and 25°12’N and longitudes 90°01’ and 90°47’E. 
The areas were chosen because of the location of Bangladesh Agricultural University (BAU) which 
manages the brucellosis diagnostic laboratory and because they have the highest livestock population 
density (>600 km
-2
) in Bangladesh. On average the study area has an elevation of 10m above sea level. 
CCBDF is the largest farm in Bangladesh with major objectives to produce crossbred heifers and bulls 
for distribution to farmers, to collect semen from tested bulls to support the national artificial 
insemination (AI) program and to supply milk to Dhaka city. During the last 25 years, this farm 
maintains on average a herd of about 2500 cattle. Holstein Friesian and Sahiwal breeds are mainly 
used for semen production. The system of animal management is intensive and only AI is used for 
reproduction. 















The cattle management system in MD is small-scale dairy with traditional crop-based subsistence 
management systems. The small-scale dairy system mainly practices zero grazing (“cut-and-carry 
system”) with occasional semi-zero and tethering systems. Occasionally when there is no crop in the 
field, animals of separate owners graze together in villages. Common ration supplements are rice 
polish, wheat bran and oil cake, but their supply to animals is low, irregular and restricted mostly to 
milking cows. The common breeds are indigenous and their crosses with Holstein Friesian and 
Sahiwal. 
The study was carried out between September 2007 and August 2008. Vaccination against brucellosis 
has not been initiated in any livestock species of Bangladesh. 
 
Sampling design 
A cross-sectional study was carried out to investigate the seroprevalence of bovine brucellosis in the 
Mymensingh district of Bangladesh. Since there is no livestock databank in Bangladesh, the first step 
of the sampling process was the digitisation of the map of Mymensingh district using ArcView 
Version 3.2 (Environmental Systems Research Institute, Inc. Redlands, California). Out of a total of 
the 146 unions (sub Upa-Zilla) of MD, 28 were randomly selected. One geographical coordinate was 
randomly selected from each selected union and located by a hand held GPS reader. Livestock farmers 
within 0.5 km radius of the selected point were informed about the survey [29]. To encourage 
livestock farmers to participate, free anthelmintic and vitamin-mineral premix were supplied to their 
animals when sampling took place and all animals of a selected herd were sampled. Blood samples 
were collected at CCBDF, including all breeding bulls and systematic random samples of cows (every 
10th cow). In addition, a questionnaire designed to collect animal and herd level data was 
administered during blood sampling of each herd. 
 
Ethics statement 
The study protocol was peer reviewed and cleared for ethics by the Faculty of Veterinary Science of 
Bangladesh Agricultural University (ref. 01/2007/EB/FVS). In this research, farm owned animals were 
used just once for jugular venepuncture following established techniques. Minimal restraining of the 
animals was needed during jugular venepuncture and it was mainly done by using a halter. This level 
of intervention has no impact on the well-being of the animal and is also routinely performed by the 
veterinarians for the purpose of disease diagnosis, treatment and research. It was not an experimental 
research on animals and thereby approval by the ethical committee was not needed. Verbal consent of 
farm owners were obtained prior to the collection of blood samples from their animals. The study took 
place on the territory of Mymensingh District of Bangladesh and within the confines of the Central 
Cattle Breeding and Dairy Farm in Dhaka District of Bangladesh. The study did not involve 
endangered or protected species. 
 




Processing of blood samples 
About 5-7 ml of blood was collected from each animal by jugular venipuncture with disposable 
needles and Venoject tubes, labelled and transported to the laboratory on ice (after clotting) within 12 
hours of collection. Blood samples were kept in the refrigerator (2-8°C) in the laboratory and one day 
later sera were separated by centrifuging at 6000g for 10 minutes. Each serum was labelled to identify 
the animal and stored at -20°C. Each serum was divided into two tubes each containing about 1-1.5 ml 
of serum. One aliquot was used for testing and the other was preserved in a serum bank. 
 
Serological tests 
All blood samples were tested in parallel using iELISA, SAT and RBT in the Medicine Department 
laboratory of BAU, Mymensingh, Bangladesh. 
iELISA was performed according to [30] using B. abortus biotype 1 (Weybridge 99) S-LPS (Brucella 
smooth lipopolysaccharide) as antigen. A detailed description of the method can be found in [31]. The 
accepted cut-off value for a positive result is 2 IU/ml of test serum [30]. The effect of using a different 
cut-off value for iELISA (5 IU/ml) was evaluated in one of the statistical models (Model 2, see 
below). RBT was performed as described by [18]. The detailed procedure was described in a previous 
paper by [31]. The result was considered positive when agglutination was noticeable after 4 minutes. 
SAT was carried out with ethylenediaminetetraacetic acid (EDTA) as described by [32]. The antigen 
used was B. abortus biotype 1 (Weybridge 99) (Synbiotics Europe, France). One hundred and sixty 
eight micro litre of SAW buffer in the first well and 100 µl in the second and the third wells were 
added in 96-well microtitre plate. Thirty two micro litre of serum was added in the first well (Dilution 
1/6.25). After well mixing of diluent and serum, 100 µl from first well was transferred to the second 
well (1/12.5). In the same way 100 µl was transferred from second to the third well (dilution 1/25) and 
100 µl discarded from the third well. Then in each well, 100 µl of standardised SAW antigen was 
added giving the serial serum dilutions of 1/12.5; 1/25 and 1/50. The plates were agitated and 
incubated at 37°C for 20-24h. Reading was done on the basis of degree of agglutination and expressed 
in international units (IU). Any serum with an antibody titre greater than or equal to 30 IU/ml, as 
prescribed by the EU [33], was considered positive. 
 
Statistical analysis 
A Bayesian analysis framework was used in WinBUGS 1.4 [34] and R 3.1.1 (R Foundation and 
Statistical Computing, 2014) to estimate the prevalence and the sensitivity and specificity of the three 
tests. Stata/MP 13.1 [35] was used to compute the ordered logistic regression. 
As fully explained in [21], converting the apparent prevalence (laboratory prevalence, seroprevalence) 
into the so-called true prevalence always requires one to solve a system of overparametrized equations 
(one test yields one independent equation with three unknown variables, two tests yield three 
independent equations with seven unknowns variables, ...). This invariably requires the input of 




external (prior, independent) information, either in the form of prior estimates of test sensitivity or test 
specificity, or in the form of some hypothesis, such as conditional independence of tests or constancy 
of test characteristics across different populations. Several solutions have been proposed, going from 
the so-called Hui-Walter model [28], based on two conditionally independent diagnostic tests applied 
in two populations with sensitivity and specificity constant over the two populations, to the fully 
parametrized models proposed by (e.g.) [36], [25], [37] and [21]. 
This paper examines two modelling approaches: 
The Hui-Walter model [28], using the three test combinations (iELISA/RBT, iELISA/SAT and 
RBT/SAT) in the two localities (MD and CCBDF). Prevalence and test characteristic estimation is 
done probabilistically by means of the WinBUGS model shown in S1 Listing 1, which gives the 
example of the iELISA/RBT combination. The posterior mean and the 95% credibility interval are 
reported. The general equation is: 
 
 
The prior (external) information for this scheme is strictly deterministic (sensitivity/specificity of 
second test independent of result of first test and sensitivity/specificity identical in two localities). It 
reduces the number of parameters to be estimated to six (two prevalences, two sensitivities and two 
specificities) and it has six independent equations. Because of reasons of symmetry ({p, Se, Sp} and 
{1-p, 1-Sp, 1-Se} are solutions, see [21] for full details), two of the parameters have to be constrained 
to the domain [0.5,1]. 
2. The full model assuming conditional dependence has the implicit characteristic of being over-
parametrized (it has seven independent equations and requires fifteen variables to be estimated for 
each of the two locations). It thus requires explicit external (prior) information for the test 
characteristics (sensitivity and specificity). An approach, proposed by (e.g.) [36] makes use of 
covariances to model the conditional dependence. The WinBUGS code for the case of MD is shown in 
S2 Listing 2. The posterior mean and 95% credibility intervals are reported. The general equation is: 
 




Prior information was obtained from a meta-analysis (see further) with the extra prior condition that 
the most likely value for the iELISA specificity was to exceed 99%, hence a very narrow prior beta 
distribution was used. Two cut-off values were tested: 2 IU/ml and 5 IU/ml. 
Model selection proceeded according to the method described in [21], making use of DIC, pD and 
Bayes-p. All models were run with a burn-in period of 50,000 iterations and estimates were based on a 
further 50,000 iterations using three chains. The external (prior) information was generated by means 
of a meta-analysis, carried out in Stata 13.1 [35], using the results published in the following 
references: (iELISA) [38], [39], [40], [41], [42], [43]; (RBT) [38], [41], [43], [44], [45], [46]; (SAT) 
[38], [43], [47], [48]. The choice of priors was driven by the aim to get as diverse as possible a range 
of field conditions, even if that meant that the actual status of the animals was not always clear. Note 
that this will result in higher uncertainty in the priors –i.e. wider distributions–, giving more weight to 
the data. The exception was the iELISA specificity, as explained above, where a narrow prior 





Mymensingh district: A total of 1,020 cattle were subjected to the three serological tests in MD. 
About 86.3% and 70.1% of the cattle in MD were indigenous and female respectively. The mean age 
was 3.72±0.09 years (mean±standard error) and ranged from 0.03 to 15 years. The average body 
weight of cattle was 72.2±1.82 with a median of 75 Kg. About 73.8% of the herds consisted of one to 
three cattle. Only one herd had more than 10 cattle in MD. The herd size ranged from 1 to 11 with a 
median of 2 animals. 




Government dairy farm: In the CCBDF herd, 340 sera samples (including 89 from breeding bulls) 
were tested by the three serological tests. The average age of cattle was 5.3 ±0.21 years and ranged 
from 0.03 to 17 years. About 87.6% and 64.1% of the GF cattle were cross-bred and female 
respectively. The average body weight of cattle was 256.83±10.43 with a median of 200 Kg. 
 
Serological results 
Table 5.1 shows the numbers of animals that tested positive in the three tests in function of the iELISA 
cut-off value. The following summary is valid for an iELISA cut-off value of 5 IU/ml. Only 6.1% 
(22/362) herds from MD were serologically positive in at least one of the three tests (one animal and 2 
animals positive per herd respectively in 19 and 3 herds). Only 0.29% (3/1020) (95% Credible Interval 
(CI): 0.06-0.86) cattle were acutely infected whereas 0.49% (95% CI: 0.16-1.1) were chronically 
infected in Mymensingh. About 2.2% (95% CI: 1.4-3.2) cattle were positive in at least one serological 
test in MD. The apparent prevalence were 0.4% (95% CI: 0.1-1.0) based on iELISA, 0.9% (0.4-1.7) 
based on RBT and 1.3% (95% CI: 0.7-2.2) based on SAT. About 22.6% (95% CI: 18.3-27.5) cattle 
were positive in at least one serological test in Govt. dairy farm. In CCBDF, about (53/340) 15.58% 
(95% CI: 11.89-19.89) cattle were acutely infected with brucellosis and only (11/340) 3.2% (95% CI: 
1.63-5.72) cattle were chronically infected. The apparent prevalence were 17.6% (95% CI: 13.7-22.1) 
based on iELISA, 18.2% (14.3-22.8) based on RBT and 19.7% (15.6-24.3) based on SAT respectively. 
 
Table 5.1. Cross-classified test results for brucellosis in cattle in Mymensingh district and 
Government Dairy Farm of Bangladesh. Results are based on iELISA (cut-off = 2 IU/ml and 
cut-off = 5 IU/ml), RBT and SAT 
iELISA RBT SAT 
Mymensingh Government Farm 
2 IU/ml 5 IU/ml 2 IU/ml 5 IU/ml 
1 1 1 2 1 51 47 
1 1 0 6 1 3 2 
1 0 1 6 2 7 6 
1 0 0 137 5 53 11 
0 1 1 0 1 8 12 
0 1 0 1 6 0 1 
0 0 1 5 9 0 12 
0 0 0 863 995 217 259 
  
Total 1020 1020 340 340 
Legend: iELISA =indirect Enzyme-Linked Immuno Sorbent Assay; RBT =Rose Bengal Test; SAT 









Table 5.2 summarises the results of the meta-analysis and the corresponding parameters for the 
respective prior beta distributions. 
 
Table 5.2. Summary values of the meta-analysis estimation of test characteristics and 
corresponding beta distribution parameters 
 Sensitivity Specificity Sensitivity Specificity 
Test Mean 95% CI Mean 95% CI shape1 shape2 shape1 shape2 
iELISA 93.9 86.9–97.2 99.8 99.1–99.9 85.00 6.4867 750.00 2.6544 
RBT 91.0 70.6–97.7 99.6 84.3–99.9 18.80 2.7583 22.60 1.0837 
SAT 82.6 27.8–98.3 99.7 97.4–99.9 3.45 1.5142 190.00 1.6483 
Legend: iELISA =indirect Enzyme-Linked Immuno Sorbent Assay; RBT =Rose Bengal Test; SAT 




The estimates obtained from the application of the Hui-Walter model (iELISA cut-off at 2 IU/ml and 5 
IU/ml) for the three possible combinations of two tests are shown in Table 5.3. The increase in cut-off 
(as per definition) results in an increase of the iELISA specificity and a drop in the estimated 
prevalence. When iELISA is in the combination (HWER and HWES) there is also an increase in pD and a 
drop in DIC, indicating a better fit (Table 5.4, e.g. in the case of HWER the pD increases from 4.89 to 
5.39 and the DIC decreases from 39.15 to 36.37, whereby this decrease is due almost entirely for MD, 
namely 18.32 to 15.76, the value for CCBDF remaining virtually constant around 20.5). 
 
  




Table 5.3. Estimated values for true prevalence and test characteristics (and their 95% 
credibility intervals) using the Hui-Walter Model for Mymensingh district and the Government 
Farm, when setting the iELISA cut-off at respectively 2 IU/ml (a) and 5 IU/ml (b) (a) iELISA 
cut-off = 2 IU/ml 
(a) iELISA cut-off= 2IU/ml 
Model PrevM PrevG iELISA RBT SAT 






































(b) iELISA cut-off= 5IU/ml 








































Legend: iELISA =indirect Enzyme-Linked Immuno Sorbent Assay; RBT =Rose Bengal Test; SAT 
=Slow Agglutination Test; PrevM =true prevalence MD; PrevG =true prevalence CCBDF herd; Se 
=sensitivity; Sp =specificity; HW = Hui-Walter; E = iELISA; R = RBT; S = SAT. 
 
  




Table 5.4. Values of DIC  and pD for Hui-Walter models at two iELISA cut-off values 
Model iELISA with cut-off=2 IU/ml iELISA with cut-off=5 IU/ml 
DICM DICG DICtot pD DICM DICG DICtot pD 
ER 18.3 20.9 32.2 4.89 15.8 20.6 36.4 5.39 
ES 19.7 21.2 40.9 5.51 16.4 20.4 36.8 5.44 
RS 16.1 18.1 34.2 4.84 16.1 18.1 34.2 4.84 
Legend: iELISA = indirect Enzyme-Linked Immuno Sorbent Assay; DICM  = Deviance Information 
Criterion at MD; DICG  = Deviance Information Criterion at CCBDF; DICtot  = total Deviance 
Information Criterion; pD  = effective number of parameters estimated; ER = combination indirect 
Enzyme-Linked ImmunoSorbent Assay and Rose Bengal Test; ES = combination between indirect 
Enzyme-Linked Immuno-Sorbent Assay and Slow Agglutination Test; RS = combination between 
Rose Bengal Test and Slow Agglutination Test. 
 
Conditional dependence model 
The values of the various statistics (DIC, pD and Bayes-p) using two different cut-off values for 
iELISA (2 IU/ml and 5 IU/ml) are summarised in Table 5.5. The estimates of the prevalence and test 
characteristics for Mymensingh and Government Farm using an iELISA cut-off of 5 IU/ml are shown 
in Table 5.6. 
 
Table 5.5. Cut-off selection for iELISA at Government Farm and Mymensingh 
  Unconstrained  Constrained 
Locality Cut-off DIC pD Bayes-p DIC pD Bayes-p 
Govt. Farm 2 37.98 4.84 0.6394 40.14 4.35 0.7704 
 5 37.82 5.29 0.5123 37.85 4.96 0.5088 
Mymensingh 2 35.87 4.58 0.6320 56.19 4.04 0.9969 
 5 32.47 4.56 0.5341 31.20 4.50 0.4429 
 









Table 5.6. Variable estimates (prevalence and test characteristics at Government Farm and 
Mymensingh) when putting iELISA cut-off at 5 IU/ml 






Govt. Farm 0.205 0.913 0.992 0.761 0.956 0.797 0.953 
Mymensingh 0.003 0.905 0.993 0.810 0.990 0.635 0.986 
Legend: iELISA= indirect Enzyme-Linked Immuno Sorbent Assay; RBT =Rose Bengal Test; SAT 
=Slow Agglutination Test; Se=Sensitivity; Sp=Specificity 
 
The distribution of the iELISA values (with a ceiling of 20 IU/ml) in function of age of the animals at 
MD and CCBDF are shown respectively in Figure 5.2 and Figure 5.3. The predictions of the ordered 
logistic regression of the serological classification (0 = negative [ELISA < 2 IU/ml]; 1 is false positive 
[2 ~ ELISA < 5 IU/ml]; 2 is true positive [5 IU/ml < ELISA]) in function of age at the two localities 











Figure 5.2. iELISA IU/ml values in function of age of the animal at Mymensingh 
 
Legend: horizontal blue line and red line indicate the cut-off of 2 IU/ml and 5 IU/ml, respectively. 
 
 
Figure 5.3. iELISA IU/ml values in function of age of the animal at Government Farm
 
Legend: horizontal blue line and red line indicate the cut-off of 2 IU/ml and 5 IU/ml, respectively. 
 
 




Figure 5.4. iELISA serological class in function of age at Mymensingh: predictions from the 
ordered logistic regression 
 
Legend: Black line, proportion animals with ELISA < 2 IU/ml (Negative); Blue line, proportion animals with 2 
≤ ELISA < 5 IU/ml (False positive); Red line, proportion animals with ELISA ≥ 5 IU/ml (True positive). 
 
Figure 5.5. iELISA serological class in function of age at Government Farm: predictions from 
the ordered logistic regression 
 
Legend: Black line, proportion animals with ELISA < 2 IU/ml (Negative); Blue line, proportion animals with 2 
≤ ELISA < 5 IU/ml (False positive); Red line, proportion animals with ELISA ≥ 5 IU/ml (True positive). 





This study estimated the true prevalence of brucellosis applying parallel multiple tests on blood 
samples from cattle in Bangladesh. The true seropositive status of a disease is an essential piece of 
information for decision makers prior to establishing prevention and control measures. Through this 
study, prevalence of brucellosis in cattle of MD and CCBDF of Bangladesh were updated to 0.3% 
(95% CI: 0.03-0.7) and 20.5% (95% CI: 16.4-26.3) respectively through a Bayesian analysis 
framework. The estimated true prevalence of brucellosis in MD is much lower than the previous 
reports 0.0%-18.4% [5–15] of apparent prevalences from Bangladesh. The smaller size and non-
randomness of the samples, types of test used, differences in management system prevailing in 
different parts of Bangladesh may be responsible for the great variation in apparent prevalences in 
earlier studies. In Bangladesh, indigenous cattle are reared in subsistence/backyard management 
system whereas in commercial management system mostly cross-bred cattle are maintained. The 
prevalence of brucellosis is reported to be significantly higher in commercial production system [15]. 
This is also supported by our data that about 86.3% cattle of MD are indigenous. However, the 
prevalence in the largest CCBDF exceeds the upper limit of the previous prevalence reports. Farmers 
are aware of the disease and the cows having signs suggestive of brucellosis such as anoestrous, repeat 
breeding syndrome, retained placenta and abortions are usually sold to butchers. Moreover around 3.5 
million cattle are slaughtered annually in the country and about 40% of them are performed during the 
festival of Eid-ul-Azha [49]. During this mass slaughter, the animals infected with brucellosis may be 
removed from the population, partially explaining the very low prevalence in the subsistence 
management system such as in MD. CCBDF does not represent the cattle population of Bangladesh 
even those of the privately managed larger farms. The disease management system, especially with 
respect to reproduction, is better in private farms than that at CCBDF. The prevalence structure 
obtained in MD will represent brucellosis status in cattle of other districts especially where small-scale 
dairy and subsistence/backyard management system prevails. Higher brucellosis prevalence was 
observed at CCBDF than in MD. Several reasons may be responsible for this observation, including 
larger herd size, irregularly/not testing cattle, high proportion of cross-breed cattle, new introduction 
of animals in the herd from local and international market without proper testing and sole use of 
artificial insemination (AI) practice at CCBDF. CCBDF also maintains breeder bulls for the 
production and dissemination of frozen semen throughout the country for AI. Breeder bulls of CCBDF 
were also found to be brucellosis positive and after reporting removed from semen production 
(Unpublished data of the same authors).Although the study of brucellosis started before liberation 
from Pakistan [5], no progress has been made regarding control of this disease at national level in 
Bangladesh. Estimation of the true prevalence along with its true credible interval may help decision 
makers to quantify the impact of this disease in bovines of Bangladesh. The average herd level 
apparent prevalence of brucellosis observed in the MD of Bangladesh was around 2.33% 
(Unpublished data of the same authors). It indicates that with a subsistence management system 




brucellosis may be naturally controlled without any directed control measures. With such a low 
prevalence of brucellosis, both at herd and animal level, test and slaughter policies of control may be 
implemented [50,51]. But considering the poor socioeconomic status of Bangladesh, we recommend 
to do nothing for further control of bovine brucellosis under small-scale dairy and subsistence 
management system. But, vaccination should be initiated to reduce the prevalence of brucellosis in 
herds where the prevalence is very high as in the largest govt. farm. Information on the performance of 
diagnostic tests is needed by clinicians, decision-makers in the context of clinical diagnoses or 
quantitative risk assessments as well as for prevalence estimation or risk-factor studies [52]. This 
study is the first to validate three serological tests for the diagnosis of bovine brucellosis in 
Bangladesh. Latent class evaluation of diagnostic tests is increasingly gaining acceptance in veterinary 
medicine with few studies noted in the literature for brucellosis diagnosis [46, 53].  According to the 
results of our study, the iELISA yielded the highest sensitivity and specificity in both MD and 
CCBDF. This was the case when we increased the cut-off to 5 IU/ml. Both validation by the Hui-
Walter model and the full conditional dependence model yielded a better fit when using a cut-off of 5 
IU/ml than when using 2 IU/ml as cut-off (expressed in terms of DIC and pD, Table 4 and Table 5). 
Based on these results, we recommend only iELISA with a cut-off value of 5 IU/ml for routine 
screening of bovine brucellosis in Bangladesh context. The iELISA test kits provided by different 
companies have different cut-offs and thereby it is difficult to compare the results of those test kits. To 
avoid false positives an appropriate cut-off should be determined under local conditions. The stage and 
duration of disease affect sensitivity of a diagnostic test and they are thought to be different in low and 
high-prevalence population [52]. As the prevalence of acute brucellosis is higher at CCBDF, the 
sensitivity of SAT (which detect mainly IgM produced in acute stage of infection) at CCBDF (79.7%) 
is also higher than that in MD (63.5%). Similarly, since the prevalence of chronic infection is 
relatively higher in MD, the sensitivity of IgG detecting (indicate chronic infection) tests gradually 
increases (SAT-RBT-iELISA: 63.5-81.0-90.5%). The decreased specificity of RBT and SAT at 
CCBDF might be due to presence of some false positive reactions, as we did not change their reading 
or cut-off. It is supported by our data also. In Table 1, twelve cases positive in both RBT and SAT, one 
case positive in RBT only and two cases positive in SAT only may be false positive reactions. 
Similarly, the relatively lower specificity of SAT in MD may also be due to the presence of false 
positive reactions (in Table 1 there are nine cases positive only in SAT). The iELISA titre declined 
significantly with the age of the cattle, which is a normal phenomenon of humoral immune response. 
The IgG response reaches peak after 3-4 weeks post-infection and stays detectable over long periods 
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Supporting Information - Listing 1: WinBUGS code for the Hui-Walter model 
 
list(r1=c(8,143,1,868), n1=1020, r2=c(54,60,8,218), n2 = 340) 
# model 
Model{ 
r1[1:4] ~ dmulti(p1[1:4], n1) 
p1[1] <- prev[1]*se[1]*se[2] + (1-prev[1])*(1-sp[1])*(1-sp[2]) 
p1[2] <- prev[1]*se[1]*(1-se[2]) + (1-prev[1])*(1-sp[1])*sp[2] 
p1[3] <- prev[1]*(1-se[1])*se[2] + (1-prev[1])*sp[1]*(1-sp[2]) 
p1[4] <- prev[1]*(1-se[1])*(1-se[2]) + (1-prev[1])*sp[1]*sp[2] 
r2[1:4] ~ dmulti(p2[1:4], n2) 
p2[1] <- prev[2]*se[1]*se[2] + (1-prev[2])*(1-sp[1])*(1-sp[2]) 
p2[2] <- prev[2]*se[1]*(1-se[2]) + (1-prev[2])*(1-sp[1])*sp[2] 
p2[3] <- prev[2]*(1-se[1])*se[2] + (1-prev[2])*sp[1]*(1-sp[2]) 
p2[4] <- prev[2]*(1-se[1])*(1-se[2]) + (1-prev[2])*sp[1]*sp[2] 
prev[1] ~ dbeta(1,1) 
prev[2] ~ dbeta(1,1) 
se[1] ~ dbeta(1,1) 
sp[1] ~ dbeta(1,1) 
se[2] ~ dunif(0.5,1)  
sp[2] ~ dunif(0.5,1) 
r3[1:4] ~ dmulti(p1[1:4], n1) 
for (i in 1:4) {  
  d1[i] <- r1[i]*log(max(r1[i],1)/(p1[i]*n1)) 
  d2[i] <- r3[i]*log(max(r3[i],1)/(p1[i]*n1)) 
} 
G01 <- 2*sum(d1[]) 
Gt1 <- 2*sum(d2[]) 
bayesp[1] <- step(G01 - Gt1) 
r4[1:4] ~ dmulti(p2[1:4], n2) 
for (i in 1:4) {  
  d3[i] <- r2[i]*log(max(r2[i],1)/(p2[i]*n2)) 
  d4[i] <- r4[i]*log(max(r4[i],1)/(p2[i]*n2)) 
} 
G02 <- 2*sum(d3[]) 
Gt2 <- 2*sum(d4[]) 
bayesp[2] <- step(G02 - Gt2) 
bayesp[3] <- step(G01 + G02 - Gt1 - Gt2) 
} 
 




Supporting Information - Listing 2: WinBUGS code for the full model. Conditional dependence 
is modelled by means of covariances 
 
list(r = c(1,1,2,5,1,6,9,995), n = 1020) 
# model 
model { 
r[1:8] ~ dmulti(p[1:8], n) 
prob_se[1] <-      se[1]  *      se[2]  *      se[3]  +      se[1]  * a[3] +      se[2]  * a[2] +      se[3]  * a[1] + a[4] 
prob_se[2] <-      se[1]  *      se[2]  * (1 - se[3]) -      se[1]  * a[3] -      se[2]  * a[2] + (1 - se[3]) * a[1] - a[4] 
prob_se[3] <-      se[1]  * (1 - se[2]) *      se[3]  -      se[1]  * a[3] + (1 - se[2]) * a[2] -      se[3]  * a[1] - a[4] 
prob_se[4] <-      se[1]  * (1 - se[2]) * (1 - se[3]) +      se[1]  * a[3] - (1 - se[2]) * a[2] - (1 - se[3]) * a[1] + a[4] 
prob_se[5] <- (1 - se[1]) *      se[2]  *      se[3]  + (1 - se[1]) * a[3] -      se[2]  * a[2] -      se[3]  * a[1] - a[4] 
prob_se[6] <- (1 - se[1]) *      se[2]  * (1 - se[3]) - (1 - se[1]) * a[3] +      se[2]  * a[2] - (1 - se[3]) * a[1] + a[4] 
prob_se[7] <- (1 - se[1]) * (1 - se[2]) *      se[3]  - (1 - se[1]) * a[3] - (1 - se[2]) * a[2] +      se[3]  * a[1] + a[4] 
prob_se[8] <- (1 - se[1]) * (1 - se[2]) * (1 - se[3]) + (1 - se[1]) * a[3] + (1 - se[2]) * a[2] + (1 - se[3]) * a[1] - a[4] 
prob_sp[8] <-      sp[1]  *      sp[2]  *      sp[3]  +      sp[1]  * b[3] +      sp[2]  * b[2] +      sp[3]  * b[1] + b[4] 
prob_sp[7] <-      sp[1]  *      sp[2]  * (1 - sp[3]) -      sp[1]  * b[3] -      sp[2]  * b[2] + (1 - sp[3]) * b[1] - b[4] 
prob_sp[6] <-      sp[1]  * (1 - sp[2]) *      sp[3]  -      sp[1]  * b[3] + (1 - sp[2]) * b[2] -      sp[3]  * b[1] - b[4] 
prob_sp[5] <-      sp[1]  * (1 - sp[2]) * (1 - sp[3]) +      sp[1]  * b[3] - (1 - sp[2]) * b[2] - (1 - sp[3]) * b[1] + b[4] 
prob_sp[4] <- (1 - sp[1]) *      sp[2]  *      sp[3]  + (1 - sp[1]) * b[3] -      sp[2]  * b[2] -      sp[3]  * b[1] - b[4] 
prob_sp[3] <- (1 - sp[1]) *      sp[2]  * (1 - sp[3]) - (1 - sp[1]) * b[3] +      sp[2]  * b[2] - (1 - sp[3]) * b[1] + b[4] 
prob_sp[2] <- (1 - sp[1]) * (1 - sp[2]) *      sp[3]  - (1 - sp[1]) * b[3] - (1 - sp[2]) * b[2] +      sp[3]  * b[1] + b[4] 
prob_sp[1] <- (1 - sp[1]) * (1 - sp[2]) * (1 - sp[3]) + (1 - sp[1]) * b[3] + (1 - sp[2]) * b[2] + (1 - sp[3]) * b[1] - 
b[4] 
for (i in 1:8) { 
  p[i] <- pr * prob_se[i] + (1 - pr) * prob_sp[i] 
} 
pr ~ dunif(0,1) 
se[1] ~ dbeta(85,6.4867) 
se[2] ~ dbeta(18.8,2.7583) 
se[3] ~ dbeta(3.45, 1.5142) 
sp[1] ~ dbeta(750,2.6544) 
sp[2] ~ dbeta(22.6,1.0837)  
sp[3] ~ dunif(0,1) 
for (i in 1:4) { 
  a[i] ~ dunif(-1, 1) 
  b[i] ~ dunif(-1, 1) 
} 
r2[1:8] ~ dmulti(p[1:8],n) 
for (i in 1:8) { 




  ## p > 0 
  constraint1[i] <- step(p[i]) 
  O1[i] ~ dbern(constraint1[i]) 
  O1[i] <- 1 
  ## p < 1 
  constraint2[i] <- step(p[i] - 1) 
  O2[i] ~ dbern(constraint2[i]) 
  O2[i] <- 0 
  ## prob_se > 0 
  constraint3[i] <- step(prob_se[i]) 
  O3[i] ~ dbern(constraint3[i]) 
  O3[i] <- 1 
  ## prob_se < 1 
  constraint4[i] <- step(prob_se[i] - 1) 
  O4[i] ~ dbern(constraint4[i]) 
  O4[i] <- 0 
  ## prob_sp > 0 
  constraint5[i] <- step(prob_sp[i]) 
  O5[i] ~ dbern(constraint5[i]) 
  O5[i] <- 1 
  ## prob_sp < 1 
  constraint6[i] <- step(prob_sp[i] - 1) 
  O6[i] ~ dbern(constraint6[i]) 
  O6[i] <- 0 
  d[i] <- r[i]*log(max(r[i],1)/(p[i]*n)) 
  d2[i] <- r2[i]*log(max(r2[i],1)/(p[i]*n)) 
} 
bayesp <- step(sum(d[]) - sum(d2[])) 
} 
# Initial values of variable nodes for three chains 
list(pr = 0.5, 
     se = c(0.93, 0.77, 0.22), 
     sp = c(0.95, 0.99, 0.7), 
     a  = c(0.0189, -0.0196, -0.0594, 0.001134), 
     b  = c(0.0045, 0.01, 0.002, -0.0004), 
     r2 = c(44,2,5,2,15,1,3,268)) 
list(pr = 0.5, 
     se = c(0.965 , 0.835 , 0.6), 
     sp = c(0.975 , 0.995 , 0.85), 
     a  = c(0.011725, 0.0035, 0.0165, -0.000595), 




     b  = c(0.002375, 0.00875, 0.00175, -0.0007875), 
     r2 = c(44,2,5,2,15,1,3,268)) 
list(pr = 0.5, 
     se = c(0.999, 0.9, 0.983), 
     sp = c(0.999, 0.999, 0.999), 
     a  = c(0.0004, 0.000483, 0.0068, -0.0001864), 
     b  = c(0.000499, 0.000499, 0.000499, -0.000248502), 
     r2 = c(44,2,5,2,15,1,3,268)) 





Brucellosis in small ruminants 
 
Preamble 
There are almost 28.3 million heads of small ruminants in Bangladesh of which 89.0% are goats. 
Small ruminants are reared mostly by poor farmers and sometimes share same premises with animals 
exposing them to the risk of zoonosis. Similar to bovine brucellosis, some studies reported apparent 
prevalence of brucellosis in small ruminants in Bangladesh. The true prevalence of brucellosis in these 
two species, the performance of serological tests for the diagnosis of brucellosis in small ruminants 
were not studied. The information about true prevalence and characteristics of commonly used 
diagnostic test will help to know impact of this disease in goats and sheep populations. This chapter 
describes the true status of brucellosis along with the sensitivity and specificity of three serological 
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Abstract 
The true prevalence of brucellosis and diagnostic test characteristics of three conditionally dependent 
serological tests were estimated using the Bayesian approach in goats and sheep populations of 
Bangladesh. Serum samples from a random selection of 636 goats and 1044 sheep were tested in 
parallel by indirect ELISA (iELISA), Rose Bengal Test (RBT) and Slow Agglutination Test (SAT). 
The true prevalence of brucellosis in goats and sheep were estimated as 1% (95% credibility interval 
(CI): 0.7–1.8) and 1.2% (95% CI: 0.6–2.2) respectively. The sensitivity of iELISA was 92.9% in goats 
and 92.0% in sheep with corresponding specificities of 96.5% and 99.5% respectively. The sensitivity 
and specificity estimates of RBT were 80.2% and 99.6% in goats and 82.8% and 98.3% in sheep. The 
sensitivity and specificity of SAT were 57.1% and 99.3% in goats and 72.0% and 98.6% in sheep. In 
this study, three conditionally dependent serological tests for the diagnosis of small ruminant 
brucellosis in Bangladesh were validated. Considerable conditional dependence between IELISA and 
RBT and between RBT and SAT was observed among sheep. The influence of the priors on the model 
fit and estimated parameter values were checked using sensitivity analysis. In multiple test validation, 
conditional dependence should not be ignored when the tests are in fact conditionally dependent. 
 
 






Brucella melitensis, primarily responsible for brucellosis in sheep and goats is by far, the most 
important zoonotic agent among Brucella spp. (Anonymous, 1986; Solorio-Rivera et al., 2007). 
Brucellosis in sheep and goats is rarely caused by Brucella abortus and Brucella suis (EC, 2001). 
Brucella ovis causes epididymitis in rams but rarely causes abortion in ewes (Van Tonder et al., 1994) 
and does not cause disease in humans. In the majority of industrialized countries, bovine brucellosis 
has been eradicated or controlled. However, small ruminant brucellosis remains a problem in some of 
these countries as well as in all developing countries. Basically, brucellosis is almost always present 
where small ruminants are kept (Godfroid et al., 2005; Franco et al., 2007). 
There are about 36.5 million goats and 1.69 million sheep representing more than 57% of the total 
livestock of Bangladesh. About 85% of rural households own animals and 75% of the population rely 
on livestock to some extent for their livelihood (Anonymous, 2005; BBS, 2004). More than 98% of 
goats are owned by the small, marginal and landless farmers in the villages. Their small body size and 
easy management especially by feeding on road side grasses, tree leaves and kitchen vegetable wastes 
i.e. investing practically nothing, attracts poor women and children to small ruminant rearing (Amin, 
2006). A good proportion of humans in Bangladesh have very close contacts with small ruminants and 
direct contact with animals is the principal route of brucellosis transmission. The epidemiological 
understanding of small ruminant brucellosis is in a very preliminary stage in Bangladesh. The 
estimated seroprevalence of brucellosis in Bangladesh based on previous studies ranges from 0.7% to 
14.6% in goats (Mustafa, 1984; Rahman et al., 1988, 2011a,b) and 0 to 4.8% in sheep (Mustafa, 1984; 
Amin, 2003; Uddin, 2006; Rahman et al., 2011a,b). 
The serological tests used in previous studies were the Rose Bengal Test (RBT), Standard Tube 
Agglutination Test, ELISA or Plate Agglutination Test. None of the aforementioned tests are perfect. 
So, the prevalence reported using these tests are not true prevalence due to misclassification of some 
of the tested animals. Moreover, the performance of these tests has not been validated in naturally 
infected small ruminants of Bangladesh. Tests are normally validated by comparing with the gold 
standard or perfect test. However, the gold standard for the diagnosis of brucellosis is isolation and 
identification of the organism (Alton et al., 1988; OIE, 2008) which is not easy to perform in a 
developing and resource-limited country like Bangladesh. In the absence of a gold standard, 
simultaneous estimation of true prevalence and diagnostic test characteristics can be performed 
successfully when applying multiple diagnostic tests to every individual subject, using a Bayesian 
approach which combines test results and external information (Berkvens et al., 2006; Adel et al., 
2010; Praud et al., 2012). 
An important consideration in the evaluation of multiple diagnostic tests is whether or not the tests can 
be assumed conditionally independent of each other given the true disease status. It has been 
demonstrated that the assumption of conditional independence may lead to biased estimates for test 




characteristics if in fact the tests are conditionally dependent (Vacek, 1985; Gardner et al., 2000). 
Since iELISA, RBT and SAT are based on the same biological process (Nielsen, 2002) i.e. detection 
of anti-Brucella-smooth-lipopolysaccharide (SLPS) antibodies, they can be considered to be 
conditionally dependent (Gardner et al., 2000). Therefore, the estimation procedures should be 
adjusted for the dependencies among the tests (Dendukuri and Joseph, 2001; Branscum et al., 2005). 
Few reports have been noted where authors considered test dependence in a multiple testing strategy 
for the diagnosis of porcine and bovine brucellosis (Ferris et al., 1995; Mainar-Jaime et al., 2005; 
Praud et al., 2012) but none was noted for the diagnosis of small ruminants brucellosis. 
The aim of this study was to estimate the true prevalence of brucellosis in small ruminants of 
Bangladesh and to evaluate the performance of three conditionally dependent serological tests namely 
indirect ELISA, RBT and SAT using a Bayesian modeling approach. 
 
2. Materials and methods 
2.1. Study and sampling design 
Livestock herds in Bangladesh are not identified regionally or centrally in the form of a data bank. To 
obtain random samples in this context a map digitization and herd selection procedure was followed in 
the Mymensingh district of Bangladesh. Out of a total of the 146 unions (sub Upa-Zilla) of 
Mymensingh district (consisting of several Upa-Zillas), 28 were randomly selected. Usually one 
geographical coordinate was randomly selected from each selected union and located by a hand held 
GPS reader. Livestock farmers within 0.5 km radius of the selected point were informed about the 
survey. All animals of the selected herds were sampled. Since there were very few sheep in 
Mymensingh district, blood samples were also collected from all other divisions of Bangladesh except 
in Khulna through the nationwide network of the Bangladesh Livestock Research Institute (BLRI) 
using the same sampling design scheme. The study area is shown in Figure 6.1. The study was 
conducted initially between September 2007 and August 2008 and then between January 2010 and 
May 2010 additional sheep samples were collected. In addition, a pretested questionnaire designed to 
collect animal and herd level data during blood sampling was administered. 
 
2.2. Processing of blood samples 
About 4 ml of blood was collected from each animal by jugular venipuncture with disposable needles 
and venoject tubes, labeled and transported to the laboratory on ice (after clotting) within 12 h of 
collection. Blood samples were kept in the refrigerator (2–8 °C) in the laboratory and one day later 
sera were separated by centrifuging at 6000 x g for 10 min. Each serum was labeled to identify the 
animal and stored at -20 °C. Blood samples collected from other districts were processed in respective 
districts and sera stored at -20 °C in regional BLRI field stations and conveniently transferred to the 
medicine department laboratory of Bangladesh Agricultural University (BAU). Each serum was 




divided into two tubes each containing about 1 ml of serum. One aliquot was used for testing and the 
other was preserved in a serum bank. 
 
2.3. Serological tests 
All blood samples were tested in parallel by iELISA, RBT and SAT in the medicine department 
laboratory of BAU, Mymensingh, Bangladesh. 
iELISA was performed according to Limet et al. (1988) using B. abortus biotype 1 (Weybridge 99) as 
antigen. The detail procedure was described in a previous paper by Rahman et al. (2012). The cut-off 
value for a positive result was defined at 2 U/ml of test serum for goats (Godfroid et al., 2002) and 6 
U/ml of test serum for sheep (Pers. Comm. David Fretin). 
RBT was performed as described by Alton et al. (1988). Briefly, sufficient antigen, test sera, positive 
and negative control sera for a day’s testing were removed from refrigeration and brought to room 
temperature (22 ± 4 ◦C). Equal volumes (30 µl) of serum and antigen (concentrated suspension of B. 
abortus biotype 1 (Weybridge 99); Institut Pourquier, France) were mixed and rotated on a glass plate 
for 4 min. The result was considered positive when agglutination was noticeable after this delay. 
  













SAT was carried out with ethylenediaminetetraacetic acid (EDTA) as described by Garin et al. (1985). 
The antigen used was B. abortus biotype 1 (Weybridge 99) (Synbiotics Europe, France). One hundred 
and sixty eight microliter of SAW buffer in the first well and 100 µl in the second and the third wells 
were added in 96-well microtiter plate. Thirty two microliter of serum was added in the first well 
(dilution 1/6.25). After proper mixing of diluent and serum, 100 µl from the first well was transferred 
to the second well (1/12.5). In the same way 100 µl was transferred from the second to the third well 
(dilution 1/25) and 100 µl discarded from the third well. Then in each well 100 µl of standardized 
SAW antigen was added giving the serial serum dilutions of 1/12.5, 1/25 and 1/50. The plates were 
agitated and incubated at 37 ◦C for 20–24 h. Reading was done on the basis of degree of agglutination 
and expressed in international units (IU). Any serum with an antibody titer greater than or equal to 30 
IU/ml, as prescribed by the EU (Shey-Njila et al., 2005), was considered positive. 
 
2.4. Statistical analysis 
2.4.1. Model building 
A Bayesian latent class analysis was implemented in WinBUGS 1.4 (Spiegelhalter et al., 2003) and R 
2.14.2 (R Foundation and Statistical Computing 2012) to estimate the prevalence, sensitivity and 
specificity of the three tests, using models developed by Branscum et al. (2005), Berkvens et al. 
(2006), Nérette et al. (2008) and Haley et al. (2011) separately for sheep and goats. In a three test 
scenario, 7 parameters need to be estimated by the multinomial model under the assumption of 
conditional independence namely; the prevalence, and the sensitivities and specificities of the three 
tests. However, under the assumption of conditional dependence, 8 additional parameters need to be 
estimated namely the conditional covariance between each pair of tests among infected and non-
infected subjects. This model is in fact non-identifiable since the data only allows for seven parameters 
to be estimated. As none of the three tests is considered a gold standard test and the tests are not 
conditionally independent, constraints have to be imposed on a subset of the parameters in order to 
make the models identifiable (Branscum et al., 2005). To evaluate the goodness of fit of the models, 
the posterior predictive p-value, Deviance Information Criterion (DIC) (Spiegelhalter et al., 2002) and 
the number of effectively estimated parameters (pD) (Berkvens et al., 2006) were used as calibrating 
parameters. Briefly, the DIC ensures that a parsimonious model is selected. It is calculated as DIC = 
pD + D with D the mean posterior deviance and pD the number of parameters effectively estimated by 
the model. Models with a smaller DIC should be preferred to models with larger DIC. The posterior 
predictive p-value is a posterior predictive check that detects lack-of-fit of the model to the data. It is 
based on the difference between the deviance of the observations and the deviance of observations 
generated randomly from the currently fitted model and for models that provide adequate fit to the 
data, the value should be around 0.50. A posterior predictive p-value of 0.5 is the value that would be 
obtained if the distribution of the deviances based on the observed and simulated data sets overlapped 
perfectly (Kelly and Smith, 2011). The apparent prevalence for sheep in 2007/2008 was 3.7% [18/482] 




(95% credibility intervals (CI): 2.2–5.8) and that in 2010 was 2.5% [14/562] (95% CI: 1.4–4.1). Using 
the “prtesti” command in Stata 12.1, we observed that the difference between the two proportions was 
not statistically significant (p-value = 0.3015) therefore data for the two phases were combined. 
 
2.4.2. Modeling conditional dependence 
Using the model that assumes conditional independence among the three tests given the true disease 
status of individuals as the baseline model, conditional dependence between each pair of tests was 
estimated using different parameterizations of the model that assumed conditional dependence 
between tests (Branscum et al., 2005; Berkvens et al., 2006; Nérette et al., 2008). Jones et al. (2010) 
proposed that in the construction of conditional dependence models, mainly simple extensions of the 
conditional independence model should be considered. Essentially, in the first set of simple 
parameterizations, the conditional dependence between iELISA and RBT, between iELISA and SAT 
and between RBT and SAT were each added in turn to the conditional independence model. In 
addition, three models were constructed with conditional dependence between the pairs: iELISA–RBT 
and iELISA–SAT, iELISA–RBT and RBT–SAT and between iELISA–SAT and RBT–SAT 
respectively (Nérette et al., 2008). Finally a model with conditional dependence among all the three 
tests was considered (all pairs inclusive) separately among infected and non-infected individuals and 
also among infected and non-infected animals combined. The models for both goats and sheep along 
with their corresponding parameters are presented in Table 6.3. 
Letting π to be the true prevalence, T1, T2 and T3 to represent the test outcomes for iELISA, RBT and 
SAT respectively, with positive test outcomes denoted by 1 (or +), negative test outcomes by 0 (or −), 
and sensitivities and specificities by Se and Sp respectively, the expected cell probabilities (p) based 
on these three tests under the assumption of conditional dependence are given as follows:  
  





Representing the conditional covariance between pairs of tests among infected animals by “a” and 
among the non-infected population by “b” (Table 6.5), and median posterior estimates were obtained 
along with their 95% CI. In addition, conditional correlations were computed as described in 
Georgiadis et al. (2003), Haley et al. (2011) and Branscum et al. (2005). According to Georgiadis et al. 
(2003), when the conditional correlations are low (≤0.2), the estimates of the conditional dependence 
and independence models are similar whereas when the correlations are high (>0.2) the conditional 
dependence model should be considered. All models were compared using the DIC and posterior 
predictive p-values. To be considered significantly different, the reduction in DIC between any two 
models should be more than 3 units (Spiegelhalter et al., 2002; Kostoulas et al., 2006; Nérette et al., 
2008). In situations where the difference in DIC was smaller than 3 units, the models were assumed to 
be similar and selection was based on parsimony (the smaller the number of effective parameters 
estimated (pD) the better) (Spiegelhalter et al., 2002). 
 
2.5. Prior distributions for parameters 
Based on a review of the literature, limited information was available regarding the true prevalence 
and test sensitivities and specificities for brucellosis among small ruminants in Bangladesh. Therefore, 
prior information from other similar studies was used. A very important source of prior information 
was the EFSA report of 2006 (EFSA-Q-2006) in which a thorough meta-analytic approach was used 
to estimate priors of Se and Sp for RBT, iELISA and SAT in sheep and goats. Based on several 
studies obtained from the literature, a meta-analysis (Random effect) was performed using “metandi” 
in Stata 12.1 (Harbord and Whiting, 2009). To perform metandi, a minimum of four studies is 
required. However, for SAT, only two studies were available therefore, the meta-analysis was 
performed for RBT and iELISA. In addition, mentandi requires that the number of true positives, true 
negatives, false positives and false negatives be known for each study. This was not available for the 
meta-analytic study based on the EFSA report so the priors were combined: the lowest limit was used 
as the lower bound and the higher value as the upper bound in uniform distributions. The same set of 
priors for the sensitivity and specificity were used both for sheep and goats data. The prior interval 
estimates used in uniform distributions for the Se and Sp were (0.870, 0.986) and (0.962, 1.00) for 
iELISA (0.670, 0.934) and (0.915, 1.00) for RBT and (0.301, 0.967) and (0.977, 1) for SAT 
respectively. The priors used for the prevalence of brucellosis in goats and sheep in Bangladesh were 
based on local prevalence reports 0.7–14.6% in goats (Mustafa, 1984; Rahman et al., 1988, 2011a,b) 
and 0–4.8% in sheep (Mustafa, 1984; Amin, 2003; Uddin, 2006; Rahman et al., 2011a,b).  
 
The prior sources for sensitivities and specificities of the three serological tests used for the Bayesian 
analysis in this study are summarized in Table 6.1. Prior information on the 8 covariance parameters 




(4 for infected and 4 for the non-infected individuals) were not available so initial values were 
generated in R 2.14.2 based on the range of possible values of the sensitivities and specificities listed 
in Table 6.1 (see Appendix B). 
 
Table 6.1. Sources of priors used for estimation of diagnostic test characteristics for brucellosis 
in goats and sheep in Bangladesh 
Reference Species iELISA RBT SAT 
  SE SP SE SP SE SP 
Blasco et al. (1994)  SG 100 100 91.8-92.5 100   
Baum et al. (1995) SG     90.3-96.7 97.7-1 
Abu-Harfeil and Abu-
Shehada (1998) 
S 66.5-78.7  34.4-47.8    
Burriel et al. (2004) SG 88.1-96.7 94.7-99.2     
Nielsen et al. (2004)
  
SG 82.1-96.6 96.4-98.4 64.7-85.3 99.0-99.9   
Nielsen et al. (2005) G 94.5-97.5 99.3-99.9     
Minas et al. (2005) S 92.7-96.3 100 67.0-74.1 99.3-1   
EFSA-Q-2006 SG 94.5-95.8 99.1-99.3 91.6-93.4 99.8-1   
Minas et al. (2008) SG 97.6-98.8 99.8-1 74.0-77.7 99.5-99.9   
Ramirez-Pfeiffer et al. 
(2008) 
SG   76.5-85.2  61.9-74.4   
Gupta et al. (2010) G     30.1-79.2 50.6-90.4 
Legend: SG: sheep and goat; G: goat only; S: sheep only; iELISA: indirect ELISA; RBT: Rose Bengal 
Test; SAT: Slow Agglutination Test; SE: Sensitivity: SP: Specificity. 
 
2.6. Model diagnostics 
All models were run using three chains, a burn-in period of 50,000 iterations and another 100,000 
iterations to obtain the posterior estimates. Trace plots were used to explore how fast the chain 
explores the posterior distribution (Ntzoufras, 2011). A more formal test for convergence, the Brooks, 
Gelman and Rubin convergence statistic was used to assess model convergence (Gelman and Rubin, 
1992). The WinBUGS codes used are presented in Appendices A and B. 





2.7. Sensitivity analyses of selected models 
The influence of the prior information on the estimates of the diagnostic test characteristics were 
verified using sensitivity analysis (Branscum et al., 2005; Kostoulas et al., 2006; Praud et al., 2012). 
This was done by using standard uniform priors and slight perturbations (in steps of 10% or 15%) of 
the prior intervals (Haley et al., 2011). The following sets of priors were considered: 
 Uniform prior (UP) for prevalence (Pr) and informative priors (IP) for sensitivities (Se) and 
Specificities (Sp) 
 UP for Pr and for Se and IP for Sp 
 UP for Pr and for Sp and IP for Se 
 IP for Pr and UP for Se and Sp 
 IP for Pr and for Se and UP for Sp 
 IP for Pr and for Sp and UP Se 
 Perturbations of the prior interval 
For each set of alternative prior distributions considered for the model parameters, the model was run 
with the same number of chains and similar diagnostics were performed. 
3. Results 
3.1. Data exploration 
The study was conducted initially between September 2007 and August 2008 for both sheep and goats 
and later between January 2010 and May 2010 for sheep. The mean age for goats was 1.6 ± 0.06 
(mean ±se) years ranging from 0.17 to 8 years whereas the mean body weight was 10.0 ± 0.19 (mean 
± se) kg ranging from 2 to 30 kg. About 95% of goats were of the Black Bengal breed and the rest 
were of Jamuanpari breed of origin. Sixty-six percent of the sampled goats were female. The median 
herd size of goats was 2 ranging from 1 to 18. The mean age of sheep was 2.1 ± 0.0.04 (mean ± se) 
years ranging from 0.08 to 8 years whereas the mean body weight of was 14.6 ± 0.15 (mean ± se) kg 
ranging from 2 to 40 kg. All sheep were of the indigenous type and 77% of them were female. The 
median herd size of sheep was 5 and ranged from 1 to 75. 
The cross classified test results of the three serological tests on the 636 sera of goats and 1044 sera of 
sheep are shown in Table 6.2. Two (0.3%) out of a total of 636 goats were positive for all three tests 
and 94% (598/636) were test negative. Similarly 8 (0.8%) out of the total of 1044 sheep were positive 
for all three tests and 96.5% (1007/1044) were negative for all three tests (Table 6.2). 
 
  




Table 6.2.  Cross-classified test results for brucellosis in goats and sheep of Bangladesh based on 
iELISA, RBT, and SAT  
iELISA RBT SAT Goat Sheep 
1 1 1 2 8 
1 1 0 1 3 
1 0 1 0 0 
1 0 0 29 5 
0 1 1 0 9 
0 1 0 2 6 
0 0 1 4 6 
0 0 0 598 1007 
Total 636 1044 
Legend: iELISA: indirect ELISA; RBT: Rose Bengal Test; SAT: Slow Agglutination Test; 1: Positive; 
0: Negative. 
 
3.2. Model selection and posterior estimates 
The priors used in the Bayesian analyses were the same for the models for both goats and sheep. For 
the data for goats, the DIC for the conditional independence model was 26.09. None of the models 
with conditional dependence terms led to a significant reduction (of greater than 3) in DIC (Table 6.3). 
In addition, all the median estimates of the conditional correlations were close to 0.2. The conditional 
independence model was therefore selected as a plausible model for the data for goats. The median 
estimates of the true prevalence of caprine brucellosis, sensitivity, and specificity of the three tests are 
summarized in Table 6.4. The true prevalence of caprine brucellosis in Bangladesh was updated to 1% 
with 95% CI of 0.7–1.8. The highest sensitivity (92.8% and 95% CI 87.3–98.3) with corresponding 
lowest specificity (96.5% and 95% CI 96.2–97.3) was estimated for iELISA among goats. The 
specificity of both RBT and SAT were greater than 99.2% and the sensitivity of RBT was higher 
(80.2%) than that of SAT (57.3%) among goats. For the data for sheep, all models that included the 
conditional covariance between RBT and SAT yielded significantly lower DICs (33.47–35.13) 
compared to the conditional independence model (52.3).  
 
  




Table 6.3. Comparison of model diagnostic parameters for conditional independence and 
different conditional dependence models used to estimate true prevalence of brucellosis in small 
ruminants and sensitivity and specificity of three diagnostic tests 
Models Goat Sheep 
 
Post. pD DIC post pD DIC 
Conditional independence 0.55 2.30 
26.09 
1.00 4.54 52.3 
Conditional Dependence (CD) between iELISA and  RBT 0.62 3.03 26.43 1.00 4.82 53.46 
CD between iELISA and SAT 0.63 3.10 27.30 1.00 5.03 52.87 
CD between RBT and SAT 0.61 3.33 27.60 0.49 5.19 
34.10 
CD between iELISA and RBT and between iELISA and 
SAT 
0.69 3.24 27.75 0.99 5.33 54.97 
CD between iELISA & SAT and between RBT & SAT  0.66 3.48 28.68 0.53 5.14 35.15 
CD between iELISA and RBT and between RBT and 
SAT 
0.64 3.35 27.74 0.48 5.10 33.50 
CD among all tests for infected animals 0.57 3.02 25.65 0.99 4.44 46.88 
CD among all tests for non-infected animals 0.71 3.47 29.37 0.64 5.50 37.61 
CD among all tests 0.69 3.54 28.90 0.52 4.98 34.53 
Legend: iELISA: indirect ELISA; RBT: Rose Bengal Test; SAT:Slow Agglutination Test; Bold 
Models were used to estimate prevalence and test characteristics for goat and sheep respectively; pD: 
the number of parameters effectively estimated by the model; Post.: Post predictive p-value; DIC: 
Deviance Information Criterion.  
 
  




Table 6.4. Median posterior estimates of prevalence, sensitivity and specificity of iELISA, RBT 
and SAT for the diagnosis of brucellosis in goats in Bangladesh 
Test Variable Median 95% Credibility interval 
 Prevalence 1.0 0.7, 1.8 
iELISA  Se 92.9 87.3, 98.3 
 Sp 96.5 96.2, 97.3 
Rose Bengal Se 80.2 67.7, 92.7 
 Sp 99.6 98.9, 99.9 
Slow Agglutination Se 57.1 31.7, 91.4 
 Sp 99.3 98.4, 99.8 
 
Table  6.5. Bayesian median posterior estimates of prevalence, conditional correlations, 
sensitivity and specificity of iELISA, RBT and SAT for the diagnosis of brucellosis in sheep in 
Bangladesh. 
Test 
Variable Median 95% 
Credibility 
Interval 
 Prevalence 1.2 0.6, 2.2 
iELISA  Se 92.0 87.2, 98.2 
 Sp 99.5 98.7, 99.9 
Rose Bengal Se 82.8 68.1, 92.9 
 Sp 98.3 97.4, 99.0 
Slow Agglutination Se 72.0 43.6, 94.5 
 Sp 98.6 97.8, 99.2 
Dependence coefficient    
Between iELISA and RBT among  infected sheep ρa12 0.18 0.0, 0.46 
Between RBT and SAT among  infected sheep ρa23 0.53 0.32, 0.72 
Between iELISA and RBT among non- infected sheep ρb12 0.29 -0.11, 0.82 
Between RBT and SAT among  non-infected sheep ρb23 0.40 -0.13, 0.87 
Legend: ρaij stands for the conditional correlation between test i and test j among infected subjects and 
ρbij stands for the conditional correlation between test i and test j among non-infected subjects. 
 




3.3. Sensitivity analyses results 
The results of the sensitivity analyses of the models for goats and sheep are shown in Tables 6.6 and 
6.7 respectively. 
The conditional independence model for goats and conditional dependence model for sheep were used 
for the sensitivity analyses. The model diagnostic parameters indicated that the different set of priors 
yielded reasonable fit to the data. The true prevalence of caprine as well as ovine brucellosis and 
specificities of all three tests obtained from the different models of sensitivity analyses were similar to 
those of the selected models since their 95% credibility intervals overlapped. Whereas the estimated 
specificities were the same as those of the selected models regardless of the set of priors used, the 
sensitivities were observed to vary and yielded wider confidence intervals. However, since the 95% 
credibility intervals overlapped, the observed differences were not statistically important (Tables 6.6 
and 6.7). For example, the true median prevalence of goats and sheep were 1.0% (95% CI: 0.7–1.8%) 
and 1.2% (95% CI: 0.6–2.2%) respectively and the ranges of the median prevalence obtained in 
sensitivity analyses respectively for goat and sheep ranged from 0.6–5% to 0.5–4.3% respectively. 
Decreasing the lower limits of all the prior intervals by 10% led to only slight and statistically 
unimportant changes in the estimated parameter values and their 95% Cr Intervals in the models for 
both goats and sheep. 
 
  




Table 6.6. Median posterior estimates of prevalence, sensitivity and specificity of iELISA, RBT 
and SAT based on a sensitivity analysis of the conditional independence model used to estimate 
true prevalence of caprine brucellosis and diagnostic test characteristics 






UP for Prev and IP for 
Se and Sp 
0.55 2.89 25.92 0.6 (0.2, 1.6)   
ELISA     93.0 (87.3, 98.3) 96.5 (96.2, 97.3) 
RBT     81.2 (67.8, 92.8) 99.6 (98.8, 99.9) 
SAT     60.1 (32.1, 92.9) 99.3 (98.4, 99.8) 
UP for Prev and  Sp 
and IP for Se 
0.40 3.65 25.32 0.6 (0.2, 1.5)   
ELISA     93.0 (87.3, 98.3) 95.3 (93.5, 96.8) 
RBT     81.7 (67.9, 92.9) 99.6 (98.8, 99.9) 
SAT     62.1 (32.3, 93.5) 99.3 (98.4, 99.8) 
IP for Prev and UP for 
Se and Sp 
0.57 3.42 27.97 1.1 (0.7, 3.3)   
ELISA     69.6 (23.9, 98.5) 95.5 (93.6, 97.2) 
RBT     62.5 (15.3, 98.1) 99.7 (98.9, 100) 
SAT     46.0 (10.2, 90.8) 99.3 (98.5, 99.9) 
IP for Prev and Se and 
UP for Sp 
0.39 3.06 25.57 0.9 (0.7, 1.7)   
ELISA     92.8 (87.3, 98.3) 95.4 (93.5, 96.9) 
RBT     80.9 (67.7, 92.8) 99.6 (98.9, 99.9) 
SAT     59.0 (31.9, 92.1) 99.3 (98.4, 99.8) 
IP for Prev and Sp and 
UP for Se 
0.70 2.07 28.03 1.3 (0.7, 5.0)   
ELISA     71.1 (26.1, 98.5) 96.6 (96.2, 98.0) 
RBT     51.1 (10.2, 97.0) 99.7 (98.9, 100) 
SAT     37.5 (6.9, 87.1) 99.3 (98.5, 99.9) 
Perturbation example: 
10% decrease of lower 
limits of  Se and Sp 
0.39 3.13 25.69 0.9 (0.7, 1.8)   
ELISA     88.0 (77.6, 98.1) 95.4 (93.5, 96.8) 
RBT     85.3 (77.4, 93.0) 99.6 (98.9, 99.9) 
SAT     56.6 (23.4, 91.9) 99.3 (98.4,99.8) 
Legend: UP: uniform prior; IP: informative prior; Prev: prevalence; Se: sensitivities; Sp: specificities; CI: Credibility 
interval; iELISA: indirect ELISA; RBT: Rose Bengal Test; SAT: Slow Agglutination Test; Post.: Post. pred. p-value; pD: the 
number of parameters effectively estimated by the model; DIC: Deviance Information Criterion. 




Table 6.7. Median posterior estimates of prevalence, sensitivity and specificity of iELISA, RBT 
and SAT based on a sensitivity analysis of a conditional dependence model used to estimate true 
prevalence of ovine brucellosis and diagnostic test characteristics 






UP for Prev and IP for Se and Sp 0.48 5.09 33.49 1.2 (0.6, 2.2)   
ELISA     92.1 (87.2, 98.2) 99.5 (98.7, 99.9) 
RBT     82.8 (68.1, 92.9) 98.3 (97.4, 99.0) 
SAT     72.2 (43.6, 94.5) 98.6 (97.8, 99.2) 
UP for Prev and Sp and IP for Se 0.49 5.18 33.70 1.2 (0.5, 2.2)   
ELISA     92.1 (87.2, 98.2) 99.5 (98.7, 99.9) 
RBT     82.7 (68.1, 92.9) 98.3 (97.3, 99.0) 
SAT     72.0 (43.6, 94.5) 98.5 (97.7, 99.2) 
IP for Prev and UP for Se and Sp 0.49 4.43 31.84 2.1 (0.8, 4.3)   
ELISA     52.7 (25.1, 94.3) 99.5 (98.7, 100) 
RBT     75.0 (37.0, 99.0) 98.8 (97.6, 99.9) 
SAT     66.4 (35.2, 96.6) 99.1 (98.0, 99.9) 
IP for Prev and Se and UP for Sp 0.49 5.21 33.77 1.2 (0.5, 2.2)   
ELISA     92.1 (87.2, 98.2) 99.5 (98.7, 99.9) 
RBT     82.8 (68.1, 92.9) 98.3 (97.3, 99.0) 
SAT     72.0 (43.7, 94.5) 98.5 (97.7, 99.2) 
IP for Prev and Sp and UP for Se 0.49 4.41 31.79 2.1 (0.8, 4.3)   
ELISA     52.7 (25.0, 94.3) 99.5 (98.7, 100) 
RBT     75.2 (37.2, 98.9) 98.8 (97.7, 99.9) 
SAT     65.5 (35.3, 96.7) 99.1 (99.1, 99.9) 
Perturbation example: 10% decrease 
of lower limits of  Se and Sp 
0.50 5.11 33.45 1.3 (0.6, 2.5)   
ELISA     85.5 (77.4, 97.7) 99.5 (98.7, 100) 
RBT     80.1 (59.6, 92.8) 98.3 (97.4, 99.1) 
SAT     70.5 (41.4, 94.3) 98.6 (97.7, 99.3) 
Legend: UP: uniform prior; IP: informative prior; Prev: prevalence; Se: sensitivities; Sp: specificities; CI: Credibility interval; iELISA: 
indirect ELISA; RBT: Rose Bengal Test; SAT: Slow Agglutination Test; Post.: Post. pred. p-value; pD: the number of parameters effectively 
estimated by the model; DIC: Deviance Information Criterion.  





In this study, the true prevalence and diagnostic test characteristics for brucellosis in goats and sheep 
were determined using a Bayesian analysis framework. More than 90% of the goats in the country 
were of the Black Bengal breed. The study area had the highest density of small ruminants (>300 km2) 
in Bangladesh (Anonymous, 2005) and about 95% of the goats sampled were of the Black Bengal 
breed. The sheep sample covered almost all the divisions except Khulna division of Bangladesh. The 
breed of sampled sheep was indigenous which is predominant all over Bangladesh (Bhuiyan, 2006). 
However, a study based on micro-satellite markers by Khan et al. (2009) described Garole sheep of 
Satkhira district (within Khulna division) as an independent sheep breed in Bangladesh. So, the 
prevalence estimated in this study is based on a representative sample of goats and sheep and would 
therefore be applicable to the goats and sheep (except Khulna division) populations of Bangladesh. 
About 1% of goats and 1.2% of sheep of Bangladesh were found to be serologically positive for 
brucellosis. The prevalence of brucellosis in goats and sheep are within the range of previously 
reported apparent prevalence. However, through this study we obtained the true prevalence along with 
their true probability interval (credibility interval contains the true parameter with 95% certainty 
(Mustafa, 1984; Rahman et al., 1988; Enøe et al., 2000; Amin, 2003; Uddin, 2006; Rahman et al., 
2011a,b). The relatively higher seroprevalence in sheep may be due to the relatively larger herd sizes 
of sheep compared to goats in Bangladesh. Larger herd sizes have been reported to be significantly 
associated with brucellosis seropositivity among livestock (Mikolon et al., 1998; Kabagambe et al., 
2001; Solorio-Rivera et al., 2007).  
 
In Bangladesh, among livestock farmers about 49% rear small ruminants either alone or with large 
ruminants and about 53% farmers who share same premises with animals are goat owners (Rahman et 
al., 2012). As small ruminants come in very close contact with humans, brucellosis in goats and sheep 
should be controlled with the highest priority in order to control this zoonosis in humans. In 
Bangladesh, goats are a very valuable asset especially for the poor people. They mature sexually quite 
early, at 6–8 months of age, and breed around the year. They kid twice a year and meat and skin 
obtained from the Black Bengal are of excellent quality and fetch high prices, even in the local market. 
Sheep of Bangladesh are also as prolific as goats. Small ruminants with clinical signs suggestive of 
brucellosis (abortion, retained fetal membrane, anestrous, etc.) are usually sold and eventually 
slaughtered by butchers. Moreover, around 15 million goats are slaughtered annually and of them 
about 40% are performed during the annual festival of Eid-ul-Azha (Anonymous, 2007). It has been 
shown that the longer infected animals are in contact with the rest of the herd, the greater the number 
of seropositive animals (Radostits et al., 2000). Large scale slaughtering of small ruminants for meat 
consumption may reduce the number of infected animals in the population. These factors may be 
responsible for low prevalence in goats and sheep of Bangladesh. In such an intermediate (1–5%) 
prevalence scenario of small ruminants brucellosis in Bangladesh, eradication can be achieved mainly 




by test and slaughter policy. However, pre-requisites for undertaking eradication programs such as: 
good organization of farmers and veterinary services, the implementation of strict movement control 
measures, an efficient identification system of the animals, no chance of sharing common grazing 
places and availability of financial resources are not yet at hand. The complete understanding of the 
disease including the species and biovars of Brucella involved in small ruminants should also be 
known for planning control programs (Anonymous, 2006; Minas, 2006). 
 
In this study, the performance of iELISA and RBT were relatively better than that of SAT in goats and 
sheep. The specificity estimates of SAT and RBT were very similar. The sensitivities of iELISA and 
RBT were similar in both sheep and goats. However, the specificity of iELISA (95.5%) was slightly 
lower in goats compared to sheep whereas that of RBT was slightly lower in sheep compared to goats. 
The increased specificity of iELISA in sheep was due to the higher cut-off values than that of goats. 
The sensitivity and specificity of iELISA estimated were in accordance with results from other studies 
(Abuharfeil and Abo-Shehada, 1998; Burriel et al., 2004). The sensitivity of RBT in goats and sheep 
were 80.2% and 82.8% respectively even though the specificity of RBT in both goats and sheep was 
more than 98%. The estimated sensitivity and specificity of RBT were coherent with findings from 
previous studies (Nielsen et al., 2004; Ramirez-Pfeiffer et al., 2008). The sensitivity and specificity of 
SAT in goats and sheep were 57.1%, 99.3% and 72.0%, 98.6% respectively. The sensitivity and 
specificity of SAT were also in accordance with results from other studies (Baum et al., 1995; Gupta 
et al., 2010). The iELISA was the most sensitive and specific test explaining the fact that acutely 
infected animals were less common in the population. The serological response observed in this study 
includes both B. abortus and B. melitensis infections  but excludes B. ovis as its antibody does not 
react with antigens prepared by SLPS. The proportion of goats and sheep infected with B. abortus and 
B. melitensis in Bangladesh is not yet known. But B. abortus was detected from goat milk using real 
time PCR assay (unpublished data). Among the three tests none was sensitive and specific enough to 
be used alone for the diagnosis of caprine brucellosis in Bangladesh. In the model for goats, the 
hypothesis of conditional dependence among the three tests was not important. This might have been 
due to small and sometimes zero cell frequencies observed for goats. In sheep, considerable 
conditional dependence between iELISA and RBT and between RBT and SAT among infected as well 
as non-infected sheep were observed. The iELISA is a quantitative test which detects only IgG, SAT 
quantifies both IgM and IgG (but mainly IgM) and RBT qualitatively detects both IgM and IgG 
(Christopher et al., 2010; Godfroid et al., 2010; Dìaz et al., 2011). The conditional correlation between 
RBT and SAT for sheep may be explained by the similarity of the type of antibody detected. The 
weaker conditional correlation between iELISA and RBT among infected as well as non-infected 
sheep may be explained by the fact that RBT also partially detects IgG. The sensitivity analysis of the 
conditional independence model for goats and a conditional dependence model for sheep revealed that 
the results can be considered to be robust. Slight differences in prevalence and sensitivities were 




observed but the differences were not statistically important as the credibility intervals of the estimates 
overlapped with those of the prevalence and sensitivities of the serological tests in the chosen models 
for goats and sheep (Tables 6.4–6.7). 
 
5. Conclusion 
This study is the first to evaluate the accuracy of brucellosis diagnostic tests among sheep and goats in 
Bangladesh considering conditional dependence between the diagnostic tests. An intermediate level of 
true prevalence of brucellosis among goats and sheep respectively was estimated. Such low prevalence 
will allow test and slaughter policy to control this zoonosis in small ruminants. There was considerable 
conditional dependence between iELISA and RBT and between RBT and SAT implying that a 
combination of the three serological tests may be a plausible choice unless other tests with very high 
sensitivity and specificity are validated. In multiple test validation, conditional dependence should not 
be ignored when the tests are in fact conditionally dependent. 
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Appendix A.  
 
Appendix A presents the WinBUGS code used to estimate true prevalence and test characteristics for 
iELISA, SAT, and RBT among goats using a model in which the three tests are assumed to be 
conditionally independent. 
 
The conditional independence model had the smallest DIC value among all models including 
condition dependence between any of the two tests. In the code presented below, the sensitivity and 
specificity of iELISA are represented by: se [1] and sp [1] respectively, of RBT by se [2] and sp [2] 
respectively, and of SAT by se [3] and sp [3] respectively. 





r[1:8] ~ dmulti(p[1:8], n) 
## p[1] = p(111); p[8] = p(000); pr = true prevalence 
p[1] <- pr*(se[1]*se[2])*se[3] + (1-pr)*((1-sp[1])*(1-sp[2]))*(1-sp[3]) 
p[2] <- pr*(se[1]*se[2])*(1-se[3]) + (1-pr)*((1-sp[1])*(1-sp[2]))*(sp[3]) 
p[3] <- pr*(se[1]*(1-se[2]))*se[3] + (1-pr)*((1-sp[1])*sp[2])*(1-sp[3]) 
p[4] <- pr*(se[1]*(1-se[2]))*(1-se[3]) + (1-pr)*((1-sp[1])*sp[2])*(sp[3]) 
p[5] <- pr*((1-se[1])*se[2])*se[3] + (1-pr)*(sp[1]*(1-sp[2]))*(1-sp[3]) 
p[6] <- pr*((1-se[1])*se[2])*(1-se[3]) + (1-pr)*(sp[1]*(1-sp[2]))*sp[3] 
p[7] <- pr*((1-se[1])*(1-se[2]))*se[3] + (1-pr)*(sp[1]*sp[2])*(1-sp[3]) 
p[8] <- pr*((1-se[1])*(1-se[2]))*(1-se[3]) + (1-pr)*(sp[1]*sp[2])*sp[3] 
pr ~ dunif(0.007,0.146) 
se[1] ~ dunif(0.870,0.986) 
se[2] ~ dunif(0.670,0.934) 
se[3] ~ dunif(0.301,0.967) 
sp[1] ~ dunif(0.962,1.00) 
sp[2] ~ dunif(0.915,1.00) 
sp[3] ~dunif(0.977,1) 
r2[1:8] ~ dmulti(p[1:8],n) 
 
for ( i in 1:8) 
{ 
d[i] <-(pow(r[i]-p[i]*n,2)/(p[i]*n)) 
d2[i] <- (pow(r2[i]-p[i]*n,2)/(p[i]*n)) 
I[i] <- step(p[i] -1)*step(-p[i]) 
} 
bayesp <- step(sum(d[]) - sum(d2[])) 
} 
#data 










Appendix B presents the WinBUGS code used to estimate true prevalence and test characteristics for 
iELISA, SAT and RBT among sheep using model in which the three tests were considered to be 
conditionally dependent given true disease status.  
 
The model with conditional dependence between the Se and Sp of iELISA and RBT (a12 and b12) and 
between the Se and Sp of RBT and SAT (a23 and b23) had the smallest DIC value among all models 
including condition dependence between any of the two tests. In the code presented below, the 
sensitivity and specificity of iELISA are represented by: se [1] and sp [1] respectively, of RBT by se 
[2] and sp [2] respectively, and of SAT by se [3] and sp [3] respectively. 






r[1:8] ~ dmulti(p[1:8], n) 
## p[1] = p(111); p[8] = p(000); pr = true prevalence 
 
p[1] <- pr*(se[1]*se[2]*se[3]+se[1]*a23+se[3]*a12) + (1-pr)*((1-sp[1])*(1-sp[2])*(1-sp[3])+(1-
sp[1])*b23+(1-sp[3])*b12) 
 
p[2] <- pr*(se[1]*se[2]*(1-se[3])-se[1]*a23+(1-se[3])*a12) + (1-pr)*((1-sp[1])*(1-sp[2])*sp[3]-(1-
sp[1])*b23+sp[3]*b12) 
 
p[3] <- pr*(se[1]*(1-se[2])*se[3]-se[1]*a23-se[3]*a12) + (1-pr)*((1-sp[1])*sp[2]*(1-sp[3])-(1-
sp[1])*b23-(1-sp[3])*b12) 
 
p[4] <- pr*(se[1]*(1-se[2])*(1-se[3])+se[1]*a23-(1-se[3])*a12) + (1-pr)*((1-sp[1])*sp[2]*sp[3]+(1-
sp[1])*b23-sp[3]*b12) 
 
p[5] <- pr*((1-se[1])*se[2]*se[3]+(1-se[1])*a23-se[3]*a12) + (1-pr)*(sp[1]*(1-sp[2])*(1-
sp[3])+sp[1]*b23-(1-sp[3])*b12) 
 
p[6] <- pr*((1-se[1])*se[2]*(1-se[3])-(1-se[1])*a23-(1-se[3])*a12) + (1-pr)*(sp[1]*(1-sp[2])*sp[3]-
sp[1]*b23-sp[3]*b12) 
 
p[7] <- pr*((1-se[1])*(1-se[2])*se[3]-(1-se[1])*a23+se[3]*a12) + (1-pr)*(sp[1]*sp[2]*(1-sp[3])-
sp[1]*b23+(1-sp[3])*b12) 
 
p[8] <- pr*((1-se[1])*(1-se[2])*(1-se[3])+(1-se[1])*a23+(1-se[3])*a12) + (1-
pr)*(sp[1]*sp[2]*sp[3]+sp[1]*b23+sp[3]*b12) 
pr ~ dunif(0,0.048) 
se[1] ~ dunif(0.870,0.986) 
se[2] ~ dunif(0.670,0.934) 
se[3] ~ dunif(0.301,0.967) 
sp[1] ~ dunif(0.962,1.00) 
sp[2] ~ dunif(0.915,1.00) 
sp[3] ~dunif(0.977,1) 




ll1 <- max(-(1-se[1])*(1-se[2]), -se[1]*se[2]) 
ul1 <- min(se[1]*(1-se[2]),(1-se[1])*se[2]) 
a12 ~ dunif(ll1,ul1) 
ll3 <- max(-(1-se[2])*(1-se[3]), -se[2]*se[3]) 
ul3 <- min(se[2]*(1-se[3]),(1-se[2])*se[3]) 
a23 ~ dunif(ll3,ul3) 
ll4 <- max(-(1-sp[1])*(1-sp[2]), -sp[1]*sp[2]) 
ul4 <- min(sp[1]*(1-sp[2]),(1-sp[1])*sp[2]) 
b12 ~ dunif(ll4,ul4) 
ll6 <- max(-(1-sp[2])*(1-sp[3]), -sp[2]*sp[3]) 
ul6 <- min(sp[2]*(1-sp[3]),(1-sp[2])*sp[3]) 
b23 ~ dunif(ll6,ul6) 
  
###Correlation between tests 
rhoDplus12 <- a12/(sqrt(se[1]*(1-se[1]))*sqrt(se[2]*(1-se[2]))) 
rhoDplus23 <- a23/(sqrt(se[2]*(1-se[2]))*sqrt(se[3]*(1-se[3]))) 
 
rhoDmin12 <- b12/(sqrt(sp[1]*(1-sp[1]))*sqrt(sp[2]*(1-sp[2]))) 
rhoDmin23 <- b23/(sqrt(sp[2]*(1-sp[2]))*sqrt(sp[3]*(1-sp[3]))) 
 
r2[1:8] ~ dmulti(p[1:8],n) 
for ( i in 1:8) 
{ 
d[i] <-(pow(r[i]-p[i]*n,2)/(p[i]*n)) 
d2[i] <- (pow(r2[i]-p[i]*n,2)/(p[i]*n)) 
I[i] <- step(p[i] -1)*step(-p[i]) 
} 








list(pr=0.025, se=c( 0.895 , 0.765 , 0.45 ), sp=c( 0.964 , 0.977 , 0.987 ), a12= 0.027825 ,a13= -0.00525 
,a23= -0.01175 ,b12=0.010672 ,b13= 0.006032 ,b23= 0.00620100000000001, 
r2=c(8,3,0,5,9,6,6,1007)) 
 
list(pr=0.015, se=c( 0.917 , 0.85 , 0.68 ), sp=c( 0.985 , 0.985 , 0.995 ), a12= 0.02905 ,a13= 0.01494 
,a23= 0.027 ,b12= 0.00727500000000001 ,b13= 0.002425 ,b23= 0.002425 , r2=c(8,3,0,5,9,6,6,1007)) 
 
list(pr=0.005, se=c( 0.958 , 0.896 , 0.867 ), sp=c( 0.998 , 0.998 , 0.998 ), a12= 0.016632 














Brucellosis is endemic in Bangladesh. However, the information on different species of Brucella 
prevalent in animals is scarce and not available in humans in Bangladesh. It is a zoonosis and almost 
every human case is directly or indirectly linked to animals or their products. So, the species of 
Brucella responsible for human infection will also reflect the prevalent species in animal populations. 
In Bangladesh, no laboratory exist with BSL-3 facilities for routine isolation of Brucella species from 
human and animal samples. The knowledge on prevalent Brucella species in humans and animals will 
help to initiate appropriate control measures against brucellosis. This chapter describes the detection of 
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Brucella abortus is the dominant species in both, man and animals in Bangladesh 
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Brief short title: Brucella abortus in humans and animals in Bangladesh 
 
Summary 
The aims of this study were to isolate Brucella spp. from samples of small ruminants, gayal and 
cattle and to identify the prevalent Brucella species in human and animal samples using species-
specific real-time PCR (rt PCR) assays.  Twenty-three placentas and 17 vaginal swabs from cattle, 
goats and sheep were initially investigated by Stamp staining to visualize Brucella-like organisms. A 
total of 62 animal samples including Milk Ring Test (MRT) positive bulk milk, bull semen, vaginal 
swabs and placentas were cultured in Farrell medium (FM) for isolation of Brucella organisms. The 
samples were initially screened by Brucella genus specific BCSP31 rt PCR. The Brucella genus 
positive samples were then tested by IS711 rt PCR to detect Brucella abortus and Brucella melitensis 
DNA. No Brucella organism was seen in stained smears and in FM. Only B. abortus DNA was 
amplified from six animal samples. Brucella abortus was found to be the only prevalent species in 
domestic and semi-wild ruminants in Bangladesh. Interestingly, no B. melitensis DNA was detected, 
which is the species most often associated with human disease. In 13 seropositive human patient sera 
only B. abortus DNA was found corroborating our conclusions and findings. No Brucella DNA was 
amplified from any of the placenta and vaginal swabs indicating that brucellae may not be a major 
cause of abortion in domestic ruminants in Bangladesh. This is the first report describing species of 
Brucella prevalent in both humans and animals in Bangladesh. 









Brucellosis is a widespread bacterial zoonosis hampering both human health and animal 
production. In humans brucellosis is a severely debilitating and disabling illness, with fever, sweating, 
fatigue, weight loss, headache, and joint pain persisting for weeks to months (Ariza et al., 2007). 
Brucellosis may become chronic or provoke life-threatening sequelae. The World Health Organization 
(WHO) has considered brucellosis as a neglected zoonosis. Brucellosis is a serious occupational 
hazard for livestock farmers, milkers, butchers, hired animal caretakers, veterinarians, and for 
consumers of raw livestock products in general (Anon., 2005). In animals, abortion, infertility and 
chronic wasting of affected animals have a considerable negative impact on the family income of 
peasants in developing countries. Brucellosis is caused by Gram-negative, facultative intracellular 
bacteria of the genus Brucella. This genus consists of at least ten nomospecies having characteristic 
host range and pathogenicity (Atluri et al., 2011). Four out of the ten known Brucella species infect 
humans commonly and the most pathogenic and invasive species for humans is Brucella melitensis 
(host: sheep and goats), followed in descending order by Brucella suis (pigs), Brucella abortus (cattle 
and buffaloes) and Brucella canis (canids) (Acha and Szyfres, 2003). In Bangladesh the first report on 
the isolation of B. abortus was made by Pharo et al. (1981) from two cows which were found to be 
positive using Milk Ring Test (MRT) and Rose Bengal Test (RBT). However, the authors failed to 
describe the procedure of typing their isolates as B. abortus. The true and apparent seroprevalence in 
domestic ruminants were found to vary from 0.3 to 1.2% and 3.6 to 7.3%, respectively, indicating that 
brucellosis is endemic in Bangladesh but with a low prevalence (Islam et al., 2013a; Rahman et al., 
2013). Indeed, Brucella spp and B. abortus DNA was amplified from human and bovine sera, 
respectively, using real time PCR (rt PCR) (Rahman et al., 2012; Rahman et al., 2014a). No data on 
the prevalent Brucella species in humans or gayals, sheep and goats exist although sero-prevalence is 
reported also for these farm animals.  
No recent Brucella isolates are available for Bangladesh to support serological or PCR generated 
data. Isolation also enables the identification of biovars of the prevalent species and thus the tracing 
back of the source of an outbreak (Al Dahouk et al., 2007). Pure culture is also needed for molecular 
typing e.g. MLVA to obtain adequate amounts of DNA. Cultivation however is time consuming and is 
associated with a high risk for laboratory-acquired infections (Yu and Nielsen, 2010).  
The aims of this study were therefore to isolate Brucella spp. from samples of small ruminants, 
gayal and cattle, or at least to identify the prevalent Brucella species in these samples using species 
specific rt PCR assays. 





Materials and Methods  
Ethical statement 
The study protocol was peer reviewed and cleared for ethics by the Ethical Review Committee of 
Mymensingh Medical College. Informed written consent was taken from all individuals prior to the 
collection of blood. 
Milk and semen samples of farm animals were collected during routine milking and semen collection 
in the farm. Placenta and vaginal swabs from farm animals were collected after abortion where 
minimal restraining of the animals was needed. This level of intervention has no impact on the well-
being of the animal and is also routinely performed by the veterinarians for the purpose of treatment 
and research.  
The faculty of veterinary science of Bangladesh Agricultural University has approved the animal part 
of this research. Verbal consent of farm owners was obtained prior to the collection of milk, semen, 
placenta and vaginal swabs from their animals. 
 
Animal samples 
Randomly collected milk ring test (MRT) positive bulk milk samples (cattle, goat and gayal [Bos 
frontalis]), convenience samples of placentas, vaginal swabs from different animals (cattle, goat and 
sheep) and semen samples of bulls (cattle) were used to isolate Brucella spp. and to detect Brucella 
genus and species specific DNA (Table 7.1). 
 
Staining 
The impression smears of vaginal swabs and placentas were stained by the Stamp method as described 
by Alton et al. (1988). In brief, the impression smears were dried by flame and stained with working 
carbol fuchsin solution for 10 min, then decolorized by 3% acetic acid solution for 1 min and 
counterstained with 1% malachite green solution for 20 seconds. After washing in tap water, they were 
dried and assessed by microscopy using 100X objective (oil immersion). Brucella organisms are pale 
red in a blue background. 
Bacteriology 
For the isolation of brucellae, samples were cultured in Farrell’s medium using the method 
described by Alton et al. (1988). Briefly, milk samples were centrifuged at 6,000 g for 15 min and 
cream and sediment were spread to half of the plate. Swab and semen (150 µl) samples were treated 
the same way. Placentas were cut into small pieces of about 5 g and 4-5 ml normal saline was added. 
A homogenate was prepared in a stomacher. About 150 µl of the homogenate was spread as described 
above. Plates were incubated at 37°C in 7.5% CO2 and observed after 48 hours of incubation as 




brucellae are slow-growing organisms and colonies are only visible after 48 hours of incubation. A 
sample was considered culture-negative if no growth occurred within 7 days. 
DNA extraction from human serum and animal samples 
DNA was extracted from a total of 62 animal samples (Table 7.2). DNA was extracted using the 
DNeasy spin column kit (QIAGEN) according to the manufacturer's protocol. Moreover, DNA 
originating from 13 human sera which were positive in Brucella genus specific rt PCR and were 
described in a previous paper by Rahman et al. (2012), were also included in this study to identify the 
disease causing Brucella species.  
BCSP31 genus specific and Brucella abortus and Brucella melitensis specific IS711 real-time PCR 
The BCSP31/IS711 rt PCRs originally described as a multiplex PCR assay (Probert et al., 2004) were 
performed as single assays to detect Brucella spp. DNA and/or to distinguish between B. melitensis 
and B. abortus DNA, respectively. No further modification of the protocols was done. The species 
specific assays were applied when a genus specific assay had detected Brucella DNA in a sample. 
Primers and probes were obtained from TIB MOLBIOL (Berlin, Germany). Amplification reaction 
mixtures were prepared in volumes of 25 μl containing 12.5 μl TaqManTM Universal Master Mix 
(Applied Biosystems, New Jersey, USA), 0.75 μl of each of the two specific primers (0.3 μM) and 0.5 
μl TaqMan probe (0.2μM), 5 μl of template, and 6.25 μl  nuclease-free water. The rt PCR reaction was 
performed in duplicate in optical 96-well microtiter plates (qPCR 96-well plates, Micro AmpTM, 
Applied Biosystems) using a Mx3000P thermocycler system (Stratagene, La Jolla, California) with the 
following run conditions, 2 min at 50°C, 10 min at 95°C, followed by 50 cycles of 95°C for 15s and 
57°C for 1 min. Cycle threshold values below 40 cycles were considered positive. The threshold was 
set automatically by the instrument. The samples scored positive by the instrument were additionally 
confirmed by visual inspection of the graphical plots showing cycle numbers versus fluorescence 
values.  
  




Table 7.1. Animal samples used to detect Brucella species using culture and real time PCR 








Cow milk ** Chittagong 5 ND 3 yes; 2 
No 
4 Yes; I no 2 yes; 3 
N0 
3 Yes; 2 
No 
 Mymensingh 3 ND No No No 1 Yes; 2 
No 
 Sirajganj 5 ND 2 Yes; 3 
No 
2 Yes; 3 
No 
2 yes; 3 
N0 
3 Yes; 2 
No 
 Dhaka, CCBDF 1 At least one 
of the three 
tests 
Yes Yes Yes Yes 
Goat milk** Rajshahi Goat 
Farm 
1 At least one 
of the three 
tests 
Yes Yes Yes No 
 Savar Goat 
Farm 
1 At least one 
of the three 
tests* 
Yes Yes Yes No 
Gayal milk** Bandarban 1 RBT, SAT 
and iELISA 
positive 
No Yes Yes Yes 
Bull semen Mymensingh 1 RBT 
positive 
NA NA NA NA 
 Savar, CCBDF 4 ND NA NA NA NA 
Placenta, 
cattle 
Mymensingh 5 ND No Yes Yes Yes 
Placenta, 
goat 
Mymensingh 10 ND Yes Yes Yes No 
Placenta, 
sheep 
Mymensingh  6 ND Yes Yes Yes No 
  Savar, Dhaka  2 At least one 
of the three 
tests 
Yes Yes Yes No 
Vaginal swab 
(cattle) 
Mymensingh 4 ND No Yes Yes No 
Vaginal swab 
(goat) 
Mymensingh 10 ND Yes Yes Yes No 
Vaginal swab 
(sheep) 
Mymensingh 3 ND Yes Yes Yes No 




Legend: * Three tests indicate RBT, SAT and iELISA; **All milk samples (herd/flock) were Milk 




Table 7.2. Summary of real time PCR results 
  Positive 
Sample Number Brucella genus rt   
PCR 
Brucella abortus rt 
PCR 
Brucella 
melitensis rt PCR 
Milk cow  14 3 3 Negative 
Milk goat 2 1 1 Negative 
Milk gayal 1 1 1 Negative 
Placenta cattle 5 Negative ND ND 
Placenta goat 10 Negative ND ND  
Placenta sheep 8 Negative ND ND 
Vaginal swab cattle  4 Negative ND ND 
Vaginal swab goat 10 Negative ND ND 
Vaginal swab sheep 3 Negative ND ND 
Bull semen 5 1 1 Negative 
Human serum 13 13 13 Negative 
Total 75 19 19 Negative 




Brucella-like bacteria were not found in any of the stained smears. No growth of Brucella spp. 
was noted in any of the clinical samples. Six out of 62 animal samples investigated were positive in 
the genus specific BCSP31 rt PCR assay (Table 2). Five milk (three cattle, one goat and one gayal) 
and one semen sample were positive in the B. abortus specific rt PCR. Brucella abortus DNA was 
amplified from 13 human serum samples. Data on demographic characteristics, occupation and animal 
contacts of 13 humans are given in Table 3. All patients (all of male sex) were positive in three 
serological tests, had one or more clinical symptoms and signs suggestive of brucellosis and had been 
treated (data not shown). No B. melitensis DNA could be amplified from either human or animal 
samples. 





Table 7.3. Characteristics of 13 patients diagnosed positive with a Brucella abortus real-time 
PCR 





HS 69 65 Secondary  Cattle 35 years Milkers 
HS 70 53 Secondary  Cattle 9 years Milkers 
HS 72 40 Secondary  Cattle 20 years Milkers 
HS 75 45 Primary Cattle 30 years Livestock farmer 
HS 76 40 Primary Cattle 20 years Milkers 
HS 77 60 Primary Cattle 40 years Milkers 
HS 78 42 Primary Cattle, goat 10 years Livestock farmer 
HS 80 40 Primary Goat 25 years Livestock farmer 
HS 83 45 Primary Cattle 22 years Milkers 
HS 85 45 Primary Cattle, goat 20 years Butcher 
HS 86 28 Secondary Cattle, goat 14 years Livestock farmer 
HS 87 12 Secondary Goat 2 years Livestock farmer 
HS 88 35 None Cattle 14 years Milkers 
 
Discussion 
We describe the successful amplification of B. abortus DNA from human serum, dairy milk (cattle, 
goat, gayal) and bull (cattlel) semen from Bangladesh. Animals and their products are the almost 
exclusive source of human infection. Consequently, the presence of B. abortus DNA in human samples 
is also proof of presence of B. abortus within the (dairy) animal populations of Bangladesh. The 
presence of B. abortus DNA in milk and semen also supports this hypothesis. Moreover, the detection 
of B. abortus DNA in bovine sera from other parts of the country added independent evidence in this 
regard (Rahman et al., 2014). At present, it can be supposed that B. abortus is the main disease causing 
Brucella species in patients and infected ruminants (Figure 7.1).  
 
Brucella abortus DNA was detected from milk samples of gayal in the Bandarban hill district of 
Bangladesh. The gayal (Bos frontalis), synonymous with mithan or mithun, is a semi-domestic 
ruminant found in the hill regions of northeast India, Myanmar, Bhutan, Bangladesh, China and 
Malaysia (Simoons and Simoons, 1968; Mason, 1988). The results of phylogenetic analyses indicate 
that the gaur (Bos gaurus) is the wild ancestor of the gayal (Dorji et al., 2010; Tanaka et al., 2011). The 
source of infection in gayals is not clear. However, Bandarban shares a common boundary with 




Mizoram State of India and Chin State of Myanmar. Although no reports on isolation of Brucella 
species from gayal in India exist, Brucella seroprevalence in gayal has been reported, with the highest 
in the Mizoram gayal  (Rajkhowa et al., 2005). Moreover, gayals from Tripura and Mizoram cross into 
Bangladesh due to their contiguous habitat in north-eastern India and Bangladesh (Choudhury et al., 
2002). 
Another possible way of introducing brucellosis in the gayal herd may be crossbreeding with 
cattle. Holstein-Friesian bull semen, which originated from Central Cattle Breeding and Dairy Farm 
(CCBDF) was used for crossbreeding purposes (Huque et al., 2001). As breeding bulls in CCBDF 
were found to be infected with brucellosis (unpublished observations), semen used for crossbreeding 
gayals could also have been the source of infection.  
Brucella abortus DNA was also detected from one goat milk sample. Although B. melitensis is the 
most common agent of caprine brucellosis, infection in goats due to B. abortus may also occur and is a 
public health hazard especially in countries where B. melitensis is non endemic e.g. Brazil (Lilenbaum 
et al., 2007). Brucella melitensis has also never been reported from Uruguay, Ecuador, El Salvador and 
Costa Rica (Moreno, 2002; Garin, 2011; Jorge Ron-Roman pers. comm.). We do believe that B. 
melitensis is yet not endemic in Bangladesh and B. abortus is spread due to cohabitation of different 
small ruminants and infected cattle on the same premise or pasture. The distribution of Brucella 
species and their biotypes may vary within a country and even within states of a country. In Indian 
cattle, B. abortus is most frequently isolated (22/78). Brucella melitensis is rarely isolated from cattle 
and buffalo (3/46) (Polding, 1942; Sen and Sharma, 1975; Mathur, 1985; Hemashettar et al., 1987). 
Among cattle, B. abortus biotype 1 (21/39) is reported to be the predominant biotype in most parts of 
India (Sen and Sharma 1975). About 84.2% (32/38) and 15.8% (6/38) sheep isolates and 78.0% 
(39/50) and 22.0% (11/50) goat isolates are B. melitensis and B. abortus, respectively (Mathur, 1985). 
Brucella melitensis is the dominant (191/191; 53/53) cause of human brucellosis in India (Mathur, 
1985; Mantur et al., 2006). Sporadic isolation of B. abortus from human cases was also reported (Sen 
and Sharma, 1975; Mathur, 1985; Mantur et al., 1994; Pathak et al., 2014).   




Figure 7.1. Map of Bangladesh showing the study areas and number of Brucella abortus 








In neighbouring Myanmar, the reported seroprevalence of brucellosis in dairy cattle is 4.01% 
(25/623) but no report on isolation of Brucella species from humans and animals was found in the 
available literature (Tun et al., 2008). Brucella abortus infection seems to be a crossborder problem 
and cooperation effort is needed to control this disease in the region. 
Detection of Brucella DNA was reported even from serum samples that were taken a long time 
after clinical signs of disease had ceased in these patients (Navaro et al., 2006). The thirteen 
individuals positive for the three serological tests presented clinical signs and symptoms suggestive of 
brucellosis and indeed all recovered after standard brucellosis treatment had been administered. We 
could demonstrate that confirmatory diagnosis by species specific rt PCR is adequate for a well-timed 
onset of treatment or switch of medication. Probert et al. (2004) developed a multiplex rt PCR to 
detect B. abortus and B. melitensis from culture growth. Modifying this technique, we were able to 
show that IS711 species-specific rt PCR is capable of amplifying Brucella DNA from human sera and 
animal samples at species level. . 
None of the stained smears showed Brucella like organisms and culture results were negative. 
Abortion is the most common clinical sign of brucellosis in female domestic ruminants and usually 
aborted foetuses, foetal membranes and fluids contain high bacterial loads contaminating the 
environment and thereby resulting in a high risk of infection to other animals (Saegerman et al., 2010). 
In our study, none of the 40 foetal membranes and vaginal swabs originating from cattle, sheep and 
goats contained Brucella DNA. Although the sample size may be small, it can be supposed that 
Brucella is not a major cause of abortion in domestic ruminants in Bangladesh. The status of other 
infectious agents causing abortion in domestic ruminants in Bangladesh is not well documented. 
Rahman (2014) reported that 15.95% (15/94) dairy cattle herds in Bangladesh are Q fever positive in 
bulk milk ELISA, a disease reported to be responsible for abortion in domestic ruminants (Angelakis 
and Raoult, 2010). Although toxoplasmosis is endemic in domestic ruminants and humans in 
Bangladesh, its association with abortion has not been elucidated yet (Samad et al., 1993; Samad et al., 
1997; Ashrafunnessa et al., 1998; Shahiduzzaman et al., 2011; Rahman et al., 2014b). The status of 
other infectious causes of abortion like Neospora, Leptospira, Listeria, Chlamydia, bovine viral 
diarrhoea virus, infectious bovine rhinotracheitis virus, etc. (Holler, 2012) in Bangladesh is not known 
at all. 
Brucella DNA was detected from MRT positive milk samples but they proved culture negative. 
The possible reason for unsuccessful recovery of isolates may be that the samples were old (in storage 
for 2-3 years after collection and having been thawed and refrozen several times). Indeed, isolation is 
most likely during the acute phase of infections caused by B. melitensis or B. suis and less successful 
in B. abortus infections. (Corbel, 1997; Al Dahouk et al., 2002). The presence of competing organisms 
(possibly with presence of antibiotic resistance) may be another potential reason of isolation failure 
when the samples were cultured in the presence of Brucella selective supplements (Al Dahouk et al., 




2002). Other authors from Bangladesh also failed to isolate Brucella from vaginal swabs and foetal 
membranes (Das et al., 2013; Dey et al., 2013; Islam et al., 2013b). 
Brucella-like organisms were not seen in stained smear and Brucella was not isolated from any of the 
clinical samples. Brucella abortus was found to be the only prevalent species among humans and 
animals in Bangladesh. Interestingly, no B. melitensis DNA was detected which is the species most 
often associated with human disease.  
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Brucellosis is a zoonosis and considered as an occupational hazard of livestock farmers, dairy workers, 
veterinarians, slaughterhouse workers, and laboratory personnel. In Bangladesh, there are almost 19 
million livestock farmers (12.7% of total population); the exact number of diary workers, 
veterinarians, and slaughterhouse workers are not known. Very little is known about the prevalence 
and risk factors of brucellosis in this group of people in Bangladesh. This chapter describes the 
prevalence and risk factors of brucellosis in occupationally exposed peoples in Bangladesh based on a 
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Abstract 
Brucellosis is an occupational hazard of livestock farmers, dairy workers, veterinarians, 
slaughterhouse workers, and laboratory personnel, all of whom are considered to belong to the high-
risk occupational group (HROG). A study was undertaken to determine the seroprevalence of 
brucellosis, identify risk factors associated with brucellosis seropositivity, and detect Brucella at genus 
level using real-time polymerase chain reaction (PCR) among people in the HROG in the Dhaka 
division of Bangladesh. A sample of 500 individuals from the HROG was collected from three 
districts of Dhaka division of Bangladesh. A multiple random effects logistic regression model was 
used to identify potential risk factors. Two types of real-time PCR methods were applied to detect 
Brucella genus–specific DNA using serum from seropositive patients. The prevalence of brucellosis 
based on the three tests was observed to be 4.4% based on a parallel interpretation. The results of the 
multiple random effects logistic regression analysis with random intercept for district revealed that the 
odds of brucellosis seropositivity among individuals who had been in contact with livestock for more 
than 26 years was about 14 times higher as compared to those who had less than 5 years of contact 
with livestock. In addition, when the contact was with goats, the odds of brucellosis seropositivity 
were about 60 times higher as compared to when contact was with cattle only. Noticeable variation in 
brucellosis seropositivity among humans within the three districts was noted. All of the 13 individuals 
who tested positive for the serological tests were also positive in two types of real-time PCR using the 
same serum samples. Livestock farmers of brucellosis positive herds had a significantly higher 
probability to be seropositive for brucellosis. The study emphasized that contact with livestock, 








Brucellosis is an occupational hazard of livestock farmers, dairy workers, veterinarians, 
slaughterhouse workers, and laboratory personnel, all of whom are considered to belong to the high-
risk occupational group (HROG). It is caused by bacteria of the genus Brucella, which manifests in 
different variants in different animal species. For example, Brucella abortus is mostly associated with 
cattle and B. melitensis with sheep, goats, and humans (Pappas et al., 2005). Infection can be acquired 
through ingestion of unpasteurized dairy products such as soft cheeses, yogurts, and ice creams. 
However, direct contact with infected animals and contact with vaginal discharge, urine, feces, or 
blood of infected animals (especially among abattoir workers, herdsmen, veterinarians, butchers, and 
personnel in microbiologic laboratories) is an important transmission route. Also, Brucella can be 
transmitted through skin lesions and the mucous membrane of conjunctiva, and by inhalation of 
infected aerosolized particles (Wise, 1980; Young, 1983; Pappas, 2005). 
 
Human brucellosis remains the commonest zoonotic disease worldwide, with more than 500,000 new 
cases reported annually (Pappas et al., 2006). It is associated with a chronic debilitating infection with 
substantial residual disabilities. The onset of the disease may be sudden, over a period of a few days, 
gradual, over a period of weeks to months, or associated with non-specific symptoms that include 
undulating fever, fatigue, malaise, headache, backache, and arthralgia (Mantur et al., 2007). 
 
Human brucellosis poses major economic and public health challenges in affected countries especially 
in the Mediterranean countries of Europe, northern and eastern Africa, Near East countries, India, 
Central Asia, Mexico, and Central and South America (Pappas et al., 2006).  A limited number of 
studies have estimated the seroprevalence of human brucellosis in Bangladesh. These studies revealed 
that the prevalence of human brucellosis is 6–12.8% (Rahman et al., 1983, 1988; Muhammad et al., 
2010). The variations in the seroprevalence reported may be due to differences in the number of 
samples (which ranged from 100 to 210 people in the HROG) and number of diagnostic tests used and 
the manner in which they were interpreted. None of these studies rigorously investigated risk factors 
associated with human brucellosis seropositivity despite substantial evidence that various factors such 
as occupational status, consumption of unpasteurized dairy products, type of animal handled, religious 
background, and whether or not assisted parturition (or assisted calf birth) is practiced influence the 
likelihood of brucellosis seropositivity (Abo-Shehadan et al., 1996; Al-Shamahy et al., 2000; Swai 
and Schoonman, 2009; Sofian et al., 2008; John et al., 2010). 
 




The diagnosis of human brucellosis in Bangladesh has predominantly been based on serological tests 
namely the Rose Bengal Plate Test (RBT), Standard Tube Agglutination Test (STAT), and the Indirect 
Enzyme-Linked Immuno-sorbent Assay (iELISA), which are not gold standard tests (Rahman et al., 
1983, 1988; Muhammad et al., 2010). These tests may not be able to differentiate between an active 
and a nonactive infection (Nimri, 2003). Isolation of Brucella spp. is the gold standard test for 
brucellosis. However, this is a slow process that sometimes requires Level 3 biocontainment facilities 
and highly skilled technical personnel, leading to high costs (Navarro et al., 2004). Handling of live 
Brucella species is also associated with possible infection to laboratory personnel if biosafety rules are 
not strictly monitored (Yu and Nielson, 2010). Due to the speed, safety, and high sensitivity and 
specificity of the polymerase chain reaction (PCR), all of the positive samples based on three 
serological tests were subjected to PCR. 
 
The aim of this study was to determine the seroprevalence of brucellosis, identify risk factors 
associated with human brucellosis seropositivity, and detect Brucella at the genus level using real-time 
PCR. The results of this study may be used to inform the development and implementation of control 
measures bent on sensitizing the population at risk, regulating management practices at abattoirs and 




The study protocol was peer reviewed and cleared for ethics by the Ethical Review Committee of 
Mymensingh Medical College. Verbal and written consents were also taken from all individuals prior 
to blood sample collection. 
 
Study population and survey area 
The study was carried out between September 2007 and August 2008 among livestock farmers, 
milkers, butchers, and veterinary practitioners in the Mymensingh, Sherpur, and Dhaka districts of 
Bangladesh. 
In Bangladesh, about 85% of rural households own animals, and 75% of the population rely on 
livestock to some extent for their livelihood (www.fao.org). Livestock farmers considered for this 
survey were the owners or hired animal caretakers of 571 herds of Mymensingh and Sherpur districts 
and also workers in two government-owned farms in Dhaka District from where blood samples were 
taken for determining the seroprevalence of brucellosis in domestic ruminants. 
Veterinary professionals at risk for brucellosis in these districts include approximately 100 individuals 
(approximately 25 veterinarians and animal production specialists, including their assistants) in the 
Department of Livestock Services (DLS) of the Bangladesh Government. Some veterinarians (actual 
number not known) work in Non-Governmental Organizations (NGOs) having livestock development 




programs. The exact number of butchers and slaughterhouse workers, as well as the actual number of 
milkers in these areas are not known. Estimates of butchers and milkers in these areas are 200 and 300, 
respectively. 
Convenience samples from the population of milkers, butchers, and veterinary practitioners were 
obtained from Mymensingh and Dhaka districts. Milkers were selected from the Central Cattle 
Breeding and Dairy Farm (CCBDF) in Savar and commercial dairy farms, and those who collect and 
sell milk from small holder dairy farms (vendors) were also counted in this group. Butchers were 
selected from different locations of Mymensingh district, where a great proportion of the people are 
involved in this profession. Veterinary practitioners included were veterinary surgeons, veterinary 
field assistants, and veterinary students of Mymensingh and Dhaka districts of Bangladesh. 
 
Questionnaire data collection 
Information was collected through personal face-to-face interviews. Questionnaires recorded the 
following information for each subject: age, sex, address with mobile telephone number where 
available, level of education, occupation, type of animal handled and duration of contact in years, and 
previous history and presence of symptoms (pyrexia, sweating, arthralgia, backache, and headache) 
suggestive of brucellosis (Mantur et al., 2006). The full questionnaire is available upon request from 
the corresponding author. 
 
Collection and handling of blood samples 
About 4 mL of blood was collected with disposable needles and Venoject tubes, labeled, and 
transported to the laboratory on ice (after clotting) within 12 h of collection. Blood samples were kept 
in the refrigerator (2–8°C) in the laboratory, and 1 day later sera were separated by centrifuging at 
6000 g for 10 min. Each serum was labeled to identify the individual and stored at - 20°C. Each serum 
was divided into two tubes, each containing about 1 mL of serum. One aliquot was used for testing, 
and the other was preserved in a serum bank. Among the total of 500 individuals considered to be in 
the HROG, 386 were livestock farmers. The serological status of these farmers was compared with 
that of the herd they managed. 
 
Serological tests 
All blood samples were tested in parallel using the RBT, STAT, and iELISA in the Medicine 
Department laboratory of Bangladesh Agricultural University (BAU), Mymensingh, Bangladesh. The 
tests are briefly described next. 
Rose Bengal Test (RBT). RBT was performed according to standard procedure (Alton et al., 1988). 
Briefly, sufficient antigen, test sera, and positive and negative control sera for a day’s testing were 
removed from refrigeration and brought to room temperature (22 – 4°C). Equal volumes (30 lL) of 
serum and antigen (concentrated suspension of B. abortus biotype 1 [Weybridge 99]; Institut 




Pourquier, Montpellier, France) were mixed and rotated on a glass plate for 4 min. The result was 
considered positive when agglutination was noticeable after this delay. 
Standard Tube Agglutination Test (STAT). STAT was carried out on doubling dilution of serum from 
1:20 to 320 according to standard procedure (Alton et al., 1988). Brucella abortus antigen (Cypress 
Diagnostics, Langdorp, Belgium) was used according to the instruction of the manufacturer. The test 
tubes were incubated at 37°C for 24 h. Positive reactions were determined by observing agglutination 
in 1:160 or more dilution of test serum. 
Indirect Enzyme-Linked Immunosorbent Assay (iELISA). iELISA was performed according to Limet 
et al. (1988) using B. abortus biotype 1 (Weybridge 99) as antigen. For the standard curve, six 
dilutions (1/270 to 1/8640) of the positive reference serum (no. 1121) were prepared. Fifty microliter 
of serum dilutions (1:50 in buffer consisting of 0.1M glycine, 0.17M sodium chloride, 50mM EDTA, 
0.1% (volume) Tween 80, and distilled water, pH 9.2) were added to the wells in duplicate. The plates 
were incubated for 1 h at room temperature. Binding antibodies were detected using a Protein G-
horseradish peroxidase (G-HRP) conjugate as described by Saegerman et al. (2004). Citrate-phosphate 
buffer containing 0.4% O-phenylenediamene and 2 mM H2O2 was used to visualize the peroxidase 
activity. Reading of optical densities (OD) was done at 492 nm and 620 nm using VMax® Micro-plate 
Reader. The results (OD492 –OD620) were expressed as antibody units in comparison with a reference 
serum. The conversion of ODs into units (U/mL) was done using six dilutions of the reference serum 




Real-time PCR was used to detect Brucella spp., mainly B. abortus and B. melitensis. DNA was 
isolated from 13 sera that tested positive on all three serological tests. About 200 ll of serum was used 
for extraction of DNA from sera using DNeasy spin columns (Qiagen Inc., Valencia, CA) according to 
the manufacturer’s recommendations. The most frequently described PCR target for the diagnosis of 
human brucellosis is the bcsp31 gene encoding a 31-kDa antigen conserved among Brucella spp. 
(Navarro et al., 2004). The BCSP31-PCR assay was carried out using standard procedure (Baily et al., 
1992; Bounaadja et al., 2009), and IS711-PCR was done using the procedure described by Halling et 
al. (1993). The cut off for the positivity is 40. Above this threshold, the sample is considered negative 
and below the threshold it is considered positive. The real-time PCR assay was performed at the 
National Reference Centre for Brucellosis, Veterinary and Agrochemical Research Centre (CODA-
CERVA) in Belgium. 
  





To determine the potential risk factors associated with human brucellosis sero-positivity, individuals 
were considered positive if they tested positive in at least one serological test along with the presence 
of any of the clinical symptoms suggestive of brucellosis as mentioned in questionnaire’s data 
collection section. 
Firstly, a univariate analysis was performed using a random effects logistic regression model. The 
model uses, as response, the brucellosis status of the individuals and each risk factor or indicator 
variable in turn as the independent variable. Occupational status was forced into the model as it is of 
primary interest. The possible effects of variations in brucellosis seropositivity among districts were 
accounted for by incorporating district as a random effect in the model (Van-Leeuwen et al., 2010). 
Variables with a p-value ≤ of 0.10 in the univariate analysis were further analyzed in a multivariable 
random effects logistic regression model. A manual forward stepwise model building approach was 
employed with the Akaike’s Information Criterion (AIC) as the calibrating parameter to select the 
final model. In this approach, the best univariate model is selected as the model with the lowest AIC 
value. The remaining variables are then added each in turn to form three variable models. The best 
three-variable model is selected based on the AIC. This is repeated until the addition of one more 
variable fails to improve the model fit; in other words if the AIC does not change or starts to increase. 
The model with the smallest AIC is considered to be the most appropriate model. The effects of 
confounding were investigated by observing the change in the estimated coefficients of the variables 
that remain in the final model once a non-selected variable is included. When the inclusion of a non-
significant variable led to a change of more than 25% of any parameter estimate, that variable was 
considered to be a confounder and was included in the model. All two-way interaction terms of the 
variables remaining in the final model were assessed for significance based on the AIC values, i.e., 
comparing the AIC values of the model with the desired interaction term and the corresponding model 
with no interaction terms (Dohoo et al., 2003). 
The intra-class correlation coefficient (ICC), which is a measure of the degree of clustering of 
individuals belonging to the same district, was computed. In random effects logistic regression 
models, the individual level variance 𝛿2 on the logit scale is usually assumed to be fixed to 𝜋
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If the ICC is zero, it implies that there is no variability in brucellosis seropositivity among districts but 
rather a higher variability among humans within districts. 
The models were built using the xtmelogit () function in STATA, version 11, software (StataCorp LP, 
College Station, TX). Model selection was done using Laplacian approximation, whereas parameter 
estimates from the final model were obtained using Adaptive Gaussian Quadrature (Twisck, 2003). 




The robustness of the final model was assessed by increasing the number of quadrature (integration) 






There were a total of 500 individuals from the Mymensingh, Sherpur, and Dhaka districts of 
Bangladesh. The prevalence of brucellosis based on the three tests was observed to be 4.4% following 
a parallel interpretation of the three tests. The prevalence of brucellosis for each category of each of 
the factors considered is presented in Table 8.1.  
The prevalence was found to be highest (28.3%) among individuals who indicated symptoms linked to 
brucellosis. The prevalence of brucellosis was also found to be higher among milkers as compared to 
livestock farmers, butchers and veterinary practitioners. The prevalence of brucellosis appeared to be 
higher among individuals who handled only goats; the prevalence was found to be higher with 
increased duration of contact with animals. The prevalence of brucellosis among males was higher 
(5.6%) compared to that of females (0.8%). Finally, among those who consumed raw milk, the 
prevalence was higher (11.4%) as compared to those who did not consume raw milk (3.9%). Out of 
571 herds, 386 people of 337 (59.0%) herds agreed to provide blood samples. 
 
Factors associated with brucellosis seropositivity in humans based on a univariate analysis 
The results of the univariate random effects logistic regression analysis with occupation forced into the 
model and a random intercept for district revealed that, type of animal handled, and duration of contact 
with animals were highly significantly associated with human brucellosis seropositivity (p < 0.05; 
Table 8.1). On the other hand, gender was not significant at the 5% level, but since its p-value was ≤ 
0.10, it was considered as a potential risk factor and was thus included in the multivariable random 
effects model. 
 
Multiple random effect logistic regression model 
Out of the potential risk factors initially considered in the multiple random effects logistic regression 
model, four were included in the final model. None of the two-way interaction terms were statistically 
significant (p > 0.05). Gender appeared to be a confounding variable and was therefore included in the 
model. Increasing the number of quadrature points had no influence on the estimated fixed effects and 
the variance component parameters indicating that the model is robust. The estimated odds ratios 
(ORs) and their 95% confidence intervals (CIs) are presented in Table 8.2. 
 
  




Table 8.1. Potential risk factors associated with household level seroprevalence of Brucellosis 
based on a univariate random effects model 
Factor Tested Positive Prevalence 95% CI 
Age group (years)     
 14-20 44 1 2.3 (0.06-12.0) 
 21-40 231 7 3.0 (1.2-6.1) 
41-80 225 14 6.2 (3.4-10.2) 
District     
 Dhaka 63 12 19.0 (10.2-30.9) 
Mymensingh 410 10 2.4 (1.2, 4.4) 
Sherpur 27 0 0.0 (0, 12.8)
 a
 
Education     
None to secondary 468 22 4.7 (3.0, 7.0) 





     
Female 125 1 0.8 (0.02, 4.4) 
Male 375 21 5.6 (3.5, 8.4) 
Occupation     
Livestock farmer 386 10 2.6 (1.2, 4.7) 
Milker 55 10 18.2 (9.1, 30.1) 
Butcher 40 1 2.5 (0.06, 13.2) 
Veterinary practitioner 19 1 5.3 (0.1, 26.0) 




    
0.08-5 169 1 0.59 (0.01, 3.3) 
6-15 166 3 1.8 (0.4, 5.2) 
16-25 91 6 6.6 (2.5, 13.8) 
≥ 26 76 14 16.2 (8.7, 26.6) 
Type of animal handled 
c
     
Cattle only 343 12 3.5 (1.8, 6.0) 
Cattle and goat 86 4 4.7 (1.3, 11.5) 
Goat 71 6 8.5 (3.2, 17.5) 
Drinking raw milk     
  No 465 18 3.9 (2.3, 6.0) 
  Yes 35 4 11.4 (3.2, 26.7) 
Symptoms 
c
     
No 440 5 1.1 (0.4, 2.7) 
Yes 60 17 28.3 (17.5, 41.4) 
Legend: 
a
Exact binomial confidence interval; 
b
Significant at 10% but not at 5% so was considered as a 
potential risk factor or indicator variable and therefore included in the multivariable random effects 
logistic regression model; 
c
Highly significant ( p < 0.001); CI, confidence interval. 
 
 




Table 8.2. Final model of risk factors associated with human Brucelosis seropositivity among 500 
people at high risk for Brucellosis within the Mymensingh, Sherpur, and Dhaka districts of 
Bangladesh 
Risk factors OR P-value 95% CI 
Occupational status    
Butcher 1 — — 
Livestock farmer 2.8 0.384 (0.28, 26.94) 
Milker 16.9 0.053 (0.99, 293.85) 
Veterinary practitioner 3.7 0.468 (0.11, 122.59) 
Animal handled    
Cattle only 1 — — 
Cattle and goat 9.5 0.053 (0.97, 98.83) 
Goat 59.8 < 0.001 (6.40, 559.93) 
Duration of contact with animals (years)    
0.08–5 1 — — 
6–15 2.6 0.427 (0.24, 28.43) 
16–25 9.9 0.047 (1.03, 95.30) 
≥ 26 14.2 0.019 (1.56, 129.6) 
Sex    
Women 1 — — 
Men 6.2 0.120 (0.62, 60.98) 
Variance components Estimate SE  
District 1.22 0.81 (0.34, 4.46) 
Legend: OR, odds ratio; SE, standard error; CI, confidence interval. 
 
The variance component of the model with no covariates yielded an ICC of 0.28. This implies that 
28% of the variance in the log odds of brucellosis seropositivity is attributed to differences among 
districts. After incorporating the significant risk factors, the ICC for districts remained almost the same 
at 0.27.  
The between-district variability of 27% suggests that there is a weak variability in human brucellosis 
cases among districts in Bangladesh but a high between-human variability within districts. From the 
final model (Table 8.2), it can be seen that for those people who owned or handled mainly goats, the 
odds of brucellosis seropositivity were significantly higher than those of people who handled only 
cattle (OR = 59.8, p < 0.001). 




Also though, not statistically significant, relative to those who owned or handled only cattle, those 
who handled cattle and goats were 9.5 times more likely to be brucellosis seropositive. The odds of 
human brucellosis seropositivity increased significantly with an increase in the duration of contact 
with animals.  
In fact, for individuals who had been working with livestock for more than 26 years, the odds of 
brucellosis seropositivity were significantly higher compared to those who had been working for less 
than 26 years (OR = 14.2, p = 0.02). 
 
Results of the real-time PCR 
The findings from the real-time PCR for the seropositive cases are shown in Table 8.3. All of the 13 
positive human cases based on the three tests were positive in both PCR. The mean Ct values of 
BCSP31 and IS711 real-time PCR test were 37.03 and 34.40, respectively, indicating a positive 
reaction in both situations. 
The relationship between brucellosis-positive animal herds and occurrence of human infection is 
shown in Table 8.4. Livestock farmers of brucellosis-positive herds had significantly higher odds to be 
infected (OR = 10.2; 95% CI: 2.8–37.1). 
 
Table 8.3. Real time polymerase chain reaction (PCR) confirmation of seropositive patients 
PCR type Tested Positive CT values 
   Mean ±SE Min Maximum 
BCSP31 13 13 37.03±0.46 33.2 39.4 
IS711 13 13 34.40±0.44 31.0 36.0 
Legend: Ct, cycle threshold; SE, standard error. 
 
 
Table 8.4. Relationship between Brucellosis seropositivity status of livestock herds (involving 
cattle, sheep, and goats) and human Brucellosis seropositivity 
Herd status Livestock farmers 
Tested Positive Prevalence 95% Confidence Interval 
Herds negative 309 3 0.1 (0.2, 2.8) 
Herds positive 77 7 9.1 (3.7, 17.8) 
Legend: CI, Confidence Interval. 





The present study represents the first report on the risk factors for brucellosis among individuals in 
high-risk occupations in Bangladesh. The results of this study suggest that the presence of brucellosis-
related symptoms, type of animals owned or handled, and duration of contact with animals are highly 
significantly associated with brucellosis seropositivity in humans in the Mymensingh, Sherpur, and 
Dhaka districts of Bangladesh. In addition, there is considerable variability in brucellosis 
seropositivity among humans due to heterogenous distribution of different HROG people in different 
districts. In Mymensingh District, all type of HROG people were sampled; in Dhaka the sample was 
predominantly composed of milkers; and in Sherpur, all people sampled were livestock farmers. It was 
observed from this study that milkers have relatively higher brucellosis seroprevalence than livestock 
farmers, butchers, and veterinary practitioners. These factors may explain the variability of brucellosis 
seropositivity among individuals within district. 
 
The prevalence of brucellosis in the HROG based on parallel interpretation of the three tests was 
observed to be 4.4%. This seroprevalence is comparable to those of other reports from this area 
(Muhammad et al., 2010; Thakur and Thapliyal, 2002). Brucellosis in humans in Bangladesh is 
ignored, misdiagnosed, and thought to have very low sporadic incidence. The findings of this study 
reveal that brucellosis among people in the HROG is not uncommon. In this study, about 28.5-fold 
increased odds of infection was found in HROG individuals having clinical symptoms suggestive of 
brucellosis. So, medical doctors should use these findings as a diagnostic clue in HROG individuals 
for brucellosis (Araj and Azzam, 1996). 
The duration of contact with animals was found to be strongly associated with human brucellosis 
seropositivity. This finding is consistent with results from other studies (Rahman et al., 1983; Abo-
Shehada et al., 1996). This could be due to long-term cumulative exposure by individuals to 
brucellosis-infected livestock or to a contaminated environment (which increases the chance of getting 
infected). 
 
It was observed in this study that about 14.2% (55/386) livestock farmers shared same premises with 
animals, and the majority (29/55) of livestock species kept are goats. The relatively low 
socioeconomic status of the farmers makes it impossible to build separate animal houses for protection 
from predators, especially in the case of small ruminants. Among those who keep goats inside their 
houses, the seroprevalence of brucellosis was 6.9%. This finding of very intimate contact with goats 
may explain the relatively higher seroprevalence of brucellosis in HROG individuals having contact 
with goats. Similar observations were also made by other authors (Rah-man et al., 1988; Omer et al., 
2002). 
Brucellosis is an occupational disease in livestock farmers, dairy workers, butchers, veterinarians, and 
laboratory personnel. For this reason, occupational status was forced into the final model. The odds of 




brucellosis seropositivity appeared to be high for milkers (OR = 16.9), which was consistent with 
findings from other studies (Rahman et al., 1983; Omer et al., 2002). Among dairy farm workers, 
undulant fever seems to be almost (but not entirely) limited to those who handle and milk the cows. 
The higher seroprevalence in milkers confirms the impression that intimate contact with animals is 
more important than consumption of infected milk (McDevitt, 1971). 
 
Even though gender was an important confounding variable in this study, its non-significance as a risk 
factor for brucellosis seropositivity in this study may be explained by the very low proportion of 
brucellosis seropositive cases among females (one out of 25). Males were apparently about six times 
more likely to be brucellosis seropositive as compared to females. This is because the occupations 
described in this study are male dominated in Bangladesh. Several other studies have indicated gender 
as significant risk factors for brucellosis (Wassif et al., 1992; Shehata et al., 2001; Mantur et al., 2004; 
Meky et al., 2007). 
 
In other studies, the consumption of raw milk has been shown to be the most significant risk factor for 
the transmission of brucellosis among humans (Godfroid et al., 2011). However, in this study, 
consumption of unpasteurized dairy products was not a significant risk factor. This is probably due to 
the fact that our study subjects are limited to those in the HROG, most of whom are not the main 
consumers of the finished dairy products. To investigate the role of consumption of unpasteurized 
dairy products, a study should be performed that covers the entire population and not only those 
people in the HROG. 
 
A total of 13 individuals from the HROG were positive in all three serological tests. From the results 
of both real-time PCR methods, Brucella genus–specific DNAs were detected in all of those 13 
seropositive cases. This indicates that, among the test positive cases, there were no false positives. The 
detection of Brucella genus specific–DNA using real-time PCR from human sera is in agreement with 
findings from other studies (Zerva et al., 2001; Debeaumont et al., 2005; Queipo-Ortuno et al., 2005). 
Detection of Brucella genus–specific DNA using real-time PCR is a rapid, highly sensitive, specific, 
and not hazardous test for laboratory personnel, which can be used as a better alternative to culture. At 
least at the regional level, a laboratory can be established with the facilities for performing serum-
based real-time PCR. This will assist in the confirmation of the disease in the HROGs having signs of 
brucellosis. It can be added here that all of the 13 seropositive patients were treated with a 
combination of doxycycline and rifampicin, which successfully cured them, except for one relapse 
case (data not shown). 
Working in a brucellosis-positive herd would normally increase the probability of getting infected 
with brucellosis. In this study, this risk was quantified as 10 times more likely for the livestock 
farmers having at least one seropositive animal in their herds. 





This is one of the first studies that rigorously investigated and quantified risk factors for brucellosis 
seropositivity in Bangladesh using a random effects logistic regression model. The advantage of such 
a modeling approach is that it accounted for clustering of individuals within districts. However, the 
limitation is that samples of milkers, butchers, and veterinary practitioners are convenience samples 
generated by the use of nonprobabilistic sampling methods, which has the effect of limiting the 
generalization of the results to the entire, at-risk Bangladesh population. Given the unavailability of a 
sampling frame, randomness of the sample from these groups of individuals is almost impossible. 
Moreover, such a study is based on the contentment of patients, and it is difficult to evince this 
constraint. 
Evidence from this study on risk factors for brucellosis seropositivity in humans can be strengthened 
by increasing the number of samples and ensuring a more representative sample including milkers, 
butchers, and veterinary practitioners. The large odds ratios with wide CIs obtained in our study 
should be cautiously interpreted, given that the distribution of the individuals within the different 
categories of the risk factors was not even and the frequencies were sometimes very low. 
 
In conclusion, our study revealed that the duration of contact with animals and the type of animal 
handled appeared to be the most significant risk factors for human brucellosis seropositivity in the 
Mymensingh, Sherpur, and Dhaka districts of Bangladesh. These two factors can be easily altered by 
educating individuals at HROG on the potential risks of extensive contact with livestock. The non-
existence of a vaccine against brucellosis in humans or the difficulty of accessing a safe and 
efficacious vaccine implies that controlling this zoonotic disease in animals will directly lead to 
prevention in humans (especially with respect to biosecurity). The significant risk factors identified in 
this study can be regarded as proxies for many other management factors that were not included in the 
questionnaire. Intervention studies will therefore be needed to confirm the role of these factors on 
human brucellosis seropositivity. 
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Pyrexia is an important clinical symptom of human brucellosis. It is also caused by other diseases like 
tuberculosis, malaria, typhoid that are endemic in Bangladesh. However, there is no report on the 
prevalence of brucellosis in patients with pyrexia of unknown origin (PUO) in Bangladesh. Moreover, 
the species of Brucella responsible for brucellosis in pyretic patients is also unknown in Bangladesh. 
This chapter describes the prevalence of brucellosis in randomly collected PUO patients and detection 
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Abstract   
This study describes the seroprevalence of human brucellosis among patients with pyrexia of unknown 
origin (PUO) and detection of Brucella (B.) abortus DNA from seropositive PUO patients using real-
time (rt) PCR for the first time in Bangladesh. Blood samples were collected from a total of 300 
patients with PUO over a period of eight months starting from October 2007 until May 2008 and 
subjected to three serological tests; the Rose Bengal plate test (RBT), Standard Tube Agglutination 
Test (STAT) and the indirect enzyme-linked immunosorbent assay (iELISA). A univariate analysis 
was performed using Firth’s logistic regression model. Brucella genus (BCSP31) and species specific 
(IS711) real time PCR (rt PCR) were applied on six human sera samples. The seroprevalence of 
brucellosis among patients with PUO was estimated to be 2.7% (95% CI: 1.2-5.2). The age, residence, 
type of patient, contact with animals, type of animal handled, arthralgia and backache were found to be 
significantly associated with brucellosis seropositivity. Brucella abortus DNA was amplified from all 
six human sera which tested positive in RBT, STAT and iELISA. Based on the performance, 
simplicity and cost, the RBT is recommended as a screening test for the diagnosis of human 
brucellosis in Bangladesh.  
 









Human brucellosis is a zoonotic bacterial infection caused by a Gram-negative facultative intracellular 
bacteria of the genus Brucella. The most pathogenic and invasive species for humans is Brucella (B.) 
melitensis, followed in descending order by Brucella suis, Brucella abortus and Brucella canis (Acha 
and Szyfre, 2003). The transmission to humans mostly results from the consumption of fresh milk and 
dairy products prepared from unpasteurized milk such as soft cheeses, yoghurts and ice creams. 
However, direct contact with infected animals is an important transmission route especially among 
abattoir workers, herdsmen, veterinarians, butchers and also through the inhalation of infected 
aerosolized particles in personnel in microbiologic laboratories (Pappas et al., 2005). 
Human brucellosis poses major economic and public health challenges in affected countries especially 
in the Mediterranean countries of Europe, northern and eastern Africa, Near Eastern countries, India, 
Central Asia, Mexico and Central and South America. However, there are only a few studies where the 
seroprevalence of brucellosis among patients with PUO has been estimated. For example, Baba et al. 
(2001) estimated the seroprevalence in northeastern Nigeria to be 5.2% whereas Tolosa et al. (2007) 
obtained a slightly lower seroprevalence of 3.6% in south eastern Ethiopia. The study by Kadri et al. 
(2000) yielded a seroprevalence of 0.8% among patients with PUO in Kashmir-India and 1.0% (1/100) 
among hospitalized patients with prolonged fever was reported by Aniyappanavar et al. (2013). The 
wide variability in estimated seroprevalence reported may be due to differences in the sampling design 
schemes used, the number of samples, exposure to Brucella spp., the number of diagnostic tests used 
and the manner in which tests were interpreted. 
The status of brucellosis among humans in Bangladesh is not well documented. There is no official 
report about the prevalence or incidence of this disease in humans in Bangladesh. Several study 
findings revealed that 4.4-12.8% of people in high-risk occupational groups were brucellosis 
seropositive in some selected areas of Bangladesh (Rahman et al., 1983; Rahman et al. 1988; 
Muhammad et al., 2010; Rahman et al., 2012).  
Moreover, brucellosis is known to be a pyrexic disease and the prevalence of brucellosis in pyrexic 
patients of Bangladesh is not yet known. The infection in humans is not clearly defined; it is mainly 
characterized by PUO yielding body temperatures of up to 38.3 °C (Petersdorf, 1992). Other 
symptoms include: backache, arthralgia, headache, chills, night sweats, weakness and weight loss 
(Mantur et al., 2007). Malaria, typhoid fever, tuberculosis and rheumatic fever are endemic in 
Bangladesh (Ahmed et al., 2005; Ram et al., 2007; Haque et al., 2009; Zaman et al., 2011). Since 
pyrexia is a characteristic of the aforementioned diseases including brucellosis, clinical examinations 
should always be accompanied by laboratory tests. The Rose Bengal (RBT), Standard Tube 
Agglutination (STAT) and indirect ELISA (iELISA) either alone or in combination were used for 
previous studies. None of these tests is perfect. However, if multiple imperfect tests are used in 
parallel on each sample, the agreement between two test pairs can be calculated. 




Among people with PUO, risk factors that have been shown to be significantly associated with 
Brucella melitensis include: gender, age, and occupation (Kadri et al., 2000; Tolosa et al. 2007; Al-
Fadhi et al., 2008).  
In Bangladesh, there is no published report on the isolation of Brucella species from man or animals, 
but Rahman et al. (2012) reported the presence of Brucella DNA at genus level from seropositive 
human sera. Laboratory detection and species identification is still based on culture and phenotypic 
characterization respectively, which are time consuming and resource-intensive.  Moreover, the risk of 
laboratory acquired infections during handling of infectious samples or isolates is very high (Yu and 
Nielsen, 2010). The PCR techniques are gradually becoming popular for rapid detection of brucellae 
from clinical samples like blood or serum (Zerva et al., 2001; Queipo-Ortuño et al., 2005; 
Debeaumont et al., 2005). The IS711 based rt PCR is reported to be specific and highly sensitive 
(Bounaadja et al., 2009). Most rt PCR assays so far developed are designed to detect brucellae at 
genus level to enable early onset of treatment. Brucella IS711 species specific multiplex rt PCRs for B. 
abortus and B. melitensis also exist for investigation of cultures (Probert et al., 2004).  
The objectives of this study were to determine the seroprevalence of brucellosis among patients with 
PUO and to detect species of Brucella prevalent among PUO patients using real-time PCR.  
 
2. Materials and Methods 
2.1. Study population and study area 
Patients with PUO were defined as those with body temperatures higher than 38°C on several 
occasions and lasting over a period of three weeks. Patients were recruited from Mymensingh Medical 
College (MMC) hospital. The geographical position of MMC hospital, place of residence of patients 
and origin of animal samples are shown in Figure 9.1. MMC is the only medical college in the region. 
Therefore, patients from the surrounding districts have to visit MMC hospital to receive specialized 
treatment.  
More than 80% of the population of this area lives in villages and crop-based livestock farming is their 
main source of income. Drinking of non-pasteurized milk and eating milk products is very unusual for 
these villagers. Milk is usually consumed after boiling, albeit milkers occasionally drink raw milk 
during milking. Cheese, yogurt and butter are usually consumed only from the wealthy city 
population. Blood samples from PUO patients were collected randomly once a week. Every day 
around 100 patients visit the outpatient facilities of MMC hospital. Ambulant and hospitalized patients 
meeting the inclusion criteria were recruited on the same date. Blood samples were collected from a 
total of 300 patients starting October 2007 until May 2008. 
  














2.2. Ethical considerations 
The study protocol was peer reviewed and cleared for ethics by the Ethical Review Committee of 
Mymensingh Medical College. Informed verbal and written consents were also taken from all 
individuals prior to blood sample collection. 
 
2.3. Questionnaire data collection 
Information was collected through personal face-to-face interviews. Questionnaires recorded 
information on age, sex, education, occupation, residency, type of patient (out and in), consumption of 
unpasteurized milk, contact with livestock (yes or no), animals handled, duration of contact in years, 
type of pyrexia, presence of arthralgia, sweating and backache (yes or no).  
 
2.4. Collection and handling of blood samples 
The collection and handling of blood samples was described in a previous paper by Rahman et al. 
(2012). 
 
2.4.1. Serological tests 
All blood samples were tested in parallel by indirect IgG ELISA, RBT and STAT. The detailed 
procedures for all three tests were described in a previous paper by Rahman et al. (2012). The 
estimated sensitivity and specificity of the iELISA, RBT and STAT were 78.6% and 99.6%, 88.4% 
and 99.4% and 81.7% and 99.6% respectively (Unpublished data). 
 
2.4.2. DNA extraction from human serum  
DNA was extracted from six human sera being positive in all three serological tests applied . DNA 
was extracted using the DNeasy spin column kit (QIAGEN) according to the manufacturer's protocol. 
 
2.4.3. BSCP31 genus specific and Brucella abortus and Brucella melitensis specific IS711 real-time 
PCR 
The IS711/BCSP31 rt PCRs originally described as a multiplex PCR assay (Probert et al., 2004) were 
performed as single assays to detect Brucella spp. DNA and/or to distinguish between B. melitensis 
and B. abortus DNA, respectively. No further modification of the protocols was done. The species 
specific assays were applied when a genus specific assay had detected BrucellaDNA in a sample. The  
primers and probes were obtained from TIB MOLBIOL (Berlin, Germany). Amplification reaction 
mixtures were prepared in volumes of 25 μl containing 12.5 μl TaqManTM Universal Master Mix 
(Applied Biosystems, New Jersey, USA), 0.75 μl of each of the two specific primers (0.3 μM) and 0.5 
μl TaqMan probe (0.2μM), 5 μl of template, and 6.25 μl  nuclease-free water. The rt PCR reaction was 
performed in duplicate in optical 96-well microtiter plates (qPCR 96-well plates, Micro AmpTM, 
Applied Biosystems) using a Mx3000P thermocycler system (Stratagene, La Jolla, California) with the 




following run conditions, 2 min at 50°C, 10 min at 95°C, followed by 50 cycles of 95°C for 15s and 
57°C for 1 min. Cycle threshold values below 40 cycles were considered positive. The threshold was 
set automatically by the instrument. The samples scored positive by the instrument were additionally 
confirmed by visual inspection of the graphical plots showing cycle numbers versus fluorescence 
values.  
 
2.5. Statistical analyses 
To determine the potential risk factors and clinical symptoms associated with brucellosis sero-
positivity in people with pyrexia of unknown origin, individuals were considered positive if they 
tested positive in at least one of the three serological tests used. 
A univariate analysis was performed using a Firth’s logistic regression model. The model used as 
response, the brucellosis status of the individuals and each risk factor or indicator variable in turn as 
the independent variable. 
The percent agreement and coefficient of agreement between two test pairs were calculated according 
to Langenbucher et al. (1996). Calculations of the different parameters were carried out in R 3.1.0 
(The R Foundation for Statistical Computing, 2014) using a ‘two-by-two’ contingency table. 
 
3. Results 
3.1. Descriptive statistics 
The distribution of brucellosis seropositivity among the 300 PUO patients is presented in Table 9.1a 
and 9.1b. The overall seroprevalence of human brucellosis was 2.7% following a parallel 
interpretation of the three tests. The mean age of the individuals was 24.4 years and ranged from 2 to 
80 years with 66% of the study population being males. Clinical symptoms of the 8 brucellosis 
seropositive PUO patients disappeared after therapy with streptomycin (1g i.m. daily) for 15 days and 
doxycycline (100mg p.o. every 12 hours) for 45 days.  
 
3.2. Factors associated with brucellosis seropositivity among people with PUO based on a 
univariate analysis 
The results of the univariate Firth’s logistic regression analysis revealed that, age, residence, type of 
patient, contact with animals, type of animal handled, arthralgia and backache were significantly 








Table 9.1a. Univariate analysis of potential risk factors and clinical symptoms for brucellosis among 300 
people with pyrexia of unknown origin in Bangladesh  
Factor Tested Positive (%)  Exact Binomial 95% CI p-value* 
Age Group (Years)    0.003 
2-20 149 1 (0.7) 0.0-3.7  
21-40 111 2 (1.8) 0.2-6.4  
41-80 40 5 (12.5) 4.2-26.8  
Education    0.517 
College to University  37 0 (0) 0.0, 9.5  
None to secondary 263 8 (3.0) 1.3, 5.9  
Sex    0.374 
Female 101 2 (2.0) 0.2-7.0  
Male 199 6 (3.0) 1.1-6.4  
Residence    0.020 
Urban 106 0 (0) 0, 3.4  
Rural 194 8 (4.3) 1.9, 8.3  
Type of patient    0.048 
Out patient 262 5 (1.9) 0.6, 4.4  
Indoor 38 3(7.9) 1.7, 21.4  
Occupation    0.885 
Business 31 0 (0) 0.0, 11.2  
Crop farmer 37 0 (0) 0.0, 9.5  
Day labour 7 0 (0) 0.0, 40.9  
Housewife 28 2 (7.1) 0.9, 23.5  
Livestock farmer 78 5 (6.4) 2.1, 14.3  
Not applicable (Age below 5 years) 20 0(0) 0.0, 16.8  
Service 12 0 (0) 0.0, 26.5  
Study 87 1 (1.1) 0.03, 6.2  
Contact with animals    0.023 
No 219 3 (1.4) 0.3-4.0  
Yes 81 5 (6.2) 2.0-13.8  
Legend: *p values obtained from Firth’s logistic regression analysis; CI, confidence interval. 




Table 9.1b. Univariate analysis of potential risk factors and clinical symptoms for brucellosis among 300 
people with pyrexia of unknown origin in Bangladesh  
Factor Tested Positive (%)  Exact Binomial 95% CI p-value* 
Animal handled    0.001 
Cattle 57 0 (0) 0, 6.3  
Cattle and goat 4 0 (0) 0.0-60.2  
Not known 219 3 (1.4) 0.3-3.9  
Goat 20 5 (25.0) 8.6, 49.1  
Drinking of raw milk    1 
No 296 8 (2.70.03) 1.2-5.3  
Yes 4 0 (0.0) 0.0-60.2  
Nature of fever    0.247 
Irregular 281 6 (2.1) (0.8, 4.6)  
Continuous 11 1 (9.1) (0.2, 41.3)  
Rising & falling 8 1 (12.5) (0.3, 52.7)  
Sweating    0.001 
No 71 6(8.5) 3.2, 17.5  
Yes 229 2 (0.9) 0.1, 3.1  
Arthralgia    <0.001 
No 282 4 (1.4) 0.4, 3.6  
Yes 18 4 (22.2) 6.4, 47.6  
Backache    <0.001 
No 287 4 (1.4) 0.4, 3.6  
Yes 13 4 (30.8) 9.1, 61.4  
Headache    0.001 
No 43 5 (11.6) 3.9, 25.1  
Yes 257 3 (1.2) 0.2, 3.4  
District    0.486 
Jamalpur 4 0 (0) 0.0-60.2  
Mymensingh 273 5 (1.8) 0.6-4.2  
Netrokona 18 2 (11.1) 1.4-34.7  
Sherpur 3 1 (33.3) 0.8-90.6  
Tangail 2 0 (0) 0.0-84.2  
Legend: *p values obtained from Firth’s logistic regression analysis; CI, confidence interval.




3.3. Real time PCR result 
From those six sera, which were positive in the three serological tests, Brucella abortus DNA was 
amplified (Table 9.2). No B. melitensis DNA could be amplified from any of the six human serums. 
 
Table 9.2. Brucella genus and Brucella species specific real time PCR among seropositive 
patients 
PCR type Tested Positive CT values Range 
   Mean ±SE Min Maximum 
BCSP31 Brucella 
genus 
6 6 36.5±0.36 34.9 38.2 
IS711 Brucella genus  6 6 34.2±0.29 32.8 35.6 
IS711 Brucella abortus 6 6 33.5 ±0.83 31.04 36.0 
IS711 Brucella 
melitensis 
6 0 - - - 
 
3.4 Agreement between test pairs 
The percent agreement, kappa value and corresponding 95% confidence interval are shown in Table 
9.3. More than 99.3% agreement was observed between RBT-iELISA, RBT-STAT and iELISA-RBT. 
The kappa value ranged from 0.85-0.93 indicates very strong agreement between tests. 
 
Table 9.3. Agreement between two diagnostic tests 
Test combination Percent 
agreement 
Kappa 95%  
Confidence Interval 
Remarks 
RBT-iELISA 99.7 0.92 0.81, 1.03 Almost perfect agreement 
RBT-STAT 99.7 0.93 0.82, 1.04 Almost perfect agreement 




The seroprevalence of brucellosis among patients with pyrexia of unknown origin is described for the 
first time in Bangladesh and was estimated to be 2.7% (95% CI: 1.2-5.2). A lower seroprevalence of 
0.8% was reported from Kashmir-India (Kadri et al., 2000) whereas a slightly higher prevalence of 
5.2% was observed in north eastern Nigeria among patients with pyrexia of unknown origin (Baba et 




al., 2001). The seroprevalence of 2.7% for our study is an indication that the majority of the patients 
with pyrexia of unknown origin were not infected with brucellosis. It is known that only about 30% of 
cases of PUO are due to infections (Williams  and Bellamy, 2008). Malaria, typhoid, tuberculosis and 
rheumatic fever are common pyrexic diseases of humans in Bangladesh and are routinely referred by 
physicians for laboratory testing. Brucellosis as a cause of PUO was neglected by medical 
professionals in Bangladesh. Through this study it was observed that about 2.7% of the PUO patients 
suffer from brucellosis. However, this study may not represent the total PUO patients in Bangladesh as 
not all PUO people visit hospitals for health services. So, there might have some bias in the selection 
of PUO patients, which is also a limitation of this study. 
Therefore, besides recommending that PUO be tested for tuberculosis, typhoid, malaria and rheumatic 
fever, clinicians should also consider brucellosis for routine testing. 
Sero-prevalence of brucellosis in PUO patients increased with age which tallies with findings from 
other studies (Abo-Shehada et al., 1996; Tolosa et al., 2007). A possible reason for this that with age 
exposure of adults to livestock or livestock related activities increases.  
Even though our results show that gender was not statistically significantly associated with human 
brucellosis seropositivity, other studies have shown otherwise (Kadri et al., 2000; Mantur et al., 2007; 
Al-Fadhi et al., 2008).  
Brucellosis is an occupational disease and therefore mostly affects livestock farmers, dairy workers, 
butchers, veterinarians and laboratory personnel. These occupations are male dominated in Bangladesh 
making them more commonly affected than females.  
All of the 8 brucellosis infected pyretic people were of rural origin. More than 80% of the people live 
in rural areas and involved with livestock production and thereby exposed to brucellosis positive 
animals.  
Hospitalized pyretic patients had significantly higher seroprevalence than outpatients. Hospitalized 
patients showed acute course of infection resulting in immediate hospitalization. On the other hand, 
outpatients were chronically infected and more often presented with intermittent fever.  
Livestock farmers, housewives and students were found to be brucellosis positive among different 
occupational groups. Housewives may get contact with Brucella contaminated meat and milk during 
preparations for cooking. Some housewives also assist in livestock production by herding, feeding, 
watering and milking in rural areas. Students living in villages also help their parents in livestock 
production by herding, feeding and watering during their free time. The brucellosis seropositivity 
among patients with pyrexia who were in contact with animals was significantly higher than for those 
who had no contact with animals. This is an indication that for those patients with chronic pyrexia and 
with a history of animal contact, brucellosis testing should be suggested. 
Significantly higher seropositivity was estimated for pyrexic patients who handled goats compared to 
those who handled only cattle. Rahman et al. (2012) also observed a relatively higher seroprevalence 
of brucellosis in people who handled only goats than those who handled only cattle and those who 




handled both cattle and goats, respectively. The same authors also reported that about 14.2% livestock 
farmers shared the same premises with their animals 52.7% kept goats in their houses. This close 
contact to animals could be responsible for the high prevalence among goat handlers. 
Arthralgia and backache were significant clinical symptoms for brucellosis among the PUO patients. 
Similar observations were also made by other authors (Alsubaie et al., 2005; Dokuzoğuz et al., 2005; 
Mantur et al., 2007). 
Based on its easy handling and low costs, the RBT is recommended as a screening test for the 
diagnosis of human brucellosis in Bangladesh. A more specific test like serum based genus or species 
specific rt PCR can be used for confirmation (Zerva et al., 2001; Rahman et al., 2012) to avoid 
unjustified costs, drug toxicity and masking of other potentially dangerous diseases like tuberculosis 
which are also endemic in Bangladesh. At the time of this investigation rt PCR assay had to be 
performed in Germany, but now the facilities to perform this test are available in Bangladesh. The 
percent agreement between the two tests pairs and corresponding Kappa values indicate similar 
performance of the tests. 
Detection of Brucella DNA was reported even for serum samples that were taken a long time after 
clinical signs of disease had ceased in these patients (Navarro et al., 2006; Vrioni et al., 2008). Our six 
ELISA, STAT and RBT positive patients presented with clinical symptoms and signs suggestive for 
brucellosis and indeed they recovered after ‘typical’ brucelosis treatment had been administered. 
Amplification was successful as we had expected. Thus, we could demonstrate that confirmatory 
diagnosis by species specific rt PCR is adequate for a well-timed onset of a combination treatment 
necessary for brucellosis (Mantur et al., 2007).  
The small sample size of 300 patients leads to sparseness (the distribution of the individuals within the 
different categories of the risk factors was not even and the frequencies were sometimes very low) of 
the data. This limitation can be resolved by future studies involving a larger number of patients. 
 
Conclusion 
Brucellosis among PUO patients is not uncommon. Brucella abortus was found to be the only species 
prevalent in pyretic patients in Bangladesh. Based on easy handling and low costs, the RBT is 
recommended as the screening test and rt PCR as the confirmatory test whenever necessary for the 
diagnosis of human brucellosis in Bangladesh.  
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This chapter critically analyzes the knowledge generated from the chapter 5 to chapter 9 and discusses 
their practical relevance to design and implement future brucellosis control program whenever 
necessary. Brucellosis is an ancient and one of the world’s most widespread zoonotic diseases 
affecting both, public health and animal production (Ariza et al., 2007). Since the first report on 
seroprevalence of brucellosis (Rahman and Mia, 1970), the brucellosis study in Bangladesh focused 
only on seroprevalence and few reports on risk factors mainly in domestic ruminants (Tables 3.7-3.9). 
As the previous prevalence reports were mostly based on non-representative samples, it helped little to 
know about the true status of the disease in animal populations. The other important aspect like 
estimation of true prevalence, evaluation of serological tests, risk factors of human brucellosis and 
identification of species responsible for brucellosis in humans and animals are not yet addressed in 
Bangladesh. The overall objective of this thesis was to investigate the epidemiology of brucellosis in 
humans and domestic ruminants in Bangladesh in terms of the evaluation of commonly used 
diagnostic tests, estimation of true prevalence, identification of  risk factors and detection of Brucella 
species in order to provide information for appropriate control strategies. 
Bangladesh has 64 districts (sub-division) and crop-livestock mixed farming system dominates all 
over the country as mentioned earlier. Out of 64 districts, Mymensingh was chosen to have a better 
understanding of the epidemiology of brucellosis in humans and domestic ruminants. Mymensingh is 
one of the highest livestock dense (>600/Km
2
) areas in Bangladesh. The studies presented in this 
thesis were mostly Mymensingh district based. So, the findings of the studies will also represent other 
districts especially where small-scale dairy and subsistence/backyard management system prevails. 
Small ruminant serum samples were also collected from other districts as they are not numerous in 
Mymensingh. Milk samples were also collected from Sirajgonj and Chittagong: two important milk 
pockets in Bangladesh. The Central Cattle Breeding and Dairy Farm (CCBDF) is the largest dairy 
farm and the sole government supplier of frozen semen for artificial insemination. The status of 
brucellosis of this herd including breeding bulls and animal caretakers were also investigated. A gayal 
herd under BLRI regional station at Naikhongchari, Bandarban, Bangladesh experienced sporadic 
abortion and thereby also studied for brucellosis.  
So, the brucellosis status in domestic ruminants (cattle, goats and sheep), pyretic and occupationally 
exposed people and in a semi-domestic animal like gayal were revealed and sometimes updated. The 
species of Brucella responsible for brucellosis in humans and animals was also described. 
  




10.1 The estimated true prevalence of brucellosis in domestic ruminants in Bangladesh 
The estimated true median prevalence of brucellosis in goats and sheep were 1.0% (95% CI: 0.7–
1.8%) and 1.2% (95% CI: 0.6–2.2%) respectively. The estimated true prevalence of brucellosis among 
cattle of Mymensingh and Govt. dairy farm were 0.3% (95% CI: 0.03-0.7) and 20.5% (95% CI: 16.4-
26.3) respectively. The prevalence estimated in this study is based on a representative sample of goats 
and sheep and would therefore be applicable to the goats and sheep populations of Bangladesh. 
Similarly, the prevalence structure obtained in Mymensingh district will represent brucellosis status in 
cattle of other districts especially where small-scale dairy and subsistence/backyard management 
system prevails. It is very likely that there might have some reasons for this level of prevalence 
without any intervention. The overall apparent prevalence of brucellosis reported by other authors in 
Bangladesh are 5.3% (4.8-6.2), 2.9% (2.1-4.1) and 5.4% (3.9-7.1) for cattle, goats and sheep respectively 
as shown in Table 3.7 and 3.8. The apparent and true prevalence might vary from each other although 
both relate to exposure status not active infection. All of the previously reported seroprevalences were 
based on non-representative laboratory results. However, in a multi-testing environment along with the 
estimation of true exposure prevalence, the acute or active infection can also be revealed which may help 
as a decision support tool in terms of test and slaughter policy. For example, 0.3% (2/636), 0.8% (8/1044) 
sheep and goats respectively were found to be acutely infected (positive in both SAT and iELISA) with 
brucellosis (Rahman et al., 2013). The estimated true prevalence and acute infection (15.6% i.e. 53/340) 
of bovine brucellosis were very high in Govt. dairy farm. Brucellosis infected animals shed organism not 
only through abortion but also through vaginal discharge, feces, urine and milk (D’anastasio et al., 2011). 
So, culling of acutely infected animals from the population will help to reduce the transmission of the 
disease in animal populations.  
The CCBDF is the herd where highly valuable breeding bulls, pure exotic breeds like Holstein Friesian 
cattle are also maintained. The central AI laboratory is also located within this herd which produces frozen 
semen for the whole country. It seems that the prevalence has been increasing steadily at CCBDF. In 2007 
only one collecting/breeding bull was found RBT positive (Islam et al., 2007) (only bulls were studied) 
and in this study (done in 2008) one breeding bull and two pre-collecting bulls were found to be acutely 
infected in addition to a lot of dairy cattle. Such a high level of exposure prevalence and acute infection in 
this herd is also a serious threat for the other livestock in Bangladesh. After reporting all of these acutely 
infected cattle including the breeding bulls were culled. In such a high level of prevalence, vaccination 
should be initiated immediately to reduce the burden of this disease. 
Prevalence structure may also vary in different regions within a country. Calculating mean prevalence 
at national level is a frequent error of decision makers, as those figures may not reflect local conditions 
(Blasco and Molina-Flores, 2011). Similarly, the control strategy will also vary based on the 
prevalence status in different regions/district. For example, it is recommended to do nothing for further 
control of brucellosis in Mymensingh and similar districts because of very low prevalence. Such a low 
prevalence of this zoonosis may be the result of a balance between host and pathogen due to their 




coexistence for millennia without significant intervention measures to control the disease (Moreno, 
2014). However, sufficient information to decide whether to initiate control strategy for brucellosis in 
dairy rich areas like Sirajgonj, Chittagong, Satkhira, etc., is unavailable. The possible reasons for such 
a low level of prevalence of domestic ruminants may be due to the: 
 large scale slaughter of cattle and small ruminants throughout the year: as already mentioned 
earlier that about 15 million goats and 3.5 million cattle are slaughtered annually in Bangladesh. 
Due to this mass slaughter, brucellosis infected carcass may be removed from the cattle 
populations. This phenomenon resembles test and slaughter method of disease control, the only 
difference is that it is done without brucellosis testing. In such a scenario, the average life span of 
animals will be short in general which was also reflected in this study: the mean (mean ±se) age 
for goats, sheep in Bangladesh and cattle of Mymensingh district were 1.6 ±0.06 years, 2.1 ±0.04 
and 3.72 ±0.09 years respectively. The age at puberty in cattle varies from 2-3 years (Mukasa, 
1989), whereas the average age of puberty in goats and sheep are 6.5 months (Hassan et al., 2007) 
and 8.2 months (Hassan and Talukder, 2011) respectively in Bangladesh. The most important 
clinical manifestation of brucellosis in domestic ruminants is abortion, through which the infection 
spreads from one animal to other, which is less likely in case of shorter life span of animals. The 
shorter life span of animals, the lower the risk of Brucella transmission as this disease is most 
common in sexually mature animals (Reviriego et al., 2000; Solorio-Rivera et al., 2007; Islam et 
al., 2010; Lopes et al., 2010). Moreover, young animals tend to be more resistant to infection and 
they frequently clear infection before puberty (Walker, 1999; Godfroid et al., 2004). 
 the other important factor for low prevalence of brucellosis in livestock is probably infrequent 
abortion in animals due to Brucellosis in Bangladesh: abortion is the main clinical sign of 
brucellosis in sexually mature female domestic ruminants (Lilenbaum et al., 2007; Xavier et al., 
2009). Vaginal discharges, fetal membranes are the most important sources of transmission of this 
disease. Based on the results of this study and also from others, it seems that Brucella is not the 
most important cause of infectious abortion in ruminants in Bangladesh. Brucella abortus or 
Brucella melitensis were not detected from any of the aborted fetal membranes, vaginal swabs 
studied in this study. Similar observations were also made by others (Das et al., 2008; Dey et al., 
2013; Islam et al., 2013c). As a result, the chance of transmission of brucellosis is less likely in the 
animal populations and thereby the low prevalence in animals. 
 the third probable cause of low prevalence of brucellosis in small ruminants may be that only 
Brucella abortus is prevalent in this country. The preferred hosts of B. abortus are cattle and 
buffalo. However, B. abortus may also infect goats and sheep but due to non-preferred host the 
intensity of infection in sheep and goats may be low (Godfroid et al., 2013). The higher apparent 
and true prevalence in sheep may be due to their prolonged lives (less slaughter). 
 
 




10.2 The performance of serological tests for the diagnosis of brucellosis in domestic ruminants 
The Sensitivity, specificity, positive predictive value and negative predictive value of RBT, SAT and 
iELISA in cattle of two locations, sheep and goats are summarized in Table 10.1.  
 
Table 10.1. Performance of RBT, SAT and iELISA for the diagnosis of brucellosis in cattle, 
goats and sheep in Bangladesh 
Test Cattle_Mym. Cattle_Govt.  Goats  Sheep  
 Se (PPV) Sp (NPV) Se (PPV) Sp (NPV) Se (PPV) Sp (NPV) Se (PPV) Sp (NPV) 


























Legend: Mym: Mymensingh, Govt.: Government farm, Se: Sensitivity, Sp: Specificity, PPV:Indicates 
the probability that an animal with positive test truly has the disease, NPV: Indicates the probability 
that an animal with a negative test is truly free from disease. 
 
The PPV and NPV of the tests were calculated using formula 10.2.1 and 10.2.2 based on the Bayes’ 
theorem: 
 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑣𝑒 𝑉𝑎𝑙𝑢𝑒 (𝑃𝑃𝑉) =
𝑆𝑒∗𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 (𝑃𝑟)
𝑆𝑒∗𝑃𝑟 +(1−𝑆𝑝)∗(1−𝑃𝑟)
        (10.2.1) 
𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑖𝑣𝑒 𝑉𝑎𝑙𝑢𝑒 (𝑁𝑃𝑉) =
𝑆𝑝∗(1−𝑃𝑟)
(1−𝑆𝑒)∗𝑃𝑟+𝑆𝑝∗(1−𝑃𝑟)
      (10.2.2)    
 
The performance of iELISA is relatively better in in cattle of Mymensingh and government farm and in 
sheep in terms of sensitivity and specificity. Similarly, the performance of RBT is better in goats. The 
iELISA cut-offs were different in three species of animals (5 IU/ml for cattle, 2 IU/ml for goats and 6 IU/ml 
for sheep). Using a higher cut-off will increase the specificity of iELISA in goats. It is evident from Table 
10.1 that even though the RBT, SAT and iELISA are highly specific the PPV are very low. It indicates that 
majority of the seropositive cattle in Mymensingh are not positive at all. For, example, the PPV of RBT in 
cattle of Mymensingh is 19.9% which means that 80.1% seropositive animals are actually not infected.  
On the other hand, when using the same test but in high prevalence scenario as in CCBDF, the PPV of RBT 
becomes 81.6%. In a low prevalence scenario, the serological test (having a very low PPV) result based 
recommendation of initiating control program may be speculative and misleading as noted from different 
authors (Rahman et al., 2011b; Islam et al., 2013b) in Bangladesh.  




For this reason, after validating three serological tests, it was recommended to do nothing (even not testing 
as it gives very high false positive serological reactions (FPSR)) for the control of brucellosis in 
Mymensingh and to initiate immediate vaccination in govt. dairy farm. However, if testing is required in any 
case, simultaneous use of SAT and iELISA in an animal and their parallel interpretation will increase the 
sensitivity and NPV and their serial interpretation will further increase the specificity and PPV. The NPV 
of all the three tests are very high in all of the three species of livestock in low prevalence area but 
relatively lower in high prevalence area. In essence, the information about PPV and NPV are essential 
for the decision makers and clinicians but their estimation is dependent on three parameters: the 
prevalence of the disease in the population (both PPV and NPV), the sensitivity (NPV) and the 
specificity (PPV) of the tests used. 
 
10.3 The species of Brucella dominant in humans and animals in Bangladesh 
Brucella abortus is the only species detected from humans, cattle, goats and gayal. Species of Brucella 
infecting humans reflects the species prevalent in animals also in that area. Detection of the same 
species from animals also provides further evidence to support preceding hypothesis. Detection of B. 
abortus from 19 humans by PCR (7 milkmen, 7 livestock farmers, 2 house wives, one student, one 
butcher and one veterinary practitioner) originating from Mymensingh, Dhaka, Netrakona and Sherpur 
districts in Bangladesh. Brucella abortus was detected from six animals by PCR (3 dairy cow, one 
dairy goat, one dairy gayal and one bull semen). The detection of Brucella abortus DNA from cattle 
and buffalo sera from other districts in Bangladesh added further evidence in this regard (Rahman et 
al., 2014).  However, isolation from the Brucella abortus DNA positive milk samples was not 
successful in Farrell’s medium. The probable reasons may be that the samples were old, repeatedly 
frozen and thawed for several times and the presence of competing microflora... Indeed, samples 
potentially containing Brucella spp. should be cultured within two hours or, if this is not possible, 
cooled at 2-8
°
C. It can also be stored at -20
°
C by adding several drops of sterile saline to keep the 
tissue moist. Isolation is most likely during the acute phase of infections caused by B. melitensis or B. 
suis and less successful in B. abortus infections. Brucellae are rarely isolated from samples with a 
competing microflora (Corbel, 1997; Al Dahouk et al., 2002).  
The presence of only B. abortus in a country may have some extra advantages over the presence of 
several species Brucella in animals and humans for future control and eradication program in 
Bangladesh. The presence of B. abortus in goats is probably a spill over infection and control of B. 
abortus infection in cattle (preferred host) will suffice to control it in spill over host (Godfroid et al., 
2011). 
Another important advantage is that it is less pathogenic to humans in comparison to Brucella 
melitensis. Isolation, identification and typing of Brucella at biovar is very important to understand the 
prevalent biovars of Brucella abortus in Bangladesh and to trace back the source of infection in an 
outbreak. These findings are important for planning and execution of disease control program also. 




However, if the facility to work with Brucella spp. is absent in a country like Bangladesh, the 
molecular detection of Brucella species from clinical samples is also of paramount importance. 
Indeed, isolation from samples in Bangladesh will add further knowledge of biovar diversity (if any) 
and sources of infection through molecular characterization. 
 
10.4 The prevalence and risk factors of human brucellosis 
The overall prevalence of brucellosis in high risk group and pyretic people in Bangladesh were 4.4% 
and 2.7% respectively based on parallel interpretation of three tests. The important risk factors 
identified are contact with goats and duration of contact with animals. B. abortus was also detected 
from goat milk and goats are sometime kept inside human house especially by poor farmers posing 
them to the risk of infection (Rahman et al., 1988, 2012a). The previously reported higher prevalence 
in humans seems to be for higher FPSR as observed in livestock in Bangladesh in low prevalence area. 
The highest prevalence of brucellosis among HROG was found in milkmen (18.2%) but it was not 
statistically significant. Most of the seropositive milkmen worked in CCBDF where the prevalence of 
cattle brucellosis is very high. 
So, relatively higher prevalence of brucellosis in milkmen may not indicate milking as a risky 
profession in Bangladesh. Consumption of raw milk is very rare and was not significantly associated 
with human brucellosis. So, in Bangladesh the main source of human brucellosis is occupational and 
the impact of brucellosis in general people is relatively lower (Seleem et al., 2010). Livestock farmers, 
butchers, milkmen, veterinary practitioners and AI worker are at risk. Previous reports from 
Bangladesh also support this fact (Rahman et al., 1983, 1988). Awareness building about the risk 
factors of brucellosis among the people at risk through education may also help to reduce the level of 
exposure and thereby the disease (Marcotty et al., 2009). 
The prevalence of human brucellosis is dependent on the burden of the disease in animal populations 
and also the prevailing species of Brucella in animals of that area. For example, when B. abortus is a 
major problem in cattle, seroprevalence in humans are estimated to be in the range of 1.0–5.0% (Swai 
and Schoonman, 2009) but if B. melitensis is endemic as in the middle East, higher prevalence have to 
be expected (Pappas et al., 2006). The prevalence of human brucellosis observed in this study also 
support the above statement. The sole (probably) presence of B. abortus which is less pathogenic to 
humans and also the lower level of prevalence in animals are responsible for the lower prevalence in 
humans. The presence of brucellosis in pyretic patients and HROG people has some diagnostic value 
for the physicians. 
In addition to clinical signs and symptoms, the history of animal contact should help clinicians to refer 
brucellosis testing in HROG and pyretic people. The RBT is recommended for routine screening. 
Along with RBT, serum based rt PCR of the RBT positive patients may also be used for confirmation 
of the serological finding in doubtful cases. 




In high prevalence endemic countries, clinical signs and symptoms suggestive of brucellosis along 
with a positive serological test result suffice for the diagnosis of human brucellosis (CDC, 1997). But 
in low prevalence endemic areas, as there is high probability of FPSR, the serum based genus or 
specific specific rt PCR will help to confirm the serological test result. In this scenario of low 
prevalence, the confirmatory diagnosis is essential otherwise it may lead to useless treatment in 
individuals for 45 days. Other than unjustified costs it may lead to drug toxicity and mask other 
potentially dangerous disease like tuberculosis which is endemic in Bangladesh. In Bangladesh, the rt 
PCR based testing of disease is gradually becoming available in different laboratories. 
 
 







This thesis described the true prevalence of brucellosis in domestic ruminants, the prevalence and risk 
factors of brucellosis in humans and also the species of Brucella prevalent in animals and humans in 
Bangladesh. The results were generated based on the collection and analysis of field data using 
appropriate study design and statistical and molecular methods. The following conclusions can be 
drawn from the thesis: 
 The true exposure prevalence of brucellosis in cattle under small-scale dairy and 
subsistence/backyard management system is very low (0.3%; 95% CI: 0.03-0.7). The active/acute 
infection is also very low (0.29%; 95% CI: 0.06-0.86) and similar to true exposure prevalence. 
The brucellosis in cattle under such management system is naturally controlled and further control 
program is not recommended considering the poor socio-economic condition. The main reason 
behind such low level of prevalence of brucellosis under small-scale dairy and subsistence 
management system is probably mass slaughter of livestock for meat all the year round. Another 
probable reason may be infrequent abortion due to Brucellosis. 
 The true exposure prevalence of brucellosis in government dairy farm (CCBDF) is very high 
(20.5%; 95% CI: 16.4-26.3). The acute infection in this farm is also very high (15.58%; 95% CI: 
11.89-19.89). Immediate control measure by initiating calfhood (female calf) vaccination is 
warranted to protect a valuable herd, which also provides frozen semen for AI all over 
Bangladesh. 
 The SAT and iELISA simultaneously may be applied to know the stage of brucellosis infection in 
domestic ruminants both in high and low prevalence scenario. The iELISA with a new cut-off of 5 
IU/ml may be used both in chronically (as at Mymensingh) and acutely infected cattle population 
(as at the Government Farm) for routine screening. 
 The infection in breeding bulls with brucellosis is a serious hazard for the AI industry. 
 The true exposure prevalence of brucellosis in goats and sheep are also low and around 1%. Due 
to the lower positive predictive value, these test results should be interpreted with caution to avoid 
misleading information. 
 Brucellosis is not a serious problem for the general people in Bangladesh as drinking raw milk is 
unusual and is not a risk factor. The apparent prevalence of brucellosis in a high risk occupationally 
exposed people (4.4%; 95% CI: 2.8-6.6) and in pyretic patients (2.7%; 95% CI: 1.2-5.2) are also low. 
 The RBT may be applied as a screening test in humans having signs and symptoms of brucellosis 
along with the history of animal contact. In case of suspicion, genus or species specific rt PCR 
may be applied for confirmation. 




 Only Brucella abortus is dominant in humans and animals in Bangladesh. Regular screening of 
HROG and pyretic patients with animal contact by serology and species specific rt PCR will 
indirectly help to know further about the species diversity of Brucella in animals in Bangladesh. 
 







While conducting this research, the importance of animal and or herd/flock identification system was 
badly felt to draw random sample from population. Due to the absence of livestock data bank, an 
alternative way of map digitization and selection of livestock farms randomly using hand held GPS 
machine was used. In this study, only one district was studied to understand the epidemiology of 
brucellosis in cattle. The prevalence of a disease vary in different areas due to the variation of animal 
husbandry practices. The milk rich dairy pockets in Bangladesh were not studied extensively where 
the prevalence of this disease may vary from Mymensingh. The isolation of Brucella abortus was not 
possible from old specimens but DNA of B. abortus was detected from human sera and animal 
samples. Based on the above facts, the following recommendations are made: 
 The Department of Livestock Services should initiate animal identification system, which is 
essential for planning research and extension work and also for disease surveillance. The 
notification of abortion should make mandatory and all abortion should be tested. However, the 
legislative support is essential for successful implementation of the above need. 
 The epidemiology of brucellosis in milk rich dairy pockets should be investigated using 
appropriate study design and using both IgM (e.g. SAT) and IgG (e.g. iELISA) detecting tests in 
parallel. Research program for the isolation and identification of Brucella species from humans and 
animals should be conducted to know the species and biovar diversities in Bangladesh. Milk ring 
test positive samples should be preferred over abortion specimens and initially guinea pig 
inoculation technique should be preferred over culture for successful recovery of Brucella 
organism. Isolation of Brucella species from pigs will further help to know whether Brucella suis 
is circulating in Bangladesh as recently 6.7% seroprevalence has been reported in pigs. 
 All infected cattle including breeding bulls should be culled from CCBDF. Immediately, all 
female calves should be vaccinated to protect this valuable herd.  
 Breeding bull should be tested regularly (once a year) for brucellosis. Before introducing for 
semen production, brucellosis status in a bull must be checked rigorously. 
 Collaboration between Department of Livestock Services and Public Health Department in terms 
of research and extension for the further control of this disease is warranted (“one health” 
approach). The activities of the One Health Hub, Bangladesh should be enhanced and brucellosis 
should be included in the priority list. At least one reference laboratory should be established for 
the diagnosis of brucellosis in humans and animals in Bangladesh. People should be educated 
about personal hygiene and risk factors of brucellosis by poster, leaflets and other mass media.  




 Regional cooperation among bordering countries with regard to movement of animals is also 
essential to control this communicable disease. Because, Bangladesh share a common boundary of 
2400 miles with India, which is known as porous, and 40% of the total cattle slaughtered annually 
in Bangladesh illegally come from India. 
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